RPS-BLAST 2.2.26 [Sep-21-2011]

Database: CDD.v3.10 
           44,354 sequences; 10,937,602 total letters

Searching..................................................done

Query= psy8517
         (614 letters)



>gnl|CDD|238006 cd00047, PTPc, Protein tyrosine phosphatases (PTP) catalyze the
           dephosphorylation of phosphotyrosine peptides; they
           regulate phosphotyrosine levels in signal transduction
           pathways. The depth of the active site cleft renders the
           enzyme specific for phosphorylated Tyr (pTyr) residues,
           instead of pSer or pThr. This family has a distinctive
           active site signature motif, HCSAGxGRxG. Characterized
           as either transmembrane, receptor-like or
           non-transmembrane (soluble) PTPs. Receptor-like PTP
           domains tend to occur in two copies in the cytoplasmic
           region of the transmembrane proteins, only one copy may
           be active.
          Length = 231

 Score =  236 bits (605), Expect = 3e-74
 Identities = 78/158 (49%), Positives = 108/158 (68%), Gaps = 3/158 (1%)

Query: 391 KNRYKNILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYIATQGCLPSTMNDFWS 450
           KNRYK+ILP+DHTRVKLK  D+   G++YINA+YI   +  K+YIATQG LP+T+ DFW 
Sbjct: 2   KNRYKDILPYDHTRVKLKPDDD--EGSDYINASYIDGYNPPKAYIATQGPLPNTVEDFWR 59

Query: 451 MVWQENVRVIVMTTKEMERGKNKCAKYWPDDHQSKTYGAVCVNNMYESVTTDYILREFLV 510
           MVW++ V VIVM T+ +E+G+ KCA+YWP++  S TYG + V  + E    DY +R   +
Sbjct: 60  MVWEQKVPVIVMLTELVEKGREKCAQYWPEEEGSLTYGDITVTLVSEEKLDDYTVRTLKL 119

Query: 511 S-KGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
           S  G+   R + H+ +  WPDHGVP  P  +L+ L +V
Sbjct: 120 SNTGTGETRTVTHFQYTGWPDHGVPESPDSLLDLLRKV 157



 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 30/102 (29%)

Query: 99  ILDQIKKH------GPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQHAW 152
           +L +++K       GP+VVHCSAG+GRTGTFI ID++L +++  G    +DI +T++   
Sbjct: 153 LLRKVRKSQQQPGSGPIVVHCSAGVGRTGTFIAIDILLQRLEAEG---VVDIFQTVKE-- 207

Query: 153 FKLKPSTNSSTSLFSITYKPYPNVSGMVQTEAQYKFVYLAVQ 194
             L+            + +P     GMVQTE QY F+Y A+ 
Sbjct: 208 --LR------------SQRP-----GMVQTEEQYIFLYRAIL 230



 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 21/37 (56%), Positives = 30/37 (81%)

Query: 75  SAGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGPVVV 111
            +GP+VVHCSAG+GRTGTFI ID++L +++  G V +
Sbjct: 165 GSGPIVVHCSAGVGRTGTFIAIDILLQRLEAEGVVDI 201


>gnl|CDD|214550 smart00194, PTPc, Protein tyrosine phosphatase, catalytic domain. 
          Length = 259

 Score =  232 bits (594), Expect = 3e-72
 Identities = 86/189 (45%), Positives = 117/189 (61%), Gaps = 5/189 (2%)

Query: 361 GFWEEFESLQQQESRHLFTRREGQKLDNRNKNRYKNILPFDHTRVKLKDVDEDVPGAEYI 420
           G  EEFE L + +     +       +NR+KNRYK++LP+DHTRVKLK       G++YI
Sbjct: 1   GLEEEFEKLDRLKP-DDESCTVAAFPENRDKNRYKDVLPYDHTRVKLKPPPG--EGSDYI 57

Query: 421 NANYIQSEDGGKSYIATQGCLPSTMNDFWSMVWQENVRVIVMTTKEMERGKNKCAKYWPD 480
           NA+YI   +G K+YIATQG LPST+ DFW MVW++ V VIVM T+ +E+G+ KCA+YWPD
Sbjct: 58  NASYIDGPNGPKAYIATQGPLPSTVEDFWRMVWEQKVTVIVMLTELVEKGREKCAQYWPD 117

Query: 481 D-HQSKTYGAVCVNNMYESVTTDYILREFLVSKGSES-PRKIYHYHFQAWPDHGVPSDPG 538
           +  +  TYG + V         DY +R   V+    S  R + HYH+  WPDHGVP  P 
Sbjct: 118 EEGEPLTYGDITVTLKSVEKVDDYTIRTLEVTNTGCSETRTVTHYHYTNWPDHGVPESPE 177

Query: 539 CVLNFLYEV 547
            +L+ +  V
Sbjct: 178 SILDLIRAV 186



 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 28/105 (26%)

Query: 95  VIDMI--LDQIKKH--GPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQH 150
           ++D+I  + + +    GP+VVHCSAG+GRTGTFI ID++L Q++      E+DI   ++ 
Sbjct: 179 ILDLIRAVRKSQSTSTGPIVVHCSAGVGRTGTFIAIDILLQQLEAGK---EVDIFEIVKE 235

Query: 151 AWFKLKPSTNSSTSLFSITYKPYPNVSGMVQTEAQYKFVYLAVQH 195
               L+            + +P     GMVQTE QY F+Y A+  
Sbjct: 236 ----LR------------SQRP-----GMVQTEEQYIFLYRAILE 259



 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 23/41 (56%), Positives = 30/41 (73%)

Query: 71  KYSISAGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGPVVV 111
             S S GP+VVHCSAG+GRTGTFI ID++L Q++    V +
Sbjct: 189 SQSTSTGPIVVHCSAGVGRTGTFIAIDILLQQLEAGKEVDI 229


>gnl|CDD|215717 pfam00102, Y_phosphatase, Protein-tyrosine phosphatase. 
          Length = 233

 Score =  213 bits (545), Expect = 2e-65
 Identities = 74/163 (45%), Positives = 102/163 (62%), Gaps = 7/163 (4%)

Query: 388 NRNKNRYKNILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYIATQGCLPSTMND 447
           N  KNRYK+ILP+DHTRVKL          +YINA+YI      +++IATQG LP+T+ D
Sbjct: 1   NLEKNRYKDILPYDHTRVKLTPGGPS----DYINASYIDGYRKPRAFIATQGPLPNTIED 56

Query: 448 FWSMVWQENVRVIVMTTKEMERGKNKCAKYWPD-DHQSKTYGAVCVNNM-YESVTTDYIL 505
           FW MVW++ V  IVM T+  E+G+ KC +YWP+ +  S TYG + V  +  E    DY +
Sbjct: 57  FWRMVWEQKVTTIVMLTELEEKGREKCDQYWPEEEEGSLTYGDISVTLVKEEEEEDDYTV 116

Query: 506 REFLVSK-GSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
           R F +   GSE  R + H+H+  WPDHGVP  P  +L+ + +V
Sbjct: 117 RTFELKNGGSEETRTVTHFHYTGWPDHGVPESPKSLLDLIRKV 159



 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 37/90 (41%), Positives = 52/90 (57%), Gaps = 24/90 (26%)

Query: 106 HGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQHAWFKLKPSTNSSTSL 165
            GP+VVHCSAG+GRTGTFI ID++L Q++  G   E+D+ + ++     L+         
Sbjct: 168 SGPIVVHCSAGVGRTGTFIAIDILLQQLEAEG---EVDVFQIVKE----LR--------- 211

Query: 166 FSITYKPYPNVSGMVQTEAQYKFVYLAVQH 195
              + +P     GMVQTE QY F+Y AV  
Sbjct: 212 ---SQRP-----GMVQTEEQYIFLYDAVLE 233



 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 23/43 (53%), Positives = 31/43 (72%)

Query: 69  NMKYSISAGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGPVVV 111
             +    +GP+VVHCSAG+GRTGTFI ID++L Q++  G V V
Sbjct: 161 KSQADPRSGPIVVHCSAGVGRTGTFIAIDILLQQLEAEGEVDV 203


>gnl|CDD|198185 cd09931, SH2_C-SH2_SHP_like, C-terminal Src homology 2 (C-SH2)
           domain found in SH2 domain Phosphatases (SHP) proteins. 
           The SH2 domain phosphatases (SHP-1, SHP-2/Syp,
           Drosophila corkscrew (csw), and Caenorhabditis elegans
           Protein Tyrosine Phosphatase (Ptp-2)) are cytoplasmic
           signaling enzymes. They are both targeted and regulated
           by interactions of their SH2 domains with
           phosphotyrosine docking sites. These proteins contain
           two SH2 domains (N-SH2, C-SH2) followed by a tyrosine
           phosphatase (PTP) domain, and a C-terminal extension.
           Shp1 and Shp2 have two tyrosyl phosphorylation sites in
           their C-tails, which are phosphorylated differentially
           by receptor and nonreceptor PTKs. Csw retains the
           proximal tyrosine and Ptp-2 lacks both sites.
           Shp-binding proteins include receptors, scaffolding
           adapters, and inhibitory receptors. Some of these bind
           both Shp1 and Shp2 while others bind only one. Most
           proteins that bind a Shp SH2 domain contain one or more
           immuno-receptor tyrosine-based inhibitory motifs
           (ITIMs): [SIVL]xpYxx[IVL].  Shp1 N-SH2 domain blocks the
           catalytic domain and keeps the enzyme in the inactive
           conformation, and is thus believed to regulate the
           phosphatase activity of SHP-1. Its C-SH2 domain is
           thought to be involved in searching for phosphotyrosine
           activators.  The SHP2 N-SH2 domain is a conformational
           switch; it either binds and inhibits the phosphatase, or
           it binds phosphoproteins and activates the enzyme. The
           C-SH2 domain contributes binding energy and specificity,
           but it does not have a direct role in activation. Csw
           SH2 domain function is essential, but either SH2 domain
           can fulfill this requirement. The role of the csw SH2
           domains during Sevenless receptor tyrosine kinase (SEV)
           signaling is to bind Daughter of Sevenless rather than
           activated SEV. Ptp-2 acts in oocytes downstream of
           sheath/oocyte gap junctions to promote major sperm
           protein (MSP)-induced MAP Kinase (MPK-1)
           phosphorylation. Ptp-2 functions in the oocyte
           cytoplasm, not at the cell surface to inhibit multiple
           RasGAPs, resulting in sustained Ras activation. It is
           thought that MSP triggers PTP-2/Ras activation and ROS
           production to stimulate MPK-1 activity essential for
           oocyte maturation and that secreted MSP domains and
           Cu/Zn superoxide dismutases function antagonistically to
           control ROS and MAPK signaling. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 99

 Score =  180 bits (458), Expect = 2e-54
 Identities = 78/91 (85%), Positives = 85/91 (93%), Gaps = 1/91 (1%)

Query: 248 GKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDD-KVTHVMIRCQAEKYDVGGGEQF 306
           GKEAE+L+L+KGK GSFLVRESQSKPGDFVLSVRTDD KVTH+MIRCQ  KYDVGGGE+F
Sbjct: 9   GKEAEKLLLEKGKPGSFLVRESQSKPGDFVLSVRTDDDKVTHIMIRCQGGKYDVGGGEEF 68

Query: 307 DSLTQLIEHYKRNPMVETSGTVVHLKQPFNA 337
           DSLT L+EHYK+NPMVETSGTVVHLKQP NA
Sbjct: 69  DSLTDLVEHYKKNPMVETSGTVVHLKQPLNA 99



 Score = 30.3 bits (69), Expect = 0.67
 Identities = 14/29 (48%), Positives = 21/29 (72%), Gaps = 2/29 (6%)

Query: 220 IRC--DCYDLYGGEKFATLSELVQFYMEN 246
           IRC    YD+ GGE+F +L++LV+ Y +N
Sbjct: 53  IRCQGGKYDVGGGEEFDSLTDLVEHYKKN 81


>gnl|CDD|227886 COG5599, PTP2, Protein tyrosine phosphatase [Signal transduction
           mechanisms].
          Length = 302

 Score =  129 bits (325), Expect = 3e-33
 Identities = 58/160 (36%), Positives = 82/160 (51%), Gaps = 12/160 (7%)

Query: 383 GQKLDNRN--KNRYKNILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYIATQGC 440
              L + N  +NRY NI+P++HTRV LK         +YINA+YI++  G   YIATQG 
Sbjct: 46  DTSLSSTNYARNRYSNIVPYEHTRVHLKYGKS---INDYINASYIKTPRG--KYIATQGP 100

Query: 441 LPSTMNDFWSMVWQ--ENVRVIVMTTKEMERGKNKCAKYWPDDHQSKT-YGAVCVNNMYE 497
            P T++DFW MVW    N  VIVM T   E  + KC +YWP  +      G   +     
Sbjct: 101 KPETIDDFWKMVWHNVPNNGVIVMLTSLPEYNREKCDQYWPLGYDDTLIIGLRVIKQKKY 160

Query: 498 SVTTD--YILREFLVSKGSESPRKIYHYHFQAWPDHGVPS 535
            +  D    +  F ++  +  P+KI+H+ +  W D  VP 
Sbjct: 161 ELFNDNIVNVHNFELTSINGPPKKIHHFQYINWVDFNVPD 200



 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 36/109 (33%), Positives = 50/109 (45%), Gaps = 19/109 (17%)

Query: 95  VIDMILDQIKKHGPVVVHCSAGIGRTGTFIVIDMILDQ--IKKHGLDCEIDIQRTIQHAW 152
           VI  + D   + GP++VHCSAG+GRTGTFI +D++L       +  D   D Q  I    
Sbjct: 207 VIHSLNDSPVRTGPIIVHCSAGVGRTGTFIALDILLRMPNDTLNHTDTWEDTQDLI---- 262

Query: 153 FKLKPSTNSSTSLFSITYKPYPNVSGMVQTEAQYKFVYLAVQHYIQTLS 201
                      SL S   K       MVQ + Q+KF+Y A     ++  
Sbjct: 263 ------FQIVLSLRSQRMK-------MVQNKTQFKFLYDAFLELNKSQI 298



 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 17/26 (65%), Positives = 23/26 (88%)

Query: 77  GPVVVHCSAGIGRTGTFIVIDMILDQ 102
           GP++VHCSAG+GRTGTFI +D++L  
Sbjct: 219 GPIIVHCSAGVGRTGTFIALDILLRM 244


>gnl|CDD|222923 PHA02738, PHA02738, hypothetical protein; Provisional.
          Length = 320

 Score =  128 bits (322), Expect = 8e-33
 Identities = 58/170 (34%), Positives = 88/170 (51%), Gaps = 6/170 (3%)

Query: 388 NRNKNRYKNILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYIATQGCLPSTMND 447
           NR  NRY + + FDH+RV L     +    +YINANY+   +  K +I  Q     T  D
Sbjct: 49  NRKLNRYLDAVCFDHSRVILP---AERNRGDYINANYVDGFEYKKKFICGQAPTRQTCYD 105

Query: 448 FWSMVWQENVRVIVMTTKEMERGKNKCAKYWPDDHQSK-TYGAVCVNNMYESVTTDYILR 506
           F+ M+W E+V++IVM  K+ E G+ KC  YW D  Q    +G   +          Y+  
Sbjct: 106 FYRMLWMEHVQIIVMLCKKKENGREKCFPYWSDVEQGSIRFGKFKITTTQVETHPHYVKS 165

Query: 507 EFLVSKGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEV--CVNNMYE 554
             L++ G+ + + + H++F AWPDH VP +    LNF+ EV  C   + +
Sbjct: 166 TLLLTDGTSATQTVTHFNFTAWPDHDVPKNTSEFLNFVLEVRQCQKELAQ 215



 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 18/54 (33%), Positives = 31/54 (57%), Gaps = 1/54 (1%)

Query: 560 YILREFLVSKGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEVNTRQ-DIHA 612
           Y+    L++ G+ + + + H++F AWPDH VP +    LNF+ EV   Q ++  
Sbjct: 162 YVKSTLLLTDGTSATQTVTHFNFTAWPDHDVPKNTSEFLNFVLEVRQCQKELAQ 215



 Score = 39.1 bits (91), Expect = 0.004
 Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 28/102 (27%)

Query: 99  ILDQIKKHGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQHAWFKLKPS 158
           I     +  P+VVHC+AG+GRT  + V+D+ +            D   T+        PS
Sbjct: 220 IGHNRLQPPPIVVHCNAGLGRTPCYCVVDISIS---------RFDACATVS------IPS 264

Query: 159 TNSS--TSLFSITYKPYPNVSGMVQTEAQYKFVYLAVQHYIQ 198
             SS     +   + P+           QY F Y AV+ Y+ 
Sbjct: 265 IVSSIRNQRYYSLFIPF-----------QYFFCYRAVKRYVN 295



 Score = 39.1 bits (91), Expect = 0.005
 Identities = 12/21 (57%), Positives = 18/21 (85%)

Query: 78  PVVVHCSAGIGRTGTFIVIDM 98
           P+VVHC+AG+GRT  + V+D+
Sbjct: 229 PIVVHCNAGLGRTPCYCVVDI 249


>gnl|CDD|165109 PHA02742, PHA02742, protein tyrosine phosphatase; Provisional.
          Length = 303

 Score =  112 bits (282), Expect = 1e-27
 Identities = 59/172 (34%), Positives = 84/172 (48%), Gaps = 5/172 (2%)

Query: 378 FTRREGQKLDNRNKNRYKNILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYIAT 437
           F+  E  +L N  K RY +   FD  RV LK  D    G ++INA+Y+   +    +I T
Sbjct: 42  FSCNESLELKNMKKCRYPDAPCFDRNRVILKIEDG---GDDFINASYVDGHNAKGRFICT 98

Query: 438 QGCLPSTMNDFWSMVWQENVRVIVMTTKEMERGKNKCAKYW-PDDHQSKTYGAVCVNNMY 496
           Q  L  T  DFW  ++Q+ VRVIVM TK ME GK  C  YW P +    T+G   +    
Sbjct: 99  QAPLEETALDFWQAIFQDQVRVIVMITKIMEDGKEACYPYWMPHERGKATHGEFKIKTKK 158

Query: 497 ESVTTDYILREF-LVSKGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
                +Y +    L    + +   I H+ ++ WP  G+P DP   L+F+  V
Sbjct: 159 IKSFRNYAVTNLCLTDTNTGASLDIKHFAYEDWPHGGLPRDPNKFLDFVLAV 210



 Score = 39.2 bits (91), Expect = 0.004
 Identities = 15/35 (42%), Positives = 23/35 (65%)

Query: 96  IDMILDQIKKHGPVVVHCSAGIGRTGTFIVIDMIL 130
           +D+  + I K  P++VHCSAG+ R G F  ID+ +
Sbjct: 219 VDIKGENIVKEPPILVHCSAGLDRAGAFCAIDICI 253



 Score = 37.3 bits (86), Expect = 0.016
 Identities = 12/23 (52%), Positives = 17/23 (73%)

Query: 78  PVVVHCSAGIGRTGTFIVIDMIL 100
           P++VHCSAG+ R G F  ID+ +
Sbjct: 231 PILVHCSAGLDRAGAFCAIDICI 253



 Score = 31.1 bits (70), Expect = 1.5
 Identities = 11/32 (34%), Positives = 17/32 (53%)

Query: 577 IYHYHFQAWPDHGVPSDPGCVLNFLYEVNTRQ 608
           I H+ ++ WP  G+P DP   L+F+  V    
Sbjct: 183 IKHFAYEDWPHGGLPRDPNKFLDFVLAVREAD 214


>gnl|CDD|198203 cd10340, SH2_N-SH2_SHP_like, N-terminal Src homology 2 (N-SH2)
           domain found in SH2 domain Phosphatases (SHP) proteins. 
           The SH2 domain phosphatases (SHP-1, SHP-2/Syp,
           Drosophila corkscrew (csw), and Caenorhabditis elegans
           Protein Tyrosine Phosphatase (Ptp-2)) are cytoplasmic
           signaling enzymes. They are both targeted and regulated
           by interactions of their SH2 domains with
           phosphotyrosine docking sites. These proteins contain
           two SH2 domains (N-SH2, C-SH2) followed by a tyrosine
           phosphatase (PTP) domain, and a C-terminal extension.
           Shp1 and Shp2 have two tyrosyl phosphorylation sites in
           their C-tails, which are phosphorylated differentially
           by receptor and nonreceptor PTKs. Csw retains the
           proximal tyrosine and Ptp-2 lacks both sites.
           Shp-binding proteins include receptors, scaffolding
           adapters, and inhibitory receptors. Some of these bind
           both Shp1 and Shp2 while others bind only one. Most
           proteins that bind a Shp SH2 domain contain one or more
           immuno-receptor tyrosine-based inhibitory motifs
           (ITIMs): [IVL]xpYxx[IVL].  Shp1 N-SH2 domain blocks the
           catalytic domain and keeps the enzyme in the inactive
           conformation, and is thus believed to regulate the
           phosphatase activity of SHP-1. Its C-SH2 domain is
           thought to be involved in searching for phosphotyrosine
           activators. The SHP2 N-SH2 domain is a conformational
           switch; it either binds and inhibits the phosphatase, or
           it binds phosphoproteins and activates the enzyme. The
           C-SH2 domain contributes binding energy and specificity,
           but it does not have a direct role in activation. Csw
           SH2 domain function is essential, but either SH2 domain
           can fulfill this requirement. The role of the csw SH2
           domains during Sevenless receptor tyrosine kinase (SEV)
           signaling is to bind Daughter of Sevenless rather than
           activated SEV.  Ptp-2 acts in oocytes downstream of
           sheath/oocyte gap junctions to promote major sperm
           protein (MSP)-induced MAP Kinase (MPK-1)
           phosphorylation. Ptp-2 functions in the oocyte
           cytoplasm, not at the cell surface to inhibit multiple
           RasGAPs, resulting in sustained Ras activation. It is
           thought that MSP triggers PTP-2/Ras activation and ROS
           production to stimulate MPK-1 activity essential for
           oocyte maturation and that secreted MSP domains and
           Cu/Zn superoxide dismutases function antagonistically to
           control ROS and MAPK signaling. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 99

 Score =  100 bits (252), Expect = 1e-25
 Identities = 43/97 (44%), Positives = 63/97 (64%), Gaps = 2/97 (2%)

Query: 242 FYMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVG 301
           F+    G EAE L+  +G +GSFL R S+S PGDF LSVR  D+VTH+ I+   + YD+ 
Sbjct: 3   FHPVISGIEAENLLKTRGVDGSFLARPSKSNPGDFTLSVRRGDEVTHIKIQNTGDYYDLY 62

Query: 302 GGEQFDSLTQLIEHYKRNP--MVETSGTVVHLKQPFN 336
           GGE+F +L++L+++Y      + E +G V+ LK P N
Sbjct: 63  GGEKFATLSELVQYYMEQHGQLREKNGDVIELKYPLN 99



 Score = 66.7 bits (163), Expect = 1e-13
 Identities = 31/61 (50%), Positives = 38/61 (62%), Gaps = 11/61 (18%)

Query: 210 SIQLGREYTNIRC----DCYDLYGGEKFATLSELVQFYMENQGKEAEQLILQKGKNGSFL 265
           S++ G E T+I+     D YDLYGGEKFATLSELVQ+YME  G+  E       KNG  +
Sbjct: 40  SVRRGDEVTHIKIQNTGDYYDLYGGEKFATLSELVQYYMEQHGQLRE-------KNGDVI 92

Query: 266 V 266
            
Sbjct: 93  E 93


>gnl|CDD|165114 PHA02747, PHA02747, protein tyrosine phosphatase; Provisional.
          Length = 312

 Score =  105 bits (263), Expect = 5e-25
 Identities = 54/156 (34%), Positives = 79/156 (50%), Gaps = 5/156 (3%)

Query: 384 QKLDNRNKNRYKNILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYIATQGCLPS 443
           +K +N+ KNRY +I  +DH RV L         ++YI+AN+I   +  K +IATQG    
Sbjct: 47  EKPENQPKNRYWDIPCWDHNRVILDS--GGGSTSDYIHANWIDGFEDDKKFIATQGPFAE 104

Query: 444 TMNDFWSMVWQENVRVIVM-TTKEMERGKNKCAKYW-PDDHQSKTYGAVCVNNMYESVTT 501
           T  DFW  VWQE+  +IVM T  +   G+ KC +YW  ++  +       +  +  SV  
Sbjct: 105 TCADFWKAVWQEHCSIIVMLTPTKGTNGEEKCYQYWCLNEDGNIDMEDFRIETLKTSVRA 164

Query: 502 DYILREF-LVSKGSESPRKIYHYHFQAWPDHGVPSD 536
            YIL    +  K  +  RKI H+    W +   PSD
Sbjct: 165 KYILTLIEITDKILKDSRKISHFQCSEWFEDETPSD 200



 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 15/34 (44%), Positives = 24/34 (70%)

Query: 78  PVVVHCSAGIGRTGTFIVIDMILDQIKKHGPVVV 111
           P+VVHCS G+G+TG F  +D+ L+Q+ K   + +
Sbjct: 231 PIVVHCSDGVGKTGIFCAVDICLNQLVKRKAICL 264



 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 15/28 (53%), Positives = 22/28 (78%)

Query: 108 PVVVHCSAGIGRTGTFIVIDMILDQIKK 135
           P+VVHCS G+G+TG F  +D+ L+Q+ K
Sbjct: 231 PIVVHCSDGVGKTGIFCAVDICLNQLVK 258


>gnl|CDD|215658 pfam00017, SH2, SH2 domain. 
          Length = 77

 Score = 97.3 bits (243), Expect = 1e-24
 Identities = 35/71 (49%), Positives = 48/71 (67%), Gaps = 1/71 (1%)

Query: 247 QGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQA-EKYDVGGGEQ 305
             +EAE+L+L    +G+FLVRES+SKPGD+ LSVR D +V H  I+      Y + GG  
Sbjct: 7   SREEAERLLLNPKPDGTFLVRESESKPGDYTLSVRDDGRVKHYRIQSLDNGGYYISGGVT 66

Query: 306 FDSLTQLIEHY 316
           F+SL +L+EHY
Sbjct: 67  FNSLPELVEHY 77



 Score = 29.5 bits (67), Expect = 1.1
 Identities = 9/19 (47%), Positives = 12/19 (63%)

Query: 225 YDLYGGEKFATLSELVQFY 243
           Y + GG  F +L ELV+ Y
Sbjct: 59  YYISGGVTFNSLPELVEHY 77


>gnl|CDD|214585 smart00252, SH2, Src homology 2 domains.  Src homology 2 domains
           bind phosphotyrosine-containing polypeptides via 2
           surface pockets. Specificity is provided via interaction
           with residues that are distinct from the
           phosphotyrosine. Only a single occurrence of a SH2
           domain has been found in S. cerevisiae.
          Length = 84

 Score = 91.9 bits (229), Expect = 1e-22
 Identities = 36/74 (48%), Positives = 51/74 (68%), Gaps = 2/74 (2%)

Query: 248 GKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAE-KYDVGGGEQF 306
            +EAE+L L+   +G FLVR+S+S PGD+VLSVR   KV H  IR   + K+ + GG +F
Sbjct: 10  REEAEKL-LKNEGDGDFLVRDSESSPGDYVLSVRVKGKVKHYRIRRNEDGKFYLEGGRKF 68

Query: 307 DSLTQLIEHYKRNP 320
            SL +L+EHY++N 
Sbjct: 69  PSLVELVEHYQKNS 82



 Score = 29.1 bits (66), Expect = 1.6
 Identities = 11/22 (50%), Positives = 15/22 (68%)

Query: 225 YDLYGGEKFATLSELVQFYMEN 246
           + L GG KF +L ELV+ Y +N
Sbjct: 60  FYLEGGRKFPSLVELVEHYQKN 81


>gnl|CDD|165113 PHA02746, PHA02746, protein tyrosine phosphatase; Provisional.
          Length = 323

 Score = 90.5 bits (224), Expect = 9e-20
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 29/218 (13%)

Query: 355 ENSSKAGFWE--EFESLQQQESRHLFTRREGQKLDNRNKNRYKNILPFDHTRV------- 405
           + ++ A F E    E  +  +     T     K +N  KNR+ +I  +DH+RV       
Sbjct: 16  DKTNHAKFCEFVLLEHAEVMDIPIRGTTNHFLKKENLKKNRFHDIPCWDHSRVVINAHES 75

Query: 406 -KLKDVDEDVP----------GAEYINANYIQSEDGGKSYIATQGCLPSTMNDFWSMVWQ 454
            K+ DV +                YI+AN++        +I  QG    T  DF+ ++ +
Sbjct: 76  LKMFDVGDSDGKKIEVTSEDNAENYIHANFVDGFKEANKFICAQGPKEDTSEDFFKLISE 135

Query: 455 ENVRVIVMTTKEMERGKNKCAKYW--PDDHQSKTYGAVCVNNM---YESVTTDYILREFL 509
              +VIV  T +++    KC + W   +D +   +G      +    E   T   L   +
Sbjct: 136 HESQVIVSLT-DIDDDDEKCFELWTKEEDSEL-AFGRFVAKILDIIEELSFTKTRLM--I 191

Query: 510 VSKGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
             K S++ R+I+H+ F  WPD+G+P+     L  + +V
Sbjct: 192 TDKISDTSREIHHFWFPDWPDNGIPTGMAEFLELINKV 229



 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 24/97 (24%)

Query: 101 DQIKKHGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQHAWFKLKPSTN 160
           +  +  GP+VVHCSAGIGR GTF  ID  L+Q++K   + E+ +   +     K++   +
Sbjct: 242 NDPQTLGPIVVHCSAGIGRAGTFCAIDNALEQLEK---EKEVCLGEIV----LKIRKQRH 294

Query: 161 SSTSLFSITYKPYPNVSGMVQTEAQYKFVYLAVQHYI 197
           SS  L                   QY F Y A+++ I
Sbjct: 295 SSVFL-----------------PEQYAFCYKALKYAI 314



 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 21/39 (53%), Positives = 27/39 (69%)

Query: 73  SISAGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGPVVV 111
             + GP+VVHCSAGIGR GTF  ID  L+Q++K   V +
Sbjct: 244 PQTLGPIVVHCSAGIGRAGTFCAIDNALEQLEKEKEVCL 282



 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 16/46 (34%), Positives = 27/46 (58%)

Query: 563 REFLVSKGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEVNTRQ 608
           R  +  K S++ R+I+H+ F  WPD+G+P+     L  + +VN  Q
Sbjct: 188 RLMITDKISDTSREIHHFWFPDWPDNGIPTGMAEFLELINKVNEEQ 233


>gnl|CDD|198173 cd00173, SH2, Src homology 2 (SH2) domain.  In general, SH2 domains
           are involved in signal transduction; they bind
           pTyr-containing polypeptide ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites. They are present in a wide array
           of proteins including: adaptor proteins (Nck1, Crk,
           Grb2), scaffolds (Slp76, Shc, Dapp1), kinases (Src, Syk,
           Fps, Tec), phosphatases (Shp-1, Shp-2), transcription
           factors (STAT1),  Ras signaling molecules (Ras-Gap),
           ubiquitination factors (c-Cbl), cytoskeleton regulators
           (Tensin), signal regulators (SAP), and phospholipid
           second messengers (PLCgamma), amongst others.
          Length = 79

 Score = 76.7 bits (189), Expect = 2e-17
 Identities = 35/71 (49%), Positives = 47/71 (66%), Gaps = 4/71 (5%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTD-DKVTHVMIRCQAEKYDVGGGE--Q 305
           +EAE+L L+   +G+FLVRES S+PGD+VLSVR+   KV H +I      Y + GG    
Sbjct: 10  EEAERL-LRGKPDGTFLVRESSSEPGDYVLSVRSGDGKVKHYLIERNEGGYYLLGGSGRT 68

Query: 306 FDSLTQLIEHY 316
           F SL +L+EHY
Sbjct: 69  FPSLPELVEHY 79


>gnl|CDD|198190 cd09937, SH2_csk_like, Src homology 2 (SH2) domain found in
           Carboxyl-Terminal Src Kinase (Csk).  Both the C-terminal
           Src kinase (CSK) and CSK-homologous kinase (CHK) are
           members of the CSK-family of protein tyrosine kinases.
           These proteins suppress activity of Src-family kinases
           (SFK) by selectively phosphorylating the conserved
           C-terminal tail regulatory tyrosine by a similar
           mechanism. CHK is also capable of inhibiting SFKs by a
           non-catalytic mechanism that involves binding of CHK to
           SFKs to form stable protein complexes. The
           unphosphorylated form of SFKs is inhibited by CSK and
           CHK by a two-step mechanism. The first step involves the
           formation of a complex of SFKs with CSK/CHK with the
           SFKs in the complex are inactive. The second step,
           involves the phosphorylation of the C-terminal tail
           tyrosine of SFKs, which then dissociates and adopt an
           inactive conformation. The structural basis of how the
           phosphorylated SFKs dissociate from CSK/CHK to adopt the
           inactive conformation is not known. The inactive
           conformation of SFKs is stabilized by two intramolecular
           inhibitory interactions: (a) the pYT:SH2 interaction in
           which the phosphorylated C-terminal tail tyrosine (YT)
           binds to the SH2 domain, and (b) the linker:SH3
           interaction of which the SH2-kinase domain linker binds
           to the SH3 domain. SFKs are activated by multiple
           mechanisms including binding of the ligands to the SH2
           and SH3 domains to displace the two inhibitory
           intramolecular interactions, autophosphorylation, and
           dephosphorylation of YT. By selective phosphorylation
           and the non-catalytic inhibitory mechanism CSK and CHK
           are able to inhibit the active forms of SFKs. CSK and
           CHK are regulated by phosphorylation and inter-domain
           interactions. They both contain SH3, SH2, and kinase
           domains separated by the SH3-SH2 connector and SH2
           kinase linker, intervening segments separating the three
           domains. They lack a conserved tyrosine phosphorylation
           site in the kinase domain and the C-terminal tail
           regulatory tyrosine phosphorylation site. The CSK SH2
           domain is crucial for stabilizing the kinase domain in
           the active conformation. A disulfide bond here regulates
           CSK kinase activity. The subcellular localization and
           activity of CSK are regulated by its SH2 domain. In
           general SH2 domains are involved in signal transduction.
            They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 98

 Score = 73.9 bits (182), Expect = 3e-16
 Identities = 30/72 (41%), Positives = 45/72 (62%), Gaps = 1/72 (1%)

Query: 248 GKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFD 307
            +EAE+L LQ  ++G FLVRES + PGD+ L V  + KV H  +  +  K  +   E F+
Sbjct: 12  REEAERL-LQPPEDGLFLVRESTNYPGDYTLCVSFEGKVEHYRVIYRNGKLTIDEEEYFE 70

Query: 308 SLTQLIEHYKRN 319
           +L QL+EHY ++
Sbjct: 71  NLIQLVEHYTKD 82


>gnl|CDD|214649 smart00404, PTPc_motif, Protein tyrosine phosphatase, catalytic
           domain motif. 
          Length = 105

 Score = 74.3 bits (183), Expect = 3e-16
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 23/92 (25%)

Query: 102 QIKKHGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQHAWFKLKPSTNS 161
           Q +  GPVVVHCSAG+GRTGTF+ ID++L Q++      E+DI  T++     L+     
Sbjct: 35  QSESSGPVVVHCSAGVGRTGTFVAIDILLQQLEAE--AGEVDIFDTVKE----LRSQRP- 87

Query: 162 STSLFSITYKPYPNVSGMVQTEAQYKFVYLAV 193
                           GMVQTE QY F+Y A+
Sbjct: 88  ----------------GMVQTEEQYLFLYRAL 103



 Score = 42.0 bits (99), Expect = 6e-05
 Identities = 14/39 (35%), Positives = 19/39 (48%)

Query: 576 KIYHYHFQAWPDHGVPSDPGCVLNFLYEVNTRQDIHAGN 614
            + HYH+  WPDHGVP  P  +L  L  V    +    +
Sbjct: 1   TVKHYHYTGWPDHGVPESPDSILELLRAVKKNLNQSESS 39



 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 14/29 (48%), Positives = 17/29 (58%)

Query: 519 KIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
            + HYH+  WPDHGVP  P  +L  L  V
Sbjct: 1   TVKHYHYTGWPDHGVPESPDSILELLRAV 29


>gnl|CDD|214469 smart00012, PTPc_DSPc, Protein tyrosine phosphatase, catalytic
           domain, undefined specificity.  Protein tyrosine
           phosphatases. Homologues detected by this profile and
           not by those of "PTPc" or "DSPc" are predicted to be
           protein phosphatases with a similar fold to DSPs and
           PTPs, yet with unpredicted specificities.
          Length = 105

 Score = 74.3 bits (183), Expect = 3e-16
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 23/92 (25%)

Query: 102 QIKKHGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGLDCEIDIQRTIQHAWFKLKPSTNS 161
           Q +  GPVVVHCSAG+GRTGTF+ ID++L Q++      E+DI  T++     L+     
Sbjct: 35  QSESSGPVVVHCSAGVGRTGTFVAIDILLQQLEAE--AGEVDIFDTVKE----LRSQRP- 87

Query: 162 STSLFSITYKPYPNVSGMVQTEAQYKFVYLAV 193
                           GMVQTE QY F+Y A+
Sbjct: 88  ----------------GMVQTEEQYLFLYRAL 103



 Score = 42.0 bits (99), Expect = 6e-05
 Identities = 14/39 (35%), Positives = 19/39 (48%)

Query: 576 KIYHYHFQAWPDHGVPSDPGCVLNFLYEVNTRQDIHAGN 614
            + HYH+  WPDHGVP  P  +L  L  V    +    +
Sbjct: 1   TVKHYHYTGWPDHGVPESPDSILELLRAVKKNLNQSESS 39



 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 14/29 (48%), Positives = 17/29 (58%)

Query: 519 KIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
            + HYH+  WPDHGVP  P  +L  L  V
Sbjct: 1   TVKHYHYTGWPDHGVPESPDSILELLRAV 29


>gnl|CDD|199827 cd09933, SH2_Src_family, Src homology 2 (SH2) domain found in the
           Src family of non-receptor tyrosine kinases.  The Src
           family kinases are nonreceptor tyrosine kinases that
           have been implicated in pathways regulating
           proliferation, angiogenesis, invasion and metastasis,
           and bone metabolism. It is thought that transforming
           ability of Src is linked to its ability to activate key
           signaling molecules in these pathways, rather than
           through direct activity. As such blocking Src activation
           has been a target for drug companies. Src family members
           can be divided into 3 groups based on their expression
           pattern: 1) Src, Fyn, and Yes; 2)  Blk, Fgr, Hck, Lck,
           and Lyn; and 3) Frk-related kinases Frk/Rak and Iyk/Bsk
           Of these, cellular c-Src is the best studied and most
           frequently implicated in oncogenesis. The c-Src contains
           five distinct regions: a unique N-terminal domain, an
           SH3 domain, an SH2 domain, a kinase domain and a
           regulatory tail, as do the other members of the family.
           Src exists in both active and inactive conformations.
           Negative regulation occurs through phosphorylation of
           Tyr, resulting in an intramolecular association between
           phosphorylated Tyr and the SH2 domain of SRC, which
           locks the protein in a closed conformation. Further
           stabilization of the inactive state occurs through
           interactions between the SH3 domain and a proline-rich
           stretch of residues within the kinase domain.
           Conversely, dephosphorylation of Tyr allows SRC to
           assume an open conformation. Full activity requires
           additional autophosphorylation of a Tyr residue within
           the catalytic domain. Loss of the negative-regulatory
           C-terminal segment has been shown to result in increased
           activity and transforming potential. Phosphorylation of
           the C-terminal Tyr residue by C-terminal Src kinase
           (Csk) and Csk homology kinase results in increased
           intramolecular interactions and consequent Src
           inactivation. Specific phosphatases, protein tyrosine
           phosphatase a (PTPa) and the SH-containing phosphatases
           SHP1/SHP2, have also been shown to take a part in Src
           activation. Src is also activated by direct binding of
           focal adhesion kinase (Fak) and Crk-associated substrate
           (Cas) to the SH2 domain. SRC activity can also be
           regulated by numerous receptor tyrosine kinases (RTKs),
           such as Her2, epidermal growth factor receptor (EGFR),
           fibroblast growth factor receptor, platelet-derived
           growth factor receptor (PDGFR), and vascular endothelial
           growth factor receptor (VEGFR). In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 101

 Score = 69.9 bits (172), Expect = 8e-15
 Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 15/82 (18%)

Query: 249 KEAE-QLILQKGKNGSFLVRESQSKPGDFVLSVRTDDK-----VTHVMIRCQAEKYDVGG 302
           K+AE  L+      G+FL+RES++ PG + LSVR  D      V H  IR    K D GG
Sbjct: 13  KDAEKLLLAPGNPRGTFLIRESETTPGAYSLSVRDGDDARGDTVKHYRIR----KLDNGG 68

Query: 303 G-----EQFDSLTQLIEHYKRN 319
                   F +L +L++HY ++
Sbjct: 69  YYITTRATFPTLQELVQHYSKD 90


>gnl|CDD|198189 cd09935, SH2_ABL, Src homology 2 (SH2) domain found in Abelson
           murine lymphosarcoma virus (ABL) proteins.  ABL-family
           proteins are highly conserved tyrosine kinases. Each ABL
           protein contains an SH3-SH2-TK (Src homology 3-Src
           homology 2-tyrosine kinase) domain cassette, which
           confers autoregulated kinase activity and is common
           among nonreceptor tyrosine kinases. Several types of
           posttranslational modifications control ABL catalytic
           activity, subcellular localization, and stability, with
           consequences for both cytoplasmic and nuclear ABL
           functions. Binding partners provide additional
           regulation of ABL catalytic activity, substrate
           specificity, and downstream signaling. By combining this
           cassette with actin-binding and -bundling domain, ABL
           proteins are capable of connecting phosphoregulation
           with actin-filament reorganization. Vertebrate paralogs,
           ABL1 and ABL2, have evolved to perform specialized
           functions. ABL1 includes nuclear localization signals
           and a DNA binding domain which is used to mediate DNA
           damage-repair functions, while ABL2 has additional
           binding capacity for actin and for microtubules to
           enhance its cytoskeletal remodeling functions.  SH2 is
           involved in several autoinhibitory mechanism that
           constrain the enzymatic activity of the ABL-family
           kinases. In one mechanism SH2 and SH3 cradle the kinase
           domain while a cap sequence stabilizes the inactive
           conformation resulting in a locked inactive state.
           Another involves phosphatidylinositol 4,5-bisphosphate
           (PIP2) which binds the SH2 domain through residues
           normally required for phosphotyrosine binding in the
           linker segment between the SH2 and kinase domains. The
           SH2 domain contributes to ABL catalytic activity and
           target site specificity. It is thought that the ABL
           catalytic site and SH2 pocket have coevolved to
           recognize the same sequences. Recent work now supports a
           hierarchical processivity model in which the substrate
           target site most compatible with ABL kinase domain
           preferences is phosphorylated with greatest efficiency.
           If this site is compatible with the ABL SH2 domain
           specificity, it will then reposition and dock in the SH2
           pocket. This mechanism also explains how ABL kinases
           phosphorylates poor targets on the same substrate if
           they are properly positioned and how relatively poor
           substrate proteins might be recruited to ABL through a
           complex with strong substrates that can also dock with
           the SH2 pocket. In general SH2 domains are involved in
           signal transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 94

 Score = 68.2 bits (167), Expect = 3e-14
 Identities = 28/74 (37%), Positives = 45/74 (60%), Gaps = 1/74 (1%)

Query: 248 GKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAE-KYDVGGGEQF 306
            + A + +L  G NGSFLVRES+S PG + +S+R D +V H  I   ++ K  V    +F
Sbjct: 11  SRNAAEYLLSSGINGSFLVRESESSPGQYSISLRYDGRVYHYRISEDSDGKVYVTQEHRF 70

Query: 307 DSLTQLIEHYKRNP 320
           ++L +L+ H+ +N 
Sbjct: 71  NTLAELVHHHSKNA 84


>gnl|CDD|199829 cd10341, SH2_N-SH2_PLC_gamma_like, N-terminal Src homology 2
           (N-SH2) domain in Phospholipase C gamma.  Phospholipase
           C gamma is a signaling molecule that is recruited to the
           C-terminal tail of the receptor upon autophosphorylation
           of a highly conserved tyrosine.  PLCgamma is composed of
           a Pleckstrin homology (PH) domain followed by an
           elongation factor (EF) domain, 2 catalytic regions of
           PLC domains that flank 2 tandem SH2 domains (N-SH2,
           C-SH2), and ending with a SH3 domain and C2 domain.
           N-SH2 SH2 domain-mediated interactions represent a
           crucial step in transmembrane signaling by receptor
           tyrosine kinases. SH2 domains recognize phosphotyrosine
           (pY) in the context of particular sequence motifs in
           receptor phosphorylation sites. Both N-SH2 and C-SH2
           have a very similar binding affinity to pY. But in
           growth factor stimulated cells these domains bind to
           different target proteins. N-SH2 binds to pY containing
           sites in the C-terminal tails of tyrosine kinases and
           other receptors. Recently it has been shown that this
           interaction is mediated by phosphorylation-independent
           interactions between a secondary binding site found
           exclusively on the N-SH2 domain and a region of the
           FGFR1 tyrosine kinase domain. This secondary site on the
           SH2 cooperates with the canonical pY site to regulate
           selectivity in mediating a specific cellular process.
           C-SH2 binds to an intramolecular site on PLCgamma itself
           which allows it to hydrolyze
           phosphatidylinositol-4,5-bisphosphate into
           diacylglycerol and inositol triphosphate. These then
           activate protein kinase C and release calcium. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 99

 Score = 67.4 bits (165), Expect = 6e-14
 Identities = 34/79 (43%), Positives = 52/79 (65%), Gaps = 6/79 (7%)

Query: 249 KEAEQLILQ--KGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAE----KYDVGG 302
            EAE+L+L+  +G +G+FLVRES++  GD+ LS   + KV H  IR + E    KY +  
Sbjct: 16  DEAEKLLLEYCEGGDGTFLVRESETFVGDYTLSFWRNGKVQHCRIRSRQENGEKKYYLTD 75

Query: 303 GEQFDSLTQLIEHYKRNPM 321
              FDSL +LI++Y++NP+
Sbjct: 76  NLVFDSLYELIDYYRQNPL 94


>gnl|CDD|165107 PHA02740, PHA02740, protein tyrosine phosphatase; Provisional.
          Length = 298

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 37/180 (20%), Positives = 72/180 (40%), Gaps = 29/180 (16%)

Query: 382 EGQKLDNRNKNRYKN------ILPFDHTRVKLKDVDEDVPGAEYINANYIQSEDGGKSYI 435
           E  K   + +N+ K+      I    H R+KL + DE V     ++A ++   D  + +I
Sbjct: 41  EANKACAQAENKAKDENLALHITRLLHRRIKLFN-DEKV-----LDARFVDGYDFEQKFI 94

Query: 436 ATQGCLPSTMNDFWSMVWQENVRVIVMTTKEMERGKNKCAKYWPDDHQSKTYGAVCVNNM 495
                     + F   +    V++IV+ ++  +  K    ++W     S   G V  ++ 
Sbjct: 95  CIINLCEDACDKFLQALSDNKVQIIVLISRHAD--KKCFNQFW-----SLKEGCVITSDK 147

Query: 496 YESVTTDYILREFLV--------SKGSESPRKIYHYHFQAWPDHGVPSDPGCVLNFLYEV 547
           ++  T + I++              G    +KI H+ + AWP  G   DP   ++F   +
Sbjct: 148 FQIETLEIIIKPHFNLTLLSLTDKFGQA--QKISHFQYTAWPADGFSHDPDAFIDFFCNI 205



 Score = 33.0 bits (75), Expect = 0.41
 Identities = 12/51 (23%), Positives = 21/51 (41%), Gaps = 5/51 (9%)

Query: 93  FIVIDMILD-----QIKKHGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGL 138
             + D+  D        K  P+++ C  GI  +  F V D+   +  K G+
Sbjct: 203 CNIDDLCADLEKHKADGKIAPIIIDCIDGISSSAVFCVFDICATEFDKTGM 253



 Score = 29.9 bits (67), Expect = 4.0
 Identities = 9/31 (29%), Positives = 15/31 (48%)

Query: 77  GPVVVHCSAGIGRTGTFIVIDMILDQIKKHG 107
            P+++ C  GI  +  F V D+   +  K G
Sbjct: 222 APIIIDCIDGISSSAVFCVFDICATEFDKTG 252


>gnl|CDD|199828 cd09941, SH2_Grb2_like, Src homology 2 domain found in Growth
           factor receptor-bound protein 2 (Grb2) and similar
           proteins.  The adaptor proteins here include homologs
           Grb2 in humans, Sex muscle abnormal protein 5 (Sem-5) in
           Caenorhabditis elegans, and Downstream of receptor
           kinase (drk) in Drosophila melanogaster. They are
           composed of one SH2 and two SH3 domains. Grb2/Sem-5/drk
           regulates the Ras pathway by linking the tyrosine
           kinases to the Ras guanine nucleotide releasing protein
           Sos, which converts Ras to the active GTP-bound state.
           The SH2 domain of Grb2/Sem-5/drk binds class II
           phosphotyrosyl peptides while its SH3 domain binds to
           Sos and Sos-derived, proline-rich peptides. Besides it
           function in Ras signaling, Grb2 is also thought to play
           a role in apoptosis. Unlike most SH2 structures in which
           the peptide binds in an extended conformation (such that
           the +3 peptide residue occupies a hydrophobic pocket in
           the protein, conferring a modest degree of selectivity),
           Grb2 forms several hydrogen bonds via main chain atoms
           with the side chain of +2 Asn. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 95

 Score = 63.4 bits (155), Expect = 1e-12
 Identities = 27/72 (37%), Positives = 48/72 (66%), Gaps = 2/72 (2%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQFDS 308
           EAE++++ +  +G+FL+RES+S PGDF LSV+  + V H  + R  A KY +    +F+S
Sbjct: 14  EAEEILMNQRPDGAFLIRESESSPGDFSLSVKFGNDVQHFKVLRDGAGKYFL-WVVKFNS 72

Query: 309 LTQLIEHYKRNP 320
           L +L+++++   
Sbjct: 73  LNELVDYHRTTS 84


>gnl|CDD|198210 cd10347, SH2_Nterm_shark_like, N-terminal Src homology 2 (SH2)
           domain found in SH2 domains, ANK, and kinase domain
           (shark) proteins.  These non-receptor protein-tyrosine
           kinases contain two SH2 domains, five ankyrin (ANK)-like
           repeats, and a potential tyrosine phosphorylation site
           in the carboxyl-terminal tail which resembles the
           phosphorylation site in members of the src family. Like,
           mammalian non-receptor protein-tyrosine kinases, ZAP-70
           and syk proteins, they do not have SH3 domains. However,
           the presence of ANK makes these unique among
           protein-tyrosine kinases. Both tyrosine kinases and ANK
           repeats have been shown to transduce developmental
           signals, and SH2 domains are known to participate
           intimately in tyrosine kinase signaling. These tyrosine
           kinases are believed to be involved in epithelial cell
           polarity. The members of this family include the shark
           (SH2 domains, ANK, and kinase domain) gene in Drosophila
           and yellow fever mosquitos, as well as the hydra protein
           HTK16. Drosophila Shark is proposed to transduce
           intracellularly the Crumbs, a protein necessary for
           proper organization of ectodermal epithelia,
           intercellular signal. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 81

 Score = 62.8 bits (153), Expect = 2e-12
 Identities = 32/70 (45%), Positives = 40/70 (57%), Gaps = 3/70 (4%)

Query: 250 EAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEK--YDVGGGEQF 306
            AE L+L++G  +G FLVRES S PGD+VLS+    +V H  IR   E   +   G   F
Sbjct: 12  VAEALLLREGGRDGLFLVRESTSAPGDYVLSLLAQGEVLHYQIRRHGEDAFFSDDGPLIF 71

Query: 307 DSLTQLIEHY 316
             L  LIEHY
Sbjct: 72  HGLDTLIEHY 81


>gnl|CDD|198186 cd09932, SH2_C-SH2_PLC_gamma_like, C-terminal Src homology 2
           (C-SH2) domain in Phospholipase C gamma.  Phospholipase
           C gamma is a signaling molecule that is recruited to the
           C-terminal tail of the receptor upon autophosphorylation
           of a highly conserved tyrosine. PLCgamma is composed of
           a Pleckstrin homology (PH) domain followed by an
           elongation factor (EF) domain, 2 catalytic regions of
           PLC domains that flank 2 tandem SH2 domains (N-SH2,
           C-SH2), and ending with a SH3 domain and C2 domain.
           N-SH2 SH2 domain-mediated interactions represent a
           crucial step in transmembrane signaling by receptor
           tyrosine kinases. SH2 domains recognize phosphotyrosine
           (pY) in the context of particular sequence motifs in
           receptor phosphorylation sites. Both N-SH2 and C-SH2
           have a very similar binding affinity to pY. But in
           growth factor stimulated cells these domains bind to
           different target proteins. N-SH2 binds to pY containing
           sites in the C-terminal tails of tyrosine kinases and
           other receptors. Recently it has been shown that this
           interaction is mediated by phosphorylation-independent
           interactions between a secondary binding site found
           exclusively on the N-SH2 domain and a region of the
           FGFR1 tyrosine kinase domain. This secondary site on the
           SH2 cooperates with the canonical pY site to regulate
           selectivity in mediating a specific cellular process.
           C-SH2 binds to an intramolecular site on PLCgamma itself
           which allows it to hydrolyze
           phosphatidylinositol-4,5-bisphosphate into
           diacylglycerol and inositol triphosphate. These then
           activate protein kinase C and release calcium. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 104

 Score = 63.1 bits (154), Expect = 3e-12
 Identities = 26/87 (29%), Positives = 54/87 (62%), Gaps = 5/87 (5%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSL 309
           +AE+++++  ++G+FLVR S++ P  F +S R + K+ H  I+ +   + + G  QF+SL
Sbjct: 15  QAEEMLMRVPRDGAFLVRPSETDPNSFAISFRAEGKIKHCRIKQEGRLFVI-GTSQFESL 73

Query: 310 TQLIEHYKRNPMVETSGTVVHLKQPFN 336
            +L+ +Y+++P+       + L+ P N
Sbjct: 74  VELVSYYEKHPLYRK----IKLRYPVN 96


>gnl|CDD|198233 cd10370, SH2_Src_Src42, Src homology 2 (SH2) domain found in the
           Src oncogene at 42A (Src42).  Src42 is a member of the
           Src non-receptor type tyrosine kinase family of
           proteins. The integration of receptor tyrosine
           kinase-induced RAS and Src42 signals by Connector
           eNhancer of KSR (CNK) as a two-component input is
           essential for RAF activation in Drosophila. Src42 is
           present in a wide variety of organisms including:
           California sea hare, pea aphid, yellow fever mosquito,
           honey bee, Panamanian leafcutter ant, and sea urchin.
           Src42 has a unique N-terminal domain, an SH3 domain, an
           SH2 domain, a kinase domain and a regulatory tail, as do
           the other members of the family. Like the other members
           of the Src family the SH2 domain in addition to binding
           the target, also plays an autoinhibitory role by binding
           to its C-terminal tail.  In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 96

 Score = 62.5 bits (152), Expect = 3e-12
 Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 14/91 (15%)

Query: 250 EAEQ-LILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGG-----G 303
           EAE+ L+L + ++G+FL+R+S+S+  D+ LSVR  D V H  IR    + D GG      
Sbjct: 14  EAEKKLLLPENEHGAFLIRDSESRHNDYSLSVRDGDTVKHYRIR----QLDEGGFFIARR 69

Query: 304 EQFDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
             F +L +L+EHY +    ++ G  V+L++P
Sbjct: 70  TTFRTLQELVEHYSK----DSDGLCVNLRKP 96


>gnl|CDD|198218 cd10355, SH2_DAPP1_BAM32_like, Src homology 2 domain found in dual
           adaptor for phosphotyrosine and 3-phosphoinositides (
           DAPP1)/B lymphocyte adaptor molecule of 32 kDa
           (Bam32)-like proteins.  DAPP1/Bam32 contains a putative
           myristoylation site at its N-terminus, followed by a SH2
           domain, and a pleckstrin homology (PH) domain at its
           C-terminus. DAPP1 could potentially be recruited to the
           cell membrane by any of these domains. Its putative
           myristoylation site could facilitate the interaction of
           DAPP1 with the lipid bilayer. Its SH2 domain may also
           interact with phosphotyrosine residues on
           membrane-associated proteins such as activated tyrosine
           kinase receptors. And finally its PH domain exhibits a
           high-affinity interaction with the PtdIns(3,4,5)P(3)
           PtdIns(3,4)P(2) second messengers produced at the cell
           membrane following the activation of PI 3-kinases. DAPP1
           is thought to interact with both tyrosine phosphorylated
           proteins and 3-phosphoinositides and therefore may play
           a role in regulating the location and/or activity of
           such proteins(s) in response to agonists that elevate
           PtdIns(3,4,5)P(3) and PtdIns(3,4)P(2). This protein is
           likely to play an important role in triggering signal
           transduction pathways that lie downstream from receptor
           tyrosine kinases and PI 3-kinase. It is likely that
           DAPP1 functions as an adaptor to recruit other proteins
           to the plasma membrane in response to extracellular
           signals. In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 92

 Score = 62.1 bits (151), Expect = 4e-12
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 1/76 (1%)

Query: 251 AEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSLT 310
           AE L+L  G +GS+L+R S    G F LSVR  D V H  +      +  G  E F SL 
Sbjct: 18  AEALLLSNGVDGSYLLRNSNEGTGLFSLSVRAKDSVKHFHVEYTGYSFKFGFNE-FSSLQ 76

Query: 311 QLIEHYKRNPMVETSG 326
             ++H+   P++ +  
Sbjct: 77  DFVKHFANQPLIGSET 92


>gnl|CDD|198224 cd10361, SH2_Fps_family, Src homology 2 (SH2) domain found in
           feline sarcoma, Fujinami poultry sarcoma, and
           fes-related (Fes/Fps/Fer) proteins.  The Fps family
           consists of members Fps/Fes and Fer/Flk/Tyk3. They are
           cytoplasmic protein-tyrosine kinases implicated in
           signaling downstream from cytokines, growth factors and
           immune receptors.  Fes/Fps/Fer contains three
           coiled-coil regions, an SH2 (Src-homology-2) and a TK
           (tyrosine kinase catalytic) domain signature. Members
           here include: Fps/Fes, Fer, Kin-31, and  In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 90

 Score = 60.2 bits (147), Expect = 2e-11
 Identities = 25/73 (34%), Positives = 41/73 (56%), Gaps = 6/73 (8%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGD---FVLSVRTDDKVTHVMIRCQAEKYDVGGGEQF 306
           +AE+L+     +G FLVR+++ K G     VLSVR D K+ H +I           G+ F
Sbjct: 17  DAEELLK---NDGDFLVRKTEPKGGGKRKLVLSVRWDGKIRHFVINRDDGGKYYIEGKSF 73

Query: 307 DSLTQLIEHYKRN 319
            S+++LI +Y++ 
Sbjct: 74  KSISELINYYQKT 86


>gnl|CDD|198217 cd10354, SH2_Cterm_RasGAP, C-terminal Src homology 2 (SH2) domain
           found in Ras GTPase-activating protein 1 (GAP).  RasGAP
           is part of the GAP1 family of GTPase-activating
           proteins. The protein is located in the cytoplasm and
           stimulates the GTPase activity of normal RAS p21, but
           not its oncogenic counterpart. Acting as a suppressor of
           RAS function, the protein enhances the weak intrinsic
           GTPase activity of RAS proteins resulting in RAS
           inactivation, thereby allowing control of cellular
           proliferation and differentiation. Mutations leading to
           changes in the binding sites of either protein are
           associated with basal cell carcinomas. Alternative
           splicing results in two isoforms. The shorter isoform
           which lacks the N-terminal hydrophobic region, has the
           same activity, and is expressed in placental tissues.
           In general longer isoform contains 2 SH2 domains, a SH3
           domain, a pleckstrin homology (PH) domain, and a
           calcium-dependent phospholipid-binding C2 domain. The
           C-terminus contains the catalytic domain of RasGap which
           catalyzes the activation of Ras by hydrolyzing GTP-bound
           active Ras into an inactive GDP-bound form of Ras. This
           model contains the C-terminal SH2 domain. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 77

 Score = 59.4 bits (144), Expect = 2e-11
 Identities = 26/68 (38%), Positives = 39/68 (57%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDS 308
           +EA  ++++ G  GSFLVRES + PGD+ LS R ++ + H  I        + GG  F S
Sbjct: 10  EEAYNMLVKVGGPGSFLVRESDNTPGDYSLSFRVNEGIKHFKIIPTGNNQFMMGGRYFSS 69

Query: 309 LTQLIEHY 316
           L  +I+ Y
Sbjct: 70  LDDVIDRY 77


>gnl|CDD|198211 cd10348, SH2_Cterm_shark_like, C-terminal Src homology 2 (SH2)
           domain found in SH2 domains, ANK, and kinase domain
           (shark) proteins.  These non-receptor protein-tyrosine
           kinases contain two SH2 domains, five ankyrin (ANK)-like
           repeats, and a potential tyrosine phosphorylation site
           in its carboxyl-terminal tail which resembles the
           phosphorylation site in members of the src family. Like,
           mammalian non-receptor protein-tyrosine kinases, ZAP-70
           and syk proteins, they do not have SH3 domains. However,
           the presence of ANK makes these unique among
           protein-tyrosine kinases. Both tyrosine kinases and ANK
           repeats have been shown to transduce developmental
           signals, and SH2 domains are known to participate
           intimately in tyrosine kinase signaling. These tyrosine
           kinases are believed to be involved in epithelial cell
           polarity. The members of this family include the shark
           (SH2 domains, ANK, and kinase domain) gene in Drosophila
           and yellow fever mosquitos, as well as the hydra protein
           HTK16.  Drosophila Shark is proposed to transduce
           intracellularly the Crumbs, a protein necessary for
           proper organization of ectodermal epithelia,
           intercellular signal. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 86

 Score = 57.8 bits (140), Expect = 1e-10
 Identities = 28/71 (39%), Positives = 46/71 (64%), Gaps = 2/71 (2%)

Query: 250 EAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEK-YDVGGGEQFD 307
           EA +++ QK   +GSFLVR S+ +PG +VL++  ++ V H  I+ + +K + +  G  F+
Sbjct: 11  EAVEILKQKADADGSFLVRYSRRRPGGYVLTLVYENHVYHFEIQNRDDKWFYIDDGPYFE 70

Query: 308 SLTQLIEHYKR 318
           SL  LIEHY +
Sbjct: 71  SLEHLIEHYTQ 81


>gnl|CDD|198216 cd10353, SH2_Nterm_RasGAP, N-terminal Src homology 2 (SH2) domain
           found in Ras GTPase-activating protein 1 (GAP).  RasGAP
           is part of the GAP1 family of GTPase-activating
           proteins. The protein is located in the cytoplasm and
           stimulates the GTPase activity of normal RAS p21, but
           not its oncogenic counterpart. Acting as a suppressor of
           RAS function, the protein enhances the weak intrinsic
           GTPase activity of RAS proteins resulting in RAS
           inactivation, thereby allowing control of cellular
           proliferation and differentiation. Mutations leading to
           changes in the binding sites of either protein are
           associated with basal cell carcinomas. Alternative
           splicing results in two isoforms. The shorter isoform
           which lacks the N-terminal hydrophobic region, has the
           same activity, and is expressed in placental tissues. In
           general the longer isoform contains 2 SH2 domains, a SH3
           domain, a pleckstrin homology (PH) domain, and a
           calcium-dependent phospholipid-binding C2 domain. The
           C-terminus contains the catalytic domain of RasGap which
           catalyzes the activation of Ras by hydrolyzing GTP-bound
           active Ras into an inactive GDP-bound form of Ras. This
           model contains the N-terminal SH2 domain. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 103

 Score = 57.9 bits (140), Expect = 2e-10
 Identities = 29/66 (43%), Positives = 39/66 (59%), Gaps = 1/66 (1%)

Query: 251 AEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSLT 310
           AE+ + Q GK GS+L+RES  +PG FVLS  +   V H  I      Y + GG +F SL+
Sbjct: 31  AEERLRQAGKLGSYLIRESDRRPGSFVLSFLSRTGVNHFRIIAMCGDYYI-GGRRFSSLS 89

Query: 311 QLIEHY 316
            LI +Y
Sbjct: 90  DLIGYY 95


>gnl|CDD|198180 cd09926, SH2_CRK_like, Src homology 2 domain found in
           cancer-related signaling adaptor protein CRK.  SH2
           domain in the CRK proteins.  CRKI (SH2-SH3) and CRKII
           (SH2-SH3-SH3) are splicing isoforms of the oncoprotein
           CRK.  CRKs regulate transcription and cytoskeletal
           reorganization for cell growth and motility by linking
           tyrosine kinases to small G proteins. The SH2 domain of
           CRK associates with tyrosine-phosphorylated receptors or
           components of focal adhesions, such as p130Cas and
           paxillin. CRK transmits signals to small G proteins
           through effectors that bind its SH3 domain, such as C3G,
           the guanine-nucleotide exchange factor (GEF) for Rap1
           and R-Ras, and DOCK180, the GEF for Rac6. The binding of
           p130Cas to the CRK-C3G complex activates Rap1, leading
           to regulation of cell adhesion, and activates R-Ras,
           leading to JNK-mediated activation of cell
           proliferation, whereas the binding of CRK DOCK180
           induces Rac1-mediated activation of cellular migration.
           The activity of the different splicing isoforms varies
           greatly with CRKI displaying substantial transforming
           activity, CRKII less so, and phosphorylated CRKII with
           no biological activity whatsoever.  CRKII has a linker
           region with a phosphorylated Tyr and an additional
           C-terminal SH3 domain. The phosphorylated Tyr creates a
           binding site for its SH2 domain which disrupts the
           association between CRK and its SH2 target proteins.  In
           general SH2 domains are involved in signal transduction.
            They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 106

 Score = 57.9 bits (140), Expect = 2e-10
 Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 5/80 (6%)

Query: 243 YMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVG 301
           Y     ++  Q +LQ  ++G FLVR+S + PGD+VLSV  + +V+H +I        +  
Sbjct: 10  YFGPMSRQEAQELLQGQRHGVFLVRDSSTIPGDYVLSVSENSRVSHYIINSLGQPAPNQS 69

Query: 302 ----GGEQFDSLTQLIEHYK 317
               G ++FD L  L+E YK
Sbjct: 70  RYRIGDQEFDDLPALLEFYK 89


>gnl|CDD|198196 cd09943, SH2_Nck_family, Src homology 2 (SH2) domain found in the
           Nck family.  Nck proteins are adaptors that modulate
           actin cytoskeleton dynamics by linking proline-rich
           effector molecules to tyrosine kinases or phosphorylated
           signaling intermediates. There are two members known in
           this family: Nck1 (Nckalpha) and Nck2 (Nckbeta and
           Growth factor receptor-bound protein 4 (Grb4)).  They
           are characterized by having 3 SH3 domains and a
           C-terminal SH2 domain. Nck1 and Nck2 have overlapping
           functions as determined by gene knockouts. Both bind
           receptor tyrosine kinases and other
           tyrosine-phosphorylated proteins through their SH2
           domains. In addition they also bind distinct targets.
           Neuronal signaling proteins: EphrinB1, EphrinB2, and
           Disabled-1 (Dab-1) all bind to Nck-2 exclusively. And in
           the case of PDGFR, Tyr(P)751 binds to  Nck1 while
           Tyr(P)1009 binds to Nck2. Nck1 and Nck2 have a role in
           the infection process of enteropathogenic Escherichia
           coli (EPEC). Their SH3 domains are involved in
           recruiting and activating the N-WASP/Arp2/3 complex
           inducing actin polymerization resulting in the
           production of pedestals, dynamic bacteria-presenting
           protrusions of the plasma membrane. A similar thing
           occurs in the vaccinia virus where motile plasma
           membrane projections are formed beneath the virus.
           Recently it has been shown that the SH2 domains of both
           Nck1 and Nck2 bind the G-protein coupled receptor
           kinase-interacting protein 1 (GIT1) in a
           phosphorylation-dependent manner. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 93

 Score = 57.1 bits (138), Expect = 2e-10
 Identities = 24/72 (33%), Positives = 45/72 (62%), Gaps = 1/72 (1%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSL 309
           +AE L+ + G  G FL+R+S+S PGD+ +S++   +  H  ++     Y + G  +F ++
Sbjct: 12  QAETLLNEHGHEGDFLIRDSESNPGDYSVSLKAPGRNKHFKVQVVDNVYCI-GQRKFHTM 70

Query: 310 TQLIEHYKRNPM 321
            +L+EHYK+ P+
Sbjct: 71  DELVEHYKKAPI 82


>gnl|CDD|198271 cd10408, SH2_Nck1, Src homology 2 (SH2) domain found in Nck.  Nck
           proteins are adaptors that modulate actin cytoskeleton
           dynamics by linking proline-rich effector molecules to
           tyrosine kinases or phosphorylated signaling
           intermediates. There are two members known in this
           family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth
           factor receptor-bound protein 4 (Grb4)). They are
           characterized by having 3 SH3 domains and a C-terminal
           SH2 domain. Nck1 and Nck2 have overlapping functions as
           determined by gene knockouts. Both bind receptor
           tyrosine kinases and other tyrosine-phosphorylated
           proteins through their SH2 domains. In addition they
           also bind distinct targets.  Neuronal signaling
           proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all
           bind to Nck-2 exclusively. And in the case of PDGFR,
           Tyr(P)751 binds to  Nck1 while Tyr(P)1009 binds to Nck2.
           Nck1 and Nck2 have a role in the infection process of
           enteropathogenic Escherichia coli (EPEC). Their SH3
           domains are involved in recruiting and activating the
           N-WASP/Arp2/3 complex inducing actin polymerization
           resulting in the production of pedestals, dynamic
           bacteria-presenting protrusions of the plasma membrane.
           A similar thing occurs in the vaccinia virus where
           motile plasma membrane projections are formed beneath
           the virus. Recently it has been shown that the SH2
           domains of both Nck1 and Nck2 bind the G-protein coupled
           receptor kinase-interacting protein 1 (GIT1) in a
           phosphorylation-dependent manner. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 97

 Score = 56.2 bits (135), Expect = 5e-10
 Identities = 26/80 (32%), Positives = 48/80 (60%), Gaps = 1/80 (1%)

Query: 242 FYMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVG 301
           +Y +    +AE  + ++G  G FL+R+S+S P DF +S++   K  H  ++ +   Y + 
Sbjct: 4   YYGKVTRHQAEMALNERGNEGDFLIRDSESSPNDFSVSLKAQGKNKHFKVQLKECVYCI- 62

Query: 302 GGEQFDSLTQLIEHYKRNPM 321
           G  +F S+ +L+EHYK+ P+
Sbjct: 63  GQRKFSSMEELVEHYKKAPI 82


>gnl|CDD|198200 cd10337, SH2_BCAR3, Src homology 2 (SH2) domain in the Breast
           Cancer Anti-estrogen Resistance protein 3.  BCAR3 is
           part of a growing family of guanine nucleotide exchange
           factors is responsible for activation of Ras-family
           GTPases, including Sos1 and 2, GRF1 and 2,
           CalDAG-GEF/GRP1-4, C3G, cAMP-GEF/Epac 1 and 2, PDZ-GEFs,
           MR-GEF, RalGDS family members, RalGPS, RasGEF, Smg GDS,
           and phospholipase C(epsilon). 12102558  21262352  BCAR3
           binds to the carboxy-terminus of BCAR1/p130Cas, a focal
           adhesion adapter protein.  Over expression of BCAR1
           (p130Cas) and BCAR3 induces estrogen independent growth
           in normally estrogen-dependent cell lines. They have
           been linked to resistance to anti-estrogens in breast
           cancer, Rac activation, and cell motility, though the
           BCAR3/p130Cas complex is not required for this activity
           in BCAR3.  Many BCAR3-mediated signaling events in
           epithelial and mesenchymal cells are independent of
           p130Cas association. Structurally these proteins contain
           a single SH2 domain upstream of their RasGEF domain,
           which is responsible for the ability of BCAR3 to enhance
           p130Cas over-expression-induced migration. In general
           SH2 domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 136

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 15/98 (15%)

Query: 251 AEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI---RCQAEKYDVG-----G 302
           AE L+ +    G FLVR+S S PGD+VL+ R   +  H  I     +  +          
Sbjct: 18  AESLVQR---EGDFLVRDSLSSPGDYVLTCRWKGQPLHFKINRVVLRPSEAYTRVQYQFE 74

Query: 303 GEQFDSLTQLIEHYKRN--PMVETSGTVVHLKQPFNAT 338
            EQFDS+  L+  Y  N  P+ + SG ++   +P N T
Sbjct: 75  DEQFDSIPALVHFYVGNRRPISQASGAIIS--RPVNRT 110


>gnl|CDD|198272 cd10409, SH2_Nck2, Src homology 2 (SH2) domain found in Nck.  Nck
           proteins are adaptors that modulate actin cytoskeleton
           dynamics by linking proline-rich effector molecules to
           tyrosine kinases or phosphorylated signaling
           intermediates.  There are two members known in this
           family: Nck1 (Nckalpha) and Nck2 (Nckbeta and Growth
           factor receptor-bound protein 4 (Grb4)).  They are
           characterized by having 3 SH3 domains and a C-terminal
           SH2 domain. Nck1 and Nck2 have overlapping functions as
           determined by gene knockouts. Both bind receptor
           tyrosine kinases and other tyrosine-phosphorylated
           proteins through their SH2 domains. In addition they
           also bind distinct targets.  Neuronal signaling
           proteins: EphrinB1, EphrinB2, and Disabled-1 (Dab-1) all
           bind to Nck-2 exclusively. And in the case of PDGFR,
           Tyr(P)751 binds to  Nck1 while Tyr(P)1009 binds to Nck2.
           Nck1 and Nck2 have a role in the infection process of
           enteropathogenic Escherichia coli (EPEC). Their SH3
           domains are involved in recruiting and activating the
           N-WASP/Arp2/3 complex inducing actin polymerization
           resulting in the production of pedestals, dynamic
           bacteria-presenting protrusions of the plasma membrane.
           A similar thing occurs in the vaccinia virus where
           motile plasma membrane projections are formed beneath
           the virus.  Recently it has been shown that the SH2
           domains of both Nck1 and Nck2 bind the G-protein coupled
           receptor kinase-interacting protein 1 (GIT1) in a
           phosphorylation-dependent manner. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 98

 Score = 56.2 bits (135), Expect = 7e-10
 Identities = 25/72 (34%), Positives = 45/72 (62%), Gaps = 1/72 (1%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSL 309
           +AE  + ++G  G FL+R+S+S P DF +S++   K  H  ++     Y + G  +F+S+
Sbjct: 12  QAECALNERGVEGDFLIRDSESSPSDFSVSLKAVGKNKHFKVQLVDNVYCI-GQRRFNSM 70

Query: 310 TQLIEHYKRNPM 321
            +L+EHYK+ P+
Sbjct: 71  DELVEHYKKAPI 82


>gnl|CDD|198197 cd09944, SH2_Grb7_family, Src homology 2 (SH2) domain found in the
           growth factor receptor bound, subclass 7 (Grb7)
           proteins.  The Grb family binds to the epidermal growth
           factor receptor (EGFR, erbB1) via their SH2 domains.
           There are 3 members of the Grb7 family of proteins:
           Grb7, Grb10, and Grb14. They are composed of an
           N-terminal Proline-rich domain, a Ras Associating-like
           (RA) domain, a Pleckstrin Homology (PH) domain, a
           phosphotyrosine interaction region (PIR, BPS) and a
           C-terminal SH2 domain. The SH2 domains of Grb7, Grb10
           and Grb14 preferentially bind to a different RTK. Grb7
           binds strongly to the erbB2 receptor, unlike Grb10 and
           Grb14 which bind weakly to it. Grb14 binds to Fibroblast
           Growth Factor Receptor (FGFR). Grb10 has been shown to
           interact with many different proteins, including the
           insulin and IGF1 receptors, platelet-derived growth
           factor (PDGF) receptor-beta, Ret, Kit, Raf1 and MEK1,
           and Nedd4.  Grb7 family proteins are phosphorylated on
           serine/threonine as well as tyrosine residues. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 108

 Score = 55.1 bits (133), Expect = 2e-09
 Identities = 32/76 (42%), Positives = 43/76 (56%), Gaps = 6/76 (7%)

Query: 250 EAEQLILQKG-KNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDV-----GGG 303
           EA +LI Q+G  +G FLVRESQS PG FVLS++   K+ H  I    ++         G 
Sbjct: 16  EAARLIRQQGLVDGVFLVRESQSNPGAFVLSLKHGQKIKHYQIIPIEDEGQWYFTLDDGV 75

Query: 304 EQFDSLTQLIEHYKRN 319
            +F  L QL+E Y+ N
Sbjct: 76  TKFYDLLQLVEFYQLN 91


>gnl|CDD|198183 cd09929, SH2_BLNK_SLP-76, Src homology 2 (SH2) domain found in
           B-cell linker (BLNK) protein and SH2 domain-containing
           leukocyte protein of 76 kDa (SLP-76).  BLNK (also known
           as SLP-65 or BASH) is an important adaptor protein
           expressed in B-lineage cells. BLNK consists of a
           N-terminal sterile alpha motif (SAM) domain and a
           C-terminal SH2 domain.  BLNK is a cytoplasmic protein,
           but a part of it is bound to the plasma membrane through
           an N-terminal leucine zipper motif and transiently bound
           to a cytoplasmic domain of Iga through its C-terminal
           SH2 domain upon B cell antigen receptor
           (BCR)-stimulation. A non-ITAM phosphotyrosine in Iga is
           necessary for the binding with the BLNK SH2 domain
           and/or for normal BLNK function in signaling and B cell
           activation. Upon phosphorylation BLNK binds Btk and
           PLCgamma2 through their SH2 domains and mediates
           PLCgamma2 activation by Btk. BLNK also binds other
           signaling molecules such as Vav, Grb2, Syk, and HPK1.
           BLNK has been shown to be necessary for BCR-mediated
           Ca2+ mobilization, for the activation of
           mitogen-activated protein kinases such as ERK, JNK, and
           p38 in a chicken B cell line DT40, and for activation of
           transcription factors such as NF-AT and NF-kappaB in
           human or mouse B cells. BLNK is involved in B cell
           development, B cell survival, activation, proliferation,
           and T-independent immune responses. BLNK is structurally
           homologous to SLP-76. SLP-76 and (linker for activation
           of T cells) LAT are adaptor/linker proteins in T cell
           antigen receptor activation and T cell development. BLNK
           interacts with many downstream signaling proteins that
           interact directly with both SLP-76 and  LAT.  New data
           suggest functional complementation of SLP-76 and LAT in
           T cell antigen receptor function with BLNK in BCR
           function. In general SH2 domains are involved in signal
           transduction.  They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 121

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 29/82 (35%), Positives = 48/82 (58%), Gaps = 8/82 (9%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGD--FVLSVRTDDKVTHVMIRCQAEK--YDVG--- 301
           KEAE+ + +  K+G+FLVR+S  K     + L V  +DKV ++ IR       Y +G   
Sbjct: 21  KEAEEALRRSNKDGTFLVRDSSGKDSSQPYTLMVLYNDKVYNIQIRFLENTRQYALGTGL 80

Query: 302 -GGEQFDSLTQLIEHYKRNPMV 322
            G E F S+ ++IEH+++ P++
Sbjct: 81  RGEETFSSVAEIIEHHQKTPLL 102


>gnl|CDD|198184 cd09930, SH2_cSH2_p85_like, C-terminal Src homology 2 (cSH2) domain
           found in p85.  Phosphoinositide 3-kinases (PI3Ks) are
           essential for cell growth, migration, and survival.
           p110, the catalytic subunit, is composed of an
           adaptor-binding domain, a Ras-binding domain, a C2
           domain, a helical domain, and a kinase domain.  The
           regulatory unit is called p85 and is composed of an SH3
           domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain,
           a inter SH2 (iSH2) domain, and C-terminal (cSH2) domain.
            There are 2 inhibitory interactions between p110alpha
           and p85 of P13K: 1) p85 nSH2 domain with the C2,
           helical, and kinase domains of p110alpha and 2) p85 iSH2
           domain with C2 domain of p110alpha. There are 3
           inhibitory interactions between p110beta and p85 of
           P13K: 1) p85 nSH2 domain with the C2, helical, and
           kinase domains of p110beta, 2) p85 iSH2 domain with C2
           domain of p110alpha, and 3) p85 cSH2 domain with the
           kinase domain of p110alpha. It is interesting to note
           that p110beta is oncogenic as a wild type protein while
           p110alpha lacks this ability. One explanation is the
           idea that the regulation of p110beta by p85 is unique
           because of the addition of inhibitory contacts from the
           cSH2 domain and the loss of contacts in the iSH2 domain.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 104

 Score = 53.2 bits (128), Expect = 8e-09
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 14/94 (14%)

Query: 251 AEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQ------AEKYDVGGGE 304
           AE+L+  K  +G+FL+RES S  G +  SV  + +V H +I         AE Y++    
Sbjct: 18  AEELLRGK-PDGTFLIRES-STQGCYACSVVCNGEVKHCVIYKTETGYGFAEPYNL---- 71

Query: 305 QFDSLTQLIEHYKRNPMVETSGTV-VHLKQPFNA 337
            ++SL +L+ HY  N + + + ++ V L  P  A
Sbjct: 72  -YESLKELVLHYAHNSLEQHNDSLTVTLAYPVLA 104


>gnl|CDD|199831 cd10369, SH2_Src_Frk, Src homology 2 (SH2) domain found in the
           Fyn-related kinase (Frk).  Frk is a member of the Src
           non-receptor type tyrosine kinase family of proteins.
           The Frk subfamily is composed of Frk/Rak and
           Iyk/Bsk/Gst. It is expressed primarily epithelial cells.
            Frk is a nuclear protein and may function during G1 and
           S phase of the cell cycle and suppress growth. Unlike
           the other Src members it lacks a glycine at position 2
           of SH4 which is important for addition of a myristic
           acid moiety that is involved in targeting Src PTKs to
           cellular membranes. FRK and SHB exert similar effects
           when overexpressed in rat phaeochromocytoma (PC12) and
           beta-cells, where both induce PC12 cell differentiation
           and beta-cell proliferation. Under conditions that cause
           beta-cell degeneration these proteins augment beta-cell
           apoptosis. The FRK-SHB responses involve FAK and insulin
           receptor substrates (IRS) -1 and -2. Frk has been
           demonstrated to interact with retinoblastoma protein.
           Frk regulates PTEN protein stability by phosphorylating
           PTEN, which in turn prevents PTEN degradation. Frk also
           plays a role in regulation of embryonal pancreatic beta
           cell formation. Frk has a unique N-terminal domain, an
           SH3 domain, an SH2 domain, a kinase domain and a
           regulatory tail, as do the other members of the family. 
           Like the other members of the Src family the SH2 domain
           in addition to binding the target, also plays an
           autoinhibitory role by binding to its activation loop.
           The tryosine involved is at the same site as the
           tyrosine involved in the autophosphorylation of Src. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 96

 Score = 52.6 bits (126), Expect = 1e-08
 Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 6/87 (6%)

Query: 250 EAE-QLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQFD 307
           +AE QL+  + + G+FL+RES+S+ G+F LSV     V H  I R     + +   + F 
Sbjct: 14  DAEKQLLYSENQTGAFLIRESESQKGEFSLSVLDGGVVKHYRIRRLDEGGFFLTRRKTFS 73

Query: 308 SLTQLIEHYKRNPMVETSGTVVHLKQP 334
           +L + + +Y       + G  V L +P
Sbjct: 74  TLNEFVNYYTTT----SDGLCVKLGKP 96


>gnl|CDD|198191 cd09938, SH2_N-SH2_Zap70_Syk_like, N-terminal Src homology 2 (SH2)
           domain found in Zeta-chain-associated protein kinase 70
           (ZAP-70) and Spleen tyrosine kinase (Syk) proteins.
           ZAP-70 and Syk comprise a family of hematopoietic cell
           specific protein tyrosine kinases (PTKs) that are
           required for antigen and antibody receptor function.
           ZAP-70 is expressed in T and natural killer (NK) cells
           and Syk is expressed in B cells, mast cells,
           polymorphonuclear leukocytes, platelets, macrophages,
           and immature T cells. They are required for the proper
           development of T and B cells, immune receptors, and
           activating NK cells. They consist of two N-terminal Src
           homology 2 (SH2) domains and a C-terminal kinase domain
           separated from the SH2 domains by a linker or hinge
           region. Phosphorylation of both tyrosine residues within
           the Immunoreceptor Tyrosine-based Activation Motifs
           (ITAM; consensus sequence Yxx[LI]x(7,8)Yxx[LI]) by the
           Src-family PTKs is required for efficient interaction of
           ZAP-70 and Syk with the receptor subunits and for
           receptor function. ZAP-70 forms two phosphotyrosine
           binding pockets, one of which is shared by both SH2
           domains.  In Syk the two SH2 domains do not form such a
           phosphotyrosine-binding site.  The SH2 domains here are
           believed to function independently. In addition, the two
           SH2 domains of Syk display flexibility in their relative
           orientation, allowing Syk to accommodate a greater
           variety of spacing sequences between the ITAM
           phosphotyrosines and singly phosphorylated non-classical
           ITAM ligands. This model contains the N-terminus SH2
           domains of both Syk and Zap70. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 104

 Score = 52.8 bits (127), Expect = 1e-08
 Identities = 28/89 (31%), Positives = 42/89 (47%), Gaps = 6/89 (6%)

Query: 250 EAEQLILQKGKN-GSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAE-KYDVGGGEQFD 307
           EAE+ +   G + G FL+R+S    G +VLSV    K  H  I  Q    Y + GG+   
Sbjct: 12  EAEEYLKLAGMSDGLFLLRQSLRSLGGYVLSVCHGRKFHHYTIERQLNGTYAIAGGKAHC 71

Query: 308 SLTQLIEHYKRNPMVETSGTVVHLKQPFN 336
              +L E++  +      G V  L++P N
Sbjct: 72  GPAELCEYHSTDL----DGLVCLLRKPCN 96


>gnl|CDD|198230 cd10367, SH2_Src_Fgr, Src homology 2 (SH2) domain found in
           Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene
           homolog, Fgr.  Fgr is a member of the Src non-receptor
           type tyrosine kinase family of proteins. The protein
           contains N-terminal sites for myristoylation and
           palmitoylation, a PTK domain, and SH2 and SH3 domains
           which are involved in mediating protein-protein
           interactions with phosphotyrosine-containing and
           proline-rich motifs, respectively. Fgr is expressed in
           B-cells and myeloid cells, localizes to plasma membrane
           ruffles, and functions as a negative regulator of cell
           migration and adhesion triggered by the beta-2 integrin
           signal transduction pathway. Multiple alternatively
           spliced variants, encoding the same protein, have been
           identified  Fgr has been shown to interact with
           Wiskott-Aldrich syndrome protein. Fgr has a unique
           N-terminal domain, an SH3 domain, an SH2 domain, a
           kinase domain and a regulatory tail, as do the other
           members of the family. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 101

 Score = 50.7 bits (121), Expect = 5e-08
 Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 15/79 (18%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRCQAEKYDVGG 302
           K+AE+ +L  G   G+FL+RES++  G + LS+R       D V H  IR    K D GG
Sbjct: 13  KDAERQLLSPGNPRGAFLIRESETTKGAYSLSIRDWDQNRGDHVKHYKIR----KLDTGG 68

Query: 303 -----GEQFDSLTQLIEHY 316
                  QFD++ +L++HY
Sbjct: 69  YYITTRAQFDTVQELVQHY 87


>gnl|CDD|198225 cd10362, SH2_Src_Lck, Src homology 2 (SH2) domain in lymphocyte
           cell kinase (Lck).  Lck is a member of the Src
           non-receptor type tyrosine kinase family of proteins. It
           is expressed in the brain, T-cells, and NK cells.  The
           unique domain of Lck mediates its interaction with two
           T-cell surface molecules, CD4 and CD8. It associates
           with their cytoplasmic tails on CD4 T helper cells  and
           CD8 cytotoxic T cells to assist signaling from the T
           cell receptor (TCR) complex. When the T cell receptor is
           engaged by the specific antigen presented by MHC, Lck
           phosphorylase the intracellular chains of the CD3 and
           zeta-chains of the TCR complex, allowing ZAP-70 to bind
           them. Lck then phosphorylates and activates ZAP-70,
           which in turn phosphorylates Linker of Activated T cells
           (LAT), a transmembrane protein that serves as a docking
           site for proteins including: Shc-Grb2-SOS, PI3K, and
           phospholipase C (PLC). The tyrosine phosphorylation
           cascade culminates in the intracellular mobilization of
           a calcium ions and activation of important signaling
           cascades within the lymphocyte, including the
           Ras-MEK-ERK pathway, which goes on to activate certain
           transcription factors such as NFAT, NF-kappaB, and AP-1.
           These transcription factors regulate the production
           cytokines such as Interleukin-2 that promote long-term
           proliferation and differentiation of the activated
           lymphocytes.  The N-terminal tail of Lck is
           myristoylated and palmitoylated and it tethers the
           protein to the plasma membrane of the cell. Lck also
           contains a SH3 domain, a SH2 domain, and a C-terminal
           tyrosine kinase domain. Lck has 2 phosphorylation sites,
           the first an autophosphorylation site that is linked to
           activation of the protein and the second which is
           phosphorylated by Csk, which inhibits it. Lck is also
           inhibited by SHP-1 dephosphorylation and by Cbl
           ubiquitin ligase, which is part of the
           ubiquitin-mediated pathway. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 101

 Score = 50.3 bits (120), Expect = 8e-08
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 19/104 (18%)

Query: 242 FYMENQGKEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRCQA 295
           F+      +AE+ +L  G  +GSFL+RES++  G F LSVR       + V H  IR   
Sbjct: 6   FFKNLSRNDAERQLLAPGNTHGSFLIRESETTAGSFSLSVRDFDQNQGEVVKHYKIR--- 62

Query: 296 EKYDVGG-----GEQFDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
              D GG        F  L +L+ HY       + G    L +P
Sbjct: 63  -NLDNGGFYISPRITFPGLHELVRHYTN----ASDGLCTRLSRP 101


>gnl|CDD|198264 cd10401, SH2_C-SH2_Syk_like, C-terminal Src homology 2 (SH2) domain
           found in Spleen tyrosine kinase (Syk) proteins.  ZAP-70
           and Syk comprise a family of hematopoietic cell specific
           protein tyrosine kinases (PTKs) that are required for
           antigen and antibody receptor function. ZAP-70 is
           expressed in T and natural killer (NK) cells  and Syk is
           expressed in B cells, mast cells, polymorphonuclear
           leukocytes, platelets, macrophages, and immature T
           cells. They are required for the proper development of T
           and B cells, immune receptors, and activating NK cells.
           They consist of two N-terminal Src homology 2 (SH2)
           domains and a C-terminal kinase domain separated from
           the SH2 domains by a linker or hinge region.
           Phosphorylation of both tyrosine residues within the
           Immunoreceptor Tyrosine-based Activation Motifs (ITAM;
           consensus sequence Yxx[LI]x(7,8)Yxx[LI]) by the
           Src-family PTKs is required for efficient interaction of
           ZAP-70 and Syk with the receptor subunits and for
           receptor function. ZAP-70 forms two phosphotyrosine
           binding pockets, one of which is shared by both SH2
           domains.  In Syk the two SH2 domains do not form such a
           phosphotyrosine-binding site.  The SH2 domains here are
           believed to function independently. In addition, the two
           SH2 domains of Syk display flexibility in their relative
           orientation, allowing Syk to accommodate a greater
           variety of spacing sequences between the ITAM
           phosphotyrosines and singly phosphorylated non-classical
           ITAM ligands. This model contains the C-terminus SH2
           domains of Syk. In general SH2 domains are involved in
           signal transduction.  They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 99

 Score = 50.3 bits (120), Expect = 8e-08
 Identities = 29/74 (39%), Positives = 44/74 (59%), Gaps = 3/74 (4%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQF 306
           +E+EQ++L   K NG FL+RE  +  G + L +  D KV H  I + +  K  +  G++F
Sbjct: 13  EESEQILLIGSKTNGKFLIRERDNN-GSYALCLLHDGKVLHYRIDKDKTGKLSIPDGKKF 71

Query: 307 DSLTQLIEHYKRNP 320
           D+L QL+EHY   P
Sbjct: 72  DTLWQLVEHYSYKP 85


>gnl|CDD|198229 cd10366, SH2_Src_Yes, Src homology 2 (SH2) domain found in Yes.
           Yes is a member of the Src non-receptor type tyrosine
           kinase family of proteins. Yes is the cellular homolog
           of the Yamaguchi sarcoma virus oncogene. In humans it is
           encoded by the YES1 gene which maps to chromosome 18 and
           is in close proximity to thymidylate synthase. A
           corresponding Yes pseudogene has been found on
           chromosome 22. YES1 has been shown to interact with
           Janus kinase 2, CTNND1,RPL10, and Occludin. Yes1 has a
           unique N-terminal domain, an SH3 domain, an SH2 domain,
           a kinase domain and a regulatory tail, as do the other
           members of the family. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 101

 Score = 50.0 bits (119), Expect = 1e-07
 Identities = 35/88 (39%), Positives = 49/88 (55%), Gaps = 16/88 (18%)

Query: 241 QFYMENQG-KEAEQLILQKG-KNGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRC 293
           ++Y    G K+AE+L+L  G + G FLVRES++  G + LS+R       D V H  IR 
Sbjct: 4   EWYFGKMGRKDAERLLLNPGNQRGIFLVRESETTKGAYSLSIRDWDEVRGDNVKHYKIR- 62

Query: 294 QAEKYDVGG-----GEQFDSLTQLIEHY 316
              K D GG       QFD+L +L++HY
Sbjct: 63  ---KLDNGGYYITTRAQFDTLQKLVKHY 87


>gnl|CDD|198195 cd09942, SH2_nSH2_p85_like, N-terminal Src homology 2 (nSH2) domain
           found in p85.  Phosphoinositide 3-kinases (PI3Ks) are
           essential for cell growth, migration, and survival.
           p110, the catalytic subunit, is composed of an
           adaptor-binding domain, a Ras-binding domain, a C2
           domain, a helical domain, and a kinase domain.  The
           regulatory unit is called p85 and is composed of an SH3
           domain, a RhoGap domain, a N-terminal SH2 (nSH2) domain,
           an internal SH2 (iSH2) domain, and C-terminal (cSH2)
           domain.  There are 2 inhibitory interactions between
           p110alpha and p85 of P13K: (1) p85 nSH2 domain with the
           C2, helical, and kinase domains of p110alpha and (2) p85
           iSH2 domain with C2 domain of p110alpha. There are 3
           inhibitory interactions between p110beta and p85 of
           P13K: (1) p85 nSH2 domain with the C2, helical, and
           kinase domains of p110beta, (2) p85 iSH2 domain with C2
           domain of p110alpha, and (3) p85 cSH2 domain with the
           kinase domain of p110alpha. It is interesting to note
           that p110beta is oncogenic as a wild type protein while
           p110alpha lacks this ability. One explanation is the
           idea that the regulation of p110beta by p85 is unique
           because of the addition of inhibitory contacts from the
           cSH2 domain and the loss of contacts in the iSH2 domain.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 110

 Score = 49.6 bits (119), Expect = 1e-07
 Identities = 19/63 (30%), Positives = 35/63 (55%)

Query: 261 NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSLTQLIEHYKRNP 320
           +G+FLVR++ +  GD+ L++R       + I  +  KY       F+S+ +LI +Y+ N 
Sbjct: 28  DGTFLVRDASTMKGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFNSVVELINYYRNNS 87

Query: 321 MVE 323
           + E
Sbjct: 88  LAE 90


>gnl|CDD|198198 cd09945, SH2_SHB_SHD_SHE_SHF_like, Src homology 2 domain found in
           SH2 domain-containing adapter proteins B, D, E, and F
           (SHB, SHD, SHE, SHF).  SHB, SHD, SHE, and SHF are SH2
           domain-containing proteins that play various roles
           throughout the cell.  SHB functions in generating
           signaling compounds in response to tyrosine kinase
           activation. SHB contains proline-rich motifs, a
           phosphotyrosine binding (PTB) domain, tyrosine
           phosphorylation sites, and a SH2 domain. SHB mediates
           certain aspects of platelet-derived growth factor (PDGF)
           receptor-, fibroblast growth factor (FGF) receptor-,
           neural growth factor (NGF) receptor TRKA-, T cell
           receptor-, interleukin-2 (IL-2) receptor- and focal
           adhesion kinase- (FAK) signaling. SRC-like FYN-Related
           Kinase FRK/RAK (also named BSK/IYK or GTK) and SHB
           regulate apoptosis, proliferation and differentiation.
           SHB promotes apoptosis and is also required for proper
           mitogenicity, spreading and tubular morphogenesis in
           endothelial cells. SHB also plays a role in preventing
           early cavitation of embryoid bodies and reduces
           differentiation to cells expressing albumin, amylase,
           insulin and glucagon. SHB is a multifunctional protein
           that has difference responses in different cells under
           various conditions. SHE is expressed in heart, lung,
           brain, and skeletal muscle, while expression of SHD is
           restricted to the brain. SHF is mainly expressed in
           skeletal muscle, brain, liver, prostate, testis, ovary,
           small intestine, and colon. SHD may be a physiological
           substrate of c-Abl and may function as an adapter
           protein in the central nervous system. It is also
           thought to be involved in apoptotic regulation.  SHD
           contains five YXXP motifs, a substrate sequence
           preferred by Abl tyrosine kinases, in addition to a
           poly-proline rich region and a C-terminal SH2 domain.
           SHE contains two pTry protein binding domains, protein
           interaction domain (PID) and a SH2 domain, followed by a
           glycine-proline rich region, all of which are N-terminal
           to the phosphotyrosine binding (PTB) domain. SHF
           contains  four putative tyrosine phosphorylation sites
           and an SH2 domain. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 98

 Score = 49.3 bits (118), Expect = 1e-07
 Identities = 26/74 (35%), Positives = 44/74 (59%), Gaps = 3/74 (4%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQ-FD 307
           EAE L L+  K GS+LVR S+S   D+ LS+++     H+ I R +  +Y +G   + F+
Sbjct: 12  EAESL-LRPCKEGSYLVRNSESTKQDYSLSLKSAKGFMHMRIQRNETGQYILGQFSRPFE 70

Query: 308 SLTQLIEHYKRNPM 321
           ++ ++I HY  N +
Sbjct: 71  TIPEMIRHYCLNKL 84


>gnl|CDD|198277 cd10414, SH2_Grb14, Src homology 2 (SH2) domain found in the growth
           factor receptor bound, subclass 14 (Grb14) proteins.
           The Grb family binds to the epidermal growth factor
           receptor (EGFR, erbB1) via their SH2 domains. Grb14 is
           part of the Grb7 family of proteins which also includes
           Grb7, and Grb14. They are composed of an N-terminal
           Proline-rich domain, a Ras Associating-like (RA) domain,
           a Pleckstrin Homology (PH) domain, a phosphotyrosine
           interaction region (PIR, BPS) and a C-terminal SH2
           domain. The SH2 domains of Grb7, Grb10 and Grb14
           preferentially bind to a different RTK. Grb14 binds to
           Fibroblast Growth Factor Receptor (FGFR) and weakly to
           the erbB2 receptor. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 108

 Score = 49.5 bits (118), Expect = 2e-07
 Identities = 30/76 (39%), Positives = 44/76 (57%), Gaps = 6/76 (7%)

Query: 250 EAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDV-----GGG 303
           EA++LI+Q+G  +G FLVR+SQS P  FVLS+    K+ H  I    +  ++      G 
Sbjct: 16  EAQRLIIQQGLVDGVFLVRDSQSNPRTFVLSMSHGQKIKHFQIIPVEDDGELFHTLDDGH 75

Query: 304 EQFDSLTQLIEHYKRN 319
            +F  L QL+E Y+ N
Sbjct: 76  TRFTDLIQLVEFYQLN 91


>gnl|CDD|198281 cd10418, SH2_Src_Fyn_isoform_a_like, Src homology 2 (SH2) domain
           found in Fyn isoform a like proteins.  Fyn is a member
           of the Src non-receptor type tyrosine kinase family of
           proteins. This cd contains the SH2 domain found in Fyn
           isoform a type proteins.  Fyn is involved in the control
           of cell growth and is required in the following
           pathways: T and B cell receptor signaling,
           integrin-mediated signaling, growth factor and cytokine
           receptor signaling, platelet activation, ion channel
           function, cell adhesion, axon guidance, fertilization,
           entry into mitosis, and differentiation of natural
           killer cells, oligodendrocytes and keratinocytes. The
           protein associates with the p85 subunit of
           phosphatidylinositol 3-kinase and interacts with the
           Fyn-binding protein. Alternatively spliced transcript
           variants encoding distinct isoforms exist. Fyn is
           primarily localized to the cytoplasmic leaflet of the
           plasma membrane. Tyrosine phosphorylation of target
           proteins by Fyn serves to either regulate target protein
           activity, and/or to generate a binding site on the
           target protein that recruits other signaling molecules.
           FYN has been shown to interact with a number of proteins
           including: BCAR1, Cbl, Janus kinase, nephrin, Sky,
           tyrosine kinase, Wiskott-Aldrich syndrome protein, and
           Zap-70. Fyn has a unique N-terminal domain, an SH3
           domain, an SH2 domain, a kinase domain and a regulatory
           tail, as do the other members of the family. In general
           SH2 domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 101

 Score = 49.2 bits (117), Expect = 2e-07
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 15/79 (18%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRCQAEKYDVGG 302
           K+AE+ +L  G   G+FL+RES++  G + LS+R       D V H  IR    K D GG
Sbjct: 13  KDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIR----KLDNGG 68

Query: 303 -----GEQFDSLTQLIEHY 316
                  QF++L QL++HY
Sbjct: 69  YYITTRAQFETLQQLVQHY 87


>gnl|CDD|198209 cd10346, SH2_SH2B_family, Src homology 2 (SH2) domain found in SH2B
           adapter protein family.  The SH2B adapter protein family
            has 3 members:  SH2B1 (SH2-B, PSM), SH2B2 (APS), and
           SH2B3 (Lnk). SH2B family members contain a pleckstrin
           homology domain, at least one dimerization domain, and a
           C-terminal SH2 domain which binds to phosphorylated
           tyrosines in a variety of tyrosine kinases.  SH2B1 and
           SH2B2  function in signaling pathways found downstream
           of growth hormone receptor and receptor tyrosine
           kinases, including the insulin, insulin-like growth
           factor-I (IGF-I), platelet-derived growth factor (PDGF),
           nerve growth factor, hepatocyte growth factor, and
           fibroblast growth factor receptors. SH2B2beta, a new
           isoform of SH2B2, is an endogenous inhibitor of SH2B1
           and/or SH2B2 (SH2B2alpha), negatively regulating insulin
           signaling and/or JAK2-mediated cellular responses. SH2B3
           negatively regulates lymphopoiesis and early
           hematopoiesis. The lnk-deficiency results in enhanced
           production of B cells, and expansion as well as enhanced
           function of hematopoietic stem cells (HSCs),
           demonstrating negative regulatory functions of Sh2b3/Lnk
           in cytokine signaling. Sh2b3/Lnk also functions in
           responses controlled by cell adhesion and in crosstalk
           between integrin- and cytokine-mediated signaling. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 97

 Score = 48.2 bits (115), Expect = 4e-07
 Identities = 25/85 (29%), Positives = 47/85 (55%), Gaps = 14/85 (16%)

Query: 250 EAEQLILQKGKN--GSFLVRESQSKPGDFVLSVRTDDKVTHVMI------RCQAEKYDVG 301
           +A QL+L  G +  G FLVR+S+++ G+FVL+     +  H+ +      +C+ +     
Sbjct: 19  DAAQLVLHSGADGHGVFLVRQSETRRGEFVLTFNFQGRAKHLRLTLNEKGQCRVQHL--- 75

Query: 302 GGEQFDSLTQLIEHYKRNPMVETSG 326
               F S+  ++EH+++NP+   SG
Sbjct: 76  ---WFPSIFDMLEHFRQNPIPLESG 97


>gnl|CDD|198188 cd09934, SH2_Tec_family, Src homology 2 (SH2) domain found in
           Tec-like proteins.  The Tec protein tyrosine kinase is
           the founding member of a family that includes Btk, Itk,
           Bmx, and Txk. The members have a PH domain, a
           zinc-binding motif, a SH3 domain, a SH2 domain, and a
           protein kinase catalytic domain. Btk is involved in
           B-cell receptor signaling with mutations in Btk
           responsible for X-linked agammaglobulinemia (XLA) in
           humans and X-linked immunodeficiency (xid) in mice. Itk
           is involved in T-cell receptor signaling. Tec is
           expressed in both T and B cells, and is thought to
           function in activated and effector T lymphocytes to
           induce the expression of genes regulated by NFAT
           transcription factors. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 104

 Score = 48.2 bits (115), Expect = 5e-07
 Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 10/90 (11%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRT----DDKVTHVMIRCQAE-KYDVGGGE 304
            AE L+ Q+ K G F+VR S S  G + +S+ T       V H  I+  A  ++ +    
Sbjct: 17  RAESLLKQEDKEGCFVVRNS-STKGLYTVSLFTKVPGSPHVKHYHIKQNARSEFYLAEKH 75

Query: 305 QFDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
            F+++ +LI +++ N      G    LK P
Sbjct: 76  CFETIPELINYHQHNS----GGLATRLKYP 101


>gnl|CDD|198193 cd09940, SH2_Vav_family, Src homology 2 (SH2) domain found in the
           Vav family.  Vav proteins are involved in several
           processes that require cytoskeletal reorganization, such
           as the formation of the immunological synapse (IS),
           phagocytosis, platelet aggregation, spreading, and
           transformation.  Vavs function as guanine nucleotide
           exchange factors (GEFs) for the Rho/Rac family of
           GTPases.  Vav family members have several conserved
           motifs/domains including: a leucine-rich region, a
           leucine-zipper, a calponin homology (CH) domain, an
           acidic domain, a Dbl-homology (DH) domain, a pleckstrin
           homology (PH) domain, a cysteine-rich domain, 2 SH3
           domains,  a proline-rich region, and a SH2 domain.  Vavs
           are the only known Rho GEFs that have both the DH/PH
           motifs and SH2/SH3 domains in the same protein. The
           leucine-rich helix-loop-helix (HLH) domain is thought to
           be involved in protein heterodimerization with other HLH
           proteins and it may function as a negative regulator by
           forming inactive heterodimers. The CH domain  is usually
           involved in the association with filamentous actin, but
           in Vav it controls NFAT stimulation, Ca2+ mobilization,
           and its transforming activity. Acidic domains are
           involved in protein-protein interactions and contain
           regulatory tyrosines. The DH domain is a GDP-GTP
           exchange factor on Rho/Rac GTPases. The PH domain in
           involved in interactions with GTP-binding proteins,
           lipids and/or phosphorylated serine/threonine residues.
           The SH3 domain is involved in localization of proteins
           to specific sites within the cell interacting with
           protein with proline-rich sequences.  The SH2 domain
           mediates a high affinity interaction with tyrosine
           phosphorylated proteins.  There are three Vav mammalian
           family members: Vav1 which is expressed in the
           hematopoietic system, Vav2 and Vav3 are more
           ubiquitously expressed. The members here include insect
           and amphibian Vavs. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 102

 Score = 48.1 bits (115), Expect = 5e-07
 Identities = 22/97 (22%), Positives = 46/97 (47%), Gaps = 2/97 (2%)

Query: 241 QFYMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYD 299
            +++    ++  +  L+   +G++LVR        + LS++ +  V H+ I +     Y 
Sbjct: 6   LWFVGEMERDTAENRLENRPDGTYLVRVRPQGETQYALSIKYNGDVKHMKIEQRSDGLYY 65

Query: 300 VGGGEQFDSLTQLIEHYKRNPMVETSGTV-VHLKQPF 335
           +     F SL +L+ +Y+RN + E    +   LK P+
Sbjct: 66  LSESRHFKSLVELVNYYERNSLGENFAGLDTTLKWPY 102


>gnl|CDD|198206 cd10343, SH2_SHIP, Src homology 2 (SH2) domain found in
           SH2-containing inositol-5'-phosphatase (SHIP) and
           SLAM-associated protein (SAP).  The SH2-containing
           inositol-5'-phosphatase, SHIP (also called
           SHIP1/SHIP1a), is a hematopoietic-restricted
           phosphatidylinositide phosphatase that translocates to
           the plasma membrane after extracellular stimulation and
           hydrolyzes the phosphatidylinositol-3-kinase
           (PI3K)-generated second messenger PI-3,4,5-P3 (PIP3) to
           PI-3,4-P2. As a result, SHIP dampens down PIP3 mediated
           signaling and represses the proliferation,
           differentiation, survival, activation, and migration of
           hematopoietic cells.  PIP3 recruits lipid-binding
           pleckstrin homology(PH) domain-containing proteins to
           the inner wall of the plasma membrane and activates
           them. PH domain-containing downstream effectors include
           the survival/proliferation enhancing serine/threonine
           kinase, Akt (protein kinase B), the tyrosine kinase,
           Btk, the regulator of protein translation, S6K, and the
           Rac and cdc42 guanine nucleotide exchange factor, Vav.
           SHIP is believed to act  as a tumor suppressor during
           leukemogenesis and lymphomagenesis, and may play a role
           in activating the immune system to combat cancer. SHIP
           contains an N-terminal SH2 domain, a centrally located
           phosphatase domain that specifically hydrolyzes the
           5'-phosphate from PIP3, PI-4,5-P2  and inositol-1,3,4,5-
           tetrakisphosphate (IP4), a C2 domain, that is an
           allosteric activating site when bound by SHIP's
           enzymatic product, PI-3,4-P2; 2 NPXY motifs that bind
           proteins with a phosphotyrosine binding (Shc, Dok 1, Dok
           2) or an SH2 (p85a, SHIP2) domain; and a proline-rich
           domain consisting of four PxxP motifs that bind a subset
           of SH3-containing proteins including Grb2, Src, Lyn,
           Hck, Abl, PLCg1, and PIAS1. The SH2 domain of SHIP binds
           to the tyrosine phosphorylated forms of Shc, SHP-2,
           Doks, Gabs, CD150, platelet-endothelial cell adhesion
           molecule, Cas, c-Cbl, immunoreceptor tyrosine-based
           inhibitory motifs (ITIMs), and immunoreceptor
           tyrosine-based activation motifs (ITAMs). The X-linked
           lymphoproliferative syndrome (XLP) gene encodes SAP
           (also called SH2D1A/DSHP) a protein that consists of a 5
           residue N-terminus, a single SH2 domain, and a short 25
           residue C-terminal tail.  XLP is characterized by an
           extreme sensitivity to Epstein-Barr virus.  Both T and
           natural killer (NK) cell dysfunctions have been seen in
           XLP patients. SAP binds the cytoplasmic tail of
           Signaling lymphocytic activation molecule (SLAM), 2B4,
           Ly-9, and CD84. SAP is believed to function as a
           signaling inhibitor, by blocking or regulating binding
           of other signaling proteins. SAP and the SAP-like
           protein EAT-2 recognize the sequence motif TIpYXX(V/I),
           which is found in the cytoplasmic domains of a
           restricted number of T, B, and NK cell surface receptors
           and are proposed to be natural inhibitors or regulators
           of the physiological role of a small family of receptors
           on the surface of these cells. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 47.8 bits (114), Expect = 7e-07
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 10/90 (11%)

Query: 251 AEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQ----- 305
           AE+L+ + GK+GSFLVR+S+S  G + L V   + V    I   AE        +     
Sbjct: 15  AEELLSKAGKDGSFLVRDSESVSGAYALCVLYQNCVHTYRILPNAEDKLSVQASEGVPVR 74

Query: 306 -FDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
            F +L +LIE Y++    E  G V HL  P
Sbjct: 75  FFTTLPELIEFYQK----ENMGLVTHLLYP 100


>gnl|CDD|198234 cd10371, SH2_Src_Blk, Src homology 2 (SH2) domain found in B
           lymphoid kinase (Blk).  Blk is a member of the Src
           non-receptor type tyrosine kinase family of proteins.
           Blk is expressed in the B-cells. Unlike most other Src
           members Blk lacks cysteine residues in the SH4 domain
           that undergo palmitylation. Blk is required for the
           development of IL-17-producing gamma-delta T cells.
           Furthermore, Blk is expressed in lymphoid precursors
           and, in this capacity, plays a role in regulating thymus
           cellularity during ontogeny. Blk has a unique N-terminal
           domain, an SH3 domain, an SH2 domain, a kinase domain
           and a regulatory tail, as do the other members of the
           family. In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 100

 Score = 47.3 bits (112), Expect = 8e-07
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 7/88 (7%)

Query: 238 ELVQFYMENQG-KEAE-QLILQKGKNGSFLVRESQSKPGDFVLSVR----TDDKVTHVMI 291
           E+ +++      K+AE QL+    K GSFL+RES+S  G F LSV+      + V H  I
Sbjct: 1   EVEKWFFRTISRKDAERQLLAPMNKAGSFLIRESESNKGAFSLSVKDVTTQGEVVKHYKI 60

Query: 292 RCQAE-KYDVGGGEQFDSLTQLIEHYKR 318
           R      Y +     F +L  L++HY +
Sbjct: 61  RSLDNGGYYISPRITFPTLQALVQHYSK 88


>gnl|CDD|198207 cd10344, SH2_SLAP, Src homology 2 domain found in Src-like adaptor
           proteins.  SLAP belongs to the subfamily of adapter
           proteins that negatively regulate cellular signaling
           initiated by tyrosine kinases. It has a myristylated
           N-terminus, SH3 and SH2 domains with high homology to
           Src family tyrosine kinases, and a unique C-terminal
           tail, which is important for c-Cbl binding. SLAP
           negatively regulates platelet-derived growth factor
           (PDGF)-induced mitogenesis in fibroblasts and regulates
           F-actin assembly for dorsal ruffles formation. c-Cbl
           mediated SLAP inhibition towards actin remodeling.
           Moreover, SLAP enhanced PDGF-induced c-Cbl
           phosphorylation by SFK. In contrast, SLAP mitogenic
           inhibition was not mediated by c-Cbl, but it rather
           involved a competitive mechanism with SFK for
           PDGF-receptor (PDGFR) association and mitogenic
           signaling. Accordingly, phosphorylation of the Src
           mitogenic substrates Stat3 and Shc were reduced by SLAP.
           Thus, we concluded that SLAP regulates PDGFR signaling
           by two independent mechanisms: a competitive mechanism
           for PDGF-induced Src mitogenic signaling and a
           non-competitive mechanism for dorsal ruffles formation
           mediated by c-Cbl. SLAP is a hematopoietic adaptor
           containing Src homology (SH)3 and SH2 motifs and a
           unique carboxy terminus. Unlike c-Src, SLAP lacks a
           tyrosine kinase domain. Unlike c-Src, SLAP does not
           impact resorptive function of mature osteoclasts but
           induces their early apoptosis. SLAP negatively regulates
           differentiation of osteoclasts and proliferation of
           their precursors. Conversely, SLAP decreases osteoclast
           death by inhibiting activation of caspase 3. In general
           SH2 domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 104

 Score = 47.5 bits (113), Expect = 9e-07
 Identities = 25/75 (33%), Positives = 41/75 (54%), Gaps = 7/75 (9%)

Query: 249 KEAEQLILQKG-KNGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMI-RCQAEKYDVG 301
           ++AE+L++  G + GSFL+RES+++ G + LSVR     + D V H  I R     + + 
Sbjct: 20  EKAEELLMLPGNQVGSFLIRESETRRGCYSLSVRHRGSQSRDSVKHYRIFRLDNGWFYIS 79

Query: 302 GGEQFDSLTQLIEHY 316
               F  L  ++ HY
Sbjct: 80  PRLTFQCLEDMVNHY 94


>gnl|CDD|198245 cd10382, SH2_SOCS1, Src homology 2 (SH2) domain found in
           suppressor of cytokine signaling (SOCS) proteins.  SH2
           domain found in SOCS proteins. SOCS was first recognized
           as a group of cytokine-inducible SH2 (CIS) domain
           proteins comprising eight family members in human (CIS
           and SOCS1-SOCS7).  In addition to the SH2 domain, SOCS
           proteins have a variable N-terminal domain and a
           conserved SOCS box in the C-terminal domain. SOCS
           proteins bind to a substrate via their SH2 domain. The
           prototypical members, CIS and SOCS1-SOCS3, have been
           shown to regulate growth hormone signaling in vitro and
           in a classic negative feedback response compete for
           binding at phosphotyrosine sites in JAK kinase and
           receptor pathways to displace effector proteins and
           target bound receptors for proteasomal degradation. Loss
           of SOCS activity results in excessive cytokine signaling
           associated with a variety of hematopoietic, autoimmune,
           and inflammatory diseases and certain cancers. Members
           (SOCS4-SOCS7) were identified by their conserved SOCS
           box, an adapter motif of 3 helices that associates
           substrate binding domains, such as the SOCS SH2 domain,
           ankryin, and WD40 with ubiquitin ligase components.
           These show limited cytokine induction. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 98

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 1/80 (1%)

Query: 242 FYMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVG 301
           FY      E     L++   G+FL+R+S+ K   F LSV+       + I  +A K+ + 
Sbjct: 12  FYWGPLSVEEAHAKLKREPVGTFLIRDSRQKNCFFALSVKMASGPVSIRILFKAGKFSLD 71

Query: 302 GGEQ-FDSLTQLIEHYKRNP 320
           G ++ FD L +L+EHY  +P
Sbjct: 72  GSKESFDCLFKLLEHYVASP 91


>gnl|CDD|198268 cd10405, SH2_Vav1, Src homology 2 (SH2) domain found in the Vav1
           proteins.  Proto-oncogene vav is a member of the Dbl
           family of guanine nucleotide exchange factors (GEF) for
           the Rho family of GTP binding proteins.  All vavs are
           activated by tyrosine phosphorylation leading to their
           activation. There are three Vav mammalian family
           members: Vav1 which is expressed in the hematopoietic
           system, and Vav2 and Vav3 are more ubiquitously
           expressed. Vav1 plays a role in T-cell and B-cell
           development and activation.  It has been identified as
           the specific binding partner of Nef proteins from HIV-1,
           resulting in morphological changes, cytoskeletal
           rearrangements, and the JNK/SAPK signaling cascade,
           leading to increased levels of viral transcription and
           replication. Vav1 has been shown to interact with Ku70,
           PLCG1, Lymphocyte cytosolic protein 2, Janus kinase 2,
           SIAH2, S100B, Abl gene, ARHGDIB, SHB, PIK3R1, PRKCQ,
           Grb2, MAPK1, Syk, Linker of activated T cells, Cbl gene
           and EZH2. Vav proteins are involved in several processes
           that require cytoskeletal reorganization, such as the
           formation of the immunological synapse (IS),
           phagocytosis, platelet aggregation, spreading, and
           transformation.  Vavs function as guanine nucleotide
           exchange factors (GEFs) for the Rho/Rac family of
           GTPases. Vav family members have several conserved
           motifs/domains including: a leucine-rich region, a
           leucine-zipper, a calponin homology (CH) domain, an
           acidic domain, a Dbl-homology (DH) domain, a pleckstrin
           homology (PH) domain, a cysteine-rich domain, 2 SH3
           domains, a proline-rich region, and a SH2 domain.  Vavs
           are the only known Rho GEFs that have both the DH/PH
           motifs and SH2/SH3 domains in the same protein. The
           leucine-rich helix-loop-helix (HLH) domain is thought to
           be involved in protein heterodimerization with other HLH
           proteins and it may function as a negative regulator by
           forming inactive heterodimers. The CH domain  is usually
           involved in the association with filamentous actin, but
           in Vav it controls NFAT stimulation, Ca2+ mobilization,
           and its transforming activity. Acidic domains are
           involved in protein-protein interactions and contain
           regulatory tyrosines. The DH domain is a GDP-GTP
           exchange factor on Rho/Rac GTPases. The PH domain in
           involved in interactions with GTP-binding proteins,
           lipids and/or phosphorylated serine/threonine residues. 
           The SH3 domain is involved in localization of proteins
           to specific sites within the cell interacting with
           protein with proline-rich sequences. The SH2 domain
           mediates a high affinity interaction with tyrosine
           phosphorylated proteins. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 46.5 bits (110), Expect = 2e-06
 Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 3/78 (3%)

Query: 244 MENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGG 303
           ME  G E+   IL    +G++LVR+      +F +S++ + +V H+ I      Y +   
Sbjct: 12  MERAGAES---ILANRSDGTYLVRQRVKDAAEFAISIKYNVEVKHIKIMTAEGLYRITEK 68

Query: 304 EQFDSLTQLIEHYKRNPM 321
           + F  LT+L+E Y++N +
Sbjct: 69  KAFRGLTELVEFYQQNSL 86


>gnl|CDD|198231 cd10368, SH2_Src_Fyn, Src homology 2 (SH2) domain found in Fyn.
           Fyn is a member of the Src non-receptor type tyrosine
           kinase family of proteins. Fyn is involved in the
           control of cell growth and is required in the following
           pathways: T and B cell receptor signaling,
           integrin-mediated signaling, growth factor and cytokine
           receptor signaling, platelet activation, ion channel
           function, cell adhesion, axon guidance, fertilization,
           entry into mitosis, and differentiation of natural
           killer cells, oligodendrocytes and keratinocytes. The
           protein associates with the p85 subunit of
           phosphatidylinositol 3-kinase and interacts with the
           Fyn-binding protein. Alternatively spliced transcript
           variants encoding distinct isoforms exist. Fyn is
           primarily localized to the cytoplasmic leaflet of the
           plasma membrane. Tyrosine phosphorylation of target
           proteins by Fyn serves to either regulate target protein
           activity, and/or to generate a binding site on the
           target protein that recruits other signaling molecules.
           FYN has been shown to interact with a number of proteins
           including: BCAR1, Cbl, Janus kinase, nephrin, Sky,
           tyrosine kinase, Wiskott-Aldrich syndrome protein, and
           Zap-70. Fyn has a unique N-terminal domain, an SH3
           domain, an SH2 domain, a kinase domain and a regulatory
           tail, as do the other members of the family. In general
           SH2 domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 101

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 15/79 (18%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRCQAEKYDVGG 302
           K+AE+ +L  G   G+FL+RES++  G + LS+R       D V H  IR    K D GG
Sbjct: 13  KDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIR----KLDNGG 68

Query: 303 -----GEQFDSLTQLIEHY 316
                  QF++L QL++HY
Sbjct: 69  YYITTRAQFETLQQLVQHY 87


>gnl|CDD|198228 cd10365, SH2_Src_Src, Src homology 2 (SH2) domain found in tyrosine
           kinase sarcoma (Src).  Src is a member of the Src
           non-receptor type tyrosine kinase family of proteins.
           Src is thought to play a role in the regulation of
           embryonic development and cell growth. Members here
           include v-Src and c-Src. v-Src lacks the C-terminal
           inhibitory phosphorylation site and is therefore
           constitutively active as opposed to normal cellular src
           (c-Src) which is only activated under certain
           circumstances where it is required (e.g. growth factor
           signaling). v-Src is an oncogene whereas c-Src is a
           proto-oncogene. c-Src consists of three domains, an
           N-terminal SH3 domain, a central SH2 domain and a
           tyrosine kinase domain. The SH2 and SH3 domains work
           together in the auto-inhibition of the kinase domain.
           The phosphorylation of an inhibitory tyrosine near the
           c-terminus of the protein produces a binding site for
           the SH2 domain which then facilitates binding of the SH3
           domain to a polyproline site within the linker between
           the SH2 domain and the kinase domain. Binding of the SH3
           domain inactivates the enzyme. This allows for multiple
           mechanisms for c-Src activation: dephosphorylation of
           the C-terminal tyrosine by a protein tyrosine
           phosphatase, binding of the SH2 domain by a competitive
           phospho-tyrosine residue, or competitive binding of a
           polyproline binding site to the SH3 domain.  Unlike most
           other Src members Src lacks cysteine residues in the SH4
           domain that undergo palmitylation. Serine and threonine
           phosphorylation sites have also been identified in the
           unique domains of Src and are believed to modulate
           protein-protein interactions or regulate catalytic
           activity. Alternatively spliced forms of Src, which
           contain 6- or 11-amino acid insertions in the SH3
           domain, are expressed in CNS neurons. c-Src has a unique
           N-terminal domain, an SH3 domain, an SH2 domain, a
           kinase domain and a regulatory tail, as do the other
           members of the family. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 101

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 15/82 (18%)

Query: 249 KEAEQLILQ-KGKNGSFLVRESQSKPGDFVLSVRTDD-----KVTHVMIRCQAEKYDVGG 302
           +E+E+L+L  +   G+FLVRES++  G + LSV   D      V H  IR    K D GG
Sbjct: 13  RESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIR----KLDSGG 68

Query: 303 -----GEQFDSLTQLIEHYKRN 319
                  QF+SL QL+ +Y ++
Sbjct: 69  FYITSRTQFNSLQQLVAYYSKH 90


>gnl|CDD|198226 cd10363, SH2_Src_HCK, Src homology 2 (SH2) domain found in HCK.
           HCK is a member of the Src non-receptor type tyrosine
           kinase family of proteins and is expressed in
           hemopoietic cells. HCK is proposed to couple the Fc
           receptor to the activation of the respiratory burst. It
           may also play a role in neutrophil migration and in the
           degranulation of neutrophils. It has two different
           translational starts that have different subcellular
           localization. HCK has been shown to interact with BCR
           gene,  ELMO1 Cbl gene, RAS p21 protein activator 1,
           RASA3, Granulocyte colony-stimulating factor receptor,
           ADAM15 and RAPGEF1.  Like the other members of the Src
           family the SH2 domain in addition to binding the target,
           also plays an autoinhibitory role by binding to its
           C-terminal tail.  In general SH2 domains are involved in
           signal transduction. HCK has a unique N-terminal domain,
           an SH3 domain, an SH2 domain, a kinase domain and a
           regulatory tail, as do the other members of the family.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 104

 Score = 45.7 bits (108), Expect = 4e-06
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 15/81 (18%)

Query: 249 KEAEQLILQKG-KNGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRCQAEKYDVGG 302
           K+AE+ +L  G   GSF++R+S++  G + LSVR       D V H  IR      D GG
Sbjct: 13  KDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPQHGDTVKHYKIR----TLDNGG 68

Query: 303 -----GEQFDSLTQLIEHYKR 318
                   F +L +L++HYK+
Sbjct: 69  FYISPRSTFSTLQELVDHYKK 89


>gnl|CDD|198276 cd10413, SH2_Grb7, Src homology 2 (SH2) domain found in the growth
           factor receptor bound, subclass 7 (Grb7) proteins.  The
           Grb family binds to the epidermal growth factor receptor
           (EGFR, erbB1) via their SH2 domains. Grb7 is part of the
           Grb7 family of proteins which also includes Grb10, and
           Grb14. They are composed of an N-terminal Proline-rich
           domain, a Ras Associating-like (RA) domain, a Pleckstrin
           Homology (PH) domain, a phosphotyrosine interaction
           region (PIR, BPS) and a C-terminal SH2 domain. The SH2
           domains of Grb7, Grb10 and Grb14 preferentially bind to
           a different RTK. Grb7 binds strongly to the erbB2
           receptor, unlike Grb10 and Grb14 which bind weakly to
           it. Grb7 family proteins are phosphorylated on
           serine/threonine as well as tyrosine residues. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 108

 Score = 45.3 bits (107), Expect = 4e-06
 Identities = 30/77 (38%), Positives = 46/77 (59%), Gaps = 6/77 (7%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEK----YDVGGG 303
           +E+++LI Q+G  +G FLVRESQ  P  FVLS+    KV H +I    E+    + +  G
Sbjct: 15  EESQRLIGQQGLVDGVFLVRESQRNPQGFVLSLCHLQKVKHYLILPSEEEGRLYFSMDDG 74

Query: 304 E-QFDSLTQLIEHYKRN 319
           + +F  L QL+E ++ N
Sbjct: 75  QTRFTDLLQLVEFHQLN 91


>gnl|CDD|198282 cd10419, SH2_Src_Fyn_isoform_b_like, Src homology 2 (SH2) domain
           found in Fyn isoform b like proteins.  Fyn is a member
           of the Src non-receptor type tyrosine kinase family of
           proteins. This cd contains the SH2 domain found in Fyn
           isoform b type proteins. Fyn is involved in the control
           of cell growth and is required in the following
           pathways: T and B cell receptor signaling,
           integrin-mediated signaling, growth factor and cytokine
           receptor signaling, platelet activation, ion channel
           function, cell adhesion, axon guidance, fertilization,
           entry into mitosis, and differentiation of natural
           killer cells, oligodendrocytes and keratinocytes. The
           protein associates with the p85 subunit of
           phosphatidylinositol 3-kinase and interacts with the
           Fyn-binding protein. Alternatively spliced transcript
           variants encoding distinct isoforms exist. Fyn is
           primarily localized to the cytoplasmic leaflet of the
           plasma membrane. Tyrosine phosphorylation of target
           proteins by Fyn serves to either regulate target protein
           activity, and/or to generate a binding site on the
           target protein that recruits other signaling molecules.
           FYN has been shown to interact with a number of proteins
           including: BCAR1, Cbl, Janus kinase, nephrin, Sky,
           tyrosine kinase, Wiskott-Aldrich syndrome protein, and
           Zap-70. Fyn has a unique N-terminal domain, an SH3
           domain, an SH2 domain, a kinase domain and a regulatory
           tail, as do the other members of the family. In general
           SH2 domains are involved in signal transduction.  They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 101

 Score = 45.0 bits (106), Expect = 5e-06
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 15/79 (18%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRCQAEKYDVGG 302
           K+AE+ +L  G   G+FL+RES++  G + LS+R       D V H  IR    K D GG
Sbjct: 13  KDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIR----KLDNGG 68

Query: 303 -----GEQFDSLTQLIEHY 316
                  QF++L QL++HY
Sbjct: 69  YYITTRAQFETLQQLVQHY 87


>gnl|CDD|199832 cd10417, SH2_SH2D7, Src homology 2 domain found in the SH2 domain
           containing protein 7 (SH2D7).  SH2D7 contains a single
           SH2 domain. In general SH2 domains are involved in
           signal transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 102

 Score = 44.9 bits (106), Expect = 6e-06
 Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 15/92 (16%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQ-F 306
           K+ EQL+  K   GSFL+R S    G ++LS R  D+  H +I + +  +Y + G     
Sbjct: 17  KQTEQLLRDKAL-GSFLIRLSDRATG-YILSYRGSDRCRHFVINQLRNRRYLISGDTSSH 74

Query: 307 DSLTQLIEHYKRNPMVETSGTVVHLKQPFNAT 338
            +L +L+ HY+   +           +PF  T
Sbjct: 75  STLAELVRHYQEVQL-----------EPFGET 95


>gnl|CDD|198260 cd10397, SH2_Tec_Btk, Src homology 2 (SH2) domain found  in Tec
           protein, Bruton's tyrosine kinase (Btk).  A member of
           the Tec protein tyrosine kinase Btk is expressed in bone
           marrow, spleen, all hematopoietic cells except T
           lymphocytes and plasma cells where it plays a  crucial
           role in B cell maturation and mast cell activation. Btk
           has been shown to interact with GNAQ, PLCG2, protein
           kinase D1, B-cell linker, SH3BP5, caveolin 1, ARID3A,
           and GTF2I. Most of the Tec family members have a PH
           domain (Txk and the short (type 1) splice variant of
           Drosophila Btk29A are exceptions), a Tec homology (TH)
           domain, a SH3 domain, a SH2 domain, and a protein kinase
           catalytic domain. Btk is implicated in the primary
           immunodeficiency disease X-linked agammaglobulinemia
           (Bruton's agammaglobulinemia).  The TH domain consists
           of a Zn2+-binding Btk motif and a proline-rich region.
           The Btk motif is found in Tec kinases, Ras GAP, and
           IGBP.  It is crucial for the function of Tec PH domains
           and it's lack of presence in Txk is not surprising since
           it lacks a PH domain. The type 1 splice form of the
           Drosophila homolog also lacks both the PH domain and the
           Btk motif.  The proline-rich regions are highly
           conserved for the most part with the exception of Bmx
           whose residues surrounding the PXXP motif are not
           conserved (TH-like) and Btk29A  which is entirely unique
           with large numbers of glycine residues (TH-extended).
           Tec family members all lack a C-terminal tyrosine having
           an autoinhibitory function in its phosphorylated state.
           Two tyrosine phosphorylation (pY) sites have been
           identified in Btk: one located in the activation loop of
           the catalytic domain which regulates the transition
           between open (active) and closed (inactive) states and
           the other in its SH3 domain.  In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 106

 Score = 44.8 bits (106), Expect = 7e-06
 Identities = 30/105 (28%), Positives = 55/105 (52%), Gaps = 13/105 (12%)

Query: 238 ELVQFYMENQGK-EAEQLILQKGKNGSFLVRESQSKPGDFVLSV------RTDDKVTHVM 290
           E+ ++Y +N  + +AEQL+ Q+GK G F+VR+S SK G + +SV           + H +
Sbjct: 4   EMYEWYSKNMTRSQAEQLLKQEGKEGGFIVRDS-SKAGKYTVSVFAKSAGDPQGVIRHYV 62

Query: 291 IRC-QAEKYDVGGGEQFDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
           +      +Y +     F ++ +LI +++ N     +G +  LK P
Sbjct: 63  VCSTPQSQYYLAEKHLFSTIPELINYHQHN----AAGLISRLKYP 103


>gnl|CDD|198223 cd10360, SH2_Srm, Src homology 2 (SH2) domain found in Src-related
           kinase lacking C-terminal regulatory tyrosine and
           N-terminal myristoylation sites (srm).  Srm is a
           nonreceptor protein kinase that has two SH2 domains, a
           SH3 domain, and a kinase domain with a tyrosine residue
           for autophosphorylation.  However it lacks an N-terminal
           glycine for myristoylation and a C-terminal tyrosine
           which suppresses kinase activity when phosphorylated.
           Srm is most similar to members of the Tec family who
           other members include: Tec, Btk/Emb, and Itk/Tsk/Emt.
           However Srm differs in its N-terminal unique domain it
           being much smaller than in the Tec family and is closer
           to Src. Srm is thought to be a new family of nonreceptor
           tyrosine kinases that may be redundant in function. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 79

 Score = 44.2 bits (104), Expect = 7e-06
 Identities = 26/70 (37%), Positives = 38/70 (54%), Gaps = 4/70 (5%)

Query: 250 EAEQLILQ-KGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYD--VGGGEQF 306
           +A+QL+L    + G+FL+R S+S  G + LSVR   KV H  I C A      +  G  F
Sbjct: 11  QAQQLLLSPPNEPGAFLIRPSESSLGGYSLSVRAQAKVCHYRI-CMAPSGSLYLQKGRLF 69

Query: 307 DSLTQLIEHY 316
             L +L+ +Y
Sbjct: 70  PGLEELLAYY 79


>gnl|CDD|198262 cd10399, SH2_Tec_Bmx, Src homology 2 (SH2) domain found  in Tec
           protein, Bmx.  A member of the Tec protein tyrosine
           kinase Bmx is expressed in the endothelium of large
           arteries, fetal endocardium, adult endocardium of the
           left ventricle, bone marrow, lung, testis, granulocytes,
           myeloid cell lines, and prostate cell lines. Bmx is
           involved in the regulation of Rho and serum response
           factor (SRF). Bmx has been shown to interact with PAK1,
           PTK2, PTPN21, and RUFY1. Most of the Tec family members
           have a PH domain (Txk and the short (type 1) splice
           variant of Drosophila Btk29A are exceptions), a Tec
           homology (TH) domain, a SH3 domain, a SH2 domain, and a
           protein kinase catalytic domain.  The TH domain consists
           of a Zn2+-binding Btk motif and a proline-rich region.
           The Btk motif is found in Tec kinases, Ras GAP, and
           IGBP.  It is crucial for the function of Tec PH domains.
           It is not present in Txk and the type 1 splice form of
           the Drosophila homolog.  The proline-rich regions are
           highly conserved for the most part with the exception of
           Bmx whose residues surrounding the PXXP motif are not
           conserved (TH-like) and Btk29A  which is entirely unique
           with large numbers of glycine residues (TH-extended).
           Tec family members all lack a C-terminal tyrosine having
           an autoinhibitory function in its phosphorylated state.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 106

 Score = 44.6 bits (105), Expect = 8e-06
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 12/92 (13%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDF---VLSVRTDDK---VTHVMIRCQAE-KYDVGG 302
           ++EQL+ QKGK G+F+VR S S+ G +   + S   +DK   V H  +   AE K  +  
Sbjct: 17  QSEQLLRQKGKEGAFMVRNS-SQVGMYTVSLFSKAVNDKKGTVKHYHVHTNAENKLYLAE 75

Query: 303 GEQFDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
              FDS+ +LI +++ N    ++G +  L+ P
Sbjct: 76  NYCFDSIPKLIHYHQHN----SAGMITRLRHP 103


>gnl|CDD|225297 COG2453, CDC14, Predicted protein-tyrosine phosphatase [Signal
           transduction mechanisms].
          Length = 180

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 15/31 (48%), Positives = 20/31 (64%)

Query: 95  VIDMILDQIKKHGPVVVHCSAGIGRTGTFIV 125
           ++D I + + K   VVVHC  GIGR+GT I 
Sbjct: 94  IVDFIEEALSKGKKVVVHCQGGIGRSGTVIA 124



 Score = 39.0 bits (91), Expect = 0.003
 Identities = 12/19 (63%), Positives = 13/19 (68%)

Query: 77  GPVVVHCSAGIGRTGTFIV 95
             VVVHC  GIGR+GT I 
Sbjct: 106 KKVVVHCQGGIGRSGTVIA 124


>gnl|CDD|198278 cd10415, SH2_Grb10, Src homology 2 (SH2) domain found in the growth
           factor receptor bound, subclass 10 (Grb10) proteins.
           The Grb family binds to the epidermal growth factor
           receptor (EGFR, erbB1) via their SH2 domains. Grb10 is
           part of the Grb7 family of proteins which also includes
           Grb7, and Grb14. They are composed of an N-terminal
           Proline-rich domain, a Ras Associating-like (RA) domain,
           a Pleckstrin Homology (PH) domain, a phosphotyrosine
           interaction region (PIR, BPS) and a C-terminal SH2
           domain. The SH2 domains of Grb7, Grb10 and Grb14
           preferentially bind to a different RTK. Grb10 has been
           shown to interact with many different proteins,
           including the insulin and IGF1 receptors,
           platelet-derived growth factor (PDGF) receptor-beta,
           Ret, Kit, Raf1 and MEK1, and Nedd4. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 108

 Score = 44.2 bits (104), Expect = 1e-05
 Identities = 24/77 (31%), Positives = 41/77 (53%), Gaps = 6/77 (7%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDV-----GG 302
           +E+ ++I Q+G  +G FL+R+SQS P  FVL++    K+ +  I    +          G
Sbjct: 15  EESHRIIKQQGLVDGLFLLRDSQSNPKAFVLTLCHHQKIKNFQILPCEDDGQTFFSLDDG 74

Query: 303 GEQFDSLTQLIEHYKRN 319
             +F  L QL++ Y+ N
Sbjct: 75  NTKFSDLIQLVDFYQLN 91


>gnl|CDD|198247 cd10384, SH2_SOCS3, Src homology 2 (SH2) domain found in
           suppressor of cytokine signaling (SOCS) proteins.  SH2
           domain found in SOCS proteins. SOCS was first recognized
           as a group of cytokine-inducible SH2 (CIS) domain
           proteins comprising eight family members in human (CIS
           and SOCS1-SOCS7). In addition to the SH2 domain, SOCS
           proteins have a variable N-terminal domain and a
           conserved SOCS box in the C-terminal domain. SOCS
           proteins bind to a substrate via their SH2 domain. The
           prototypical members, CIS and SOCS1-SOCS3, have been
           shown to regulate growth hormone signaling in vitro and
           in a classic negative feedback response compete for
           binding at phosphotyrosine sites in JAK kinase and
           receptor pathways to displace effector proteins and
           target bound receptors for proteasomal degradation. Loss
           of SOCS activity results in excessive cytokine signaling
           associated with a variety of hematopoietic, autoimmune,
           and inflammatory diseases and certain cancers. Members
           (SOCS4-SOCS7) were identified by their conserved SOCS
           box, an adapter motif of 3 helices that associates
           substrate binding domains, such as the SOCS SH2 domain,
           ankryin, and WD40 with ubiquitin ligase components.
           These show limited cytokine induction. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 101

 Score = 44.0 bits (104), Expect = 1e-05
 Identities = 24/80 (30%), Positives = 38/80 (47%), Gaps = 8/80 (10%)

Query: 248 GKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKY---DVGGGE 304
           GKEA  L L     G+FL+R+S  +   F LSV+T+    ++ I+C+   +         
Sbjct: 19  GKEANLL-LSAEPAGTFLIRDSSDQRHFFTLSVKTESGTKNLRIQCEGGSFSLQTDPRST 77

Query: 305 Q----FDSLTQLIEHYKRNP 320
           Q    FD + +L+ HY    
Sbjct: 78  QPVPRFDCVLKLVHHYMPPS 97


>gnl|CDD|199830 cd10349, SH2_SH2D2A_SH2D7, Src homology 2 domain found in the SH2
           domain containing protein 2A and 7 (SH2D2A and SH2D7).
           SH2D2A and SH7 both contain a single SH2 domain. In
           general SH2 domains are involved in signal transduction.
            They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 77

 Score = 42.9 bits (101), Expect = 2e-05
 Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 4/70 (5%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQFD 307
           +EAE+L L+    G +LVR S+S    FVLS R+     H ++ + +  ++ V G +   
Sbjct: 10  REAERL-LEPKPQGCYLVRFSESAVT-FVLSYRSRTCCRHFLLAQLRDGRHVVLGEDSAH 67

Query: 308 S-LTQLIEHY 316
           + L  L+ HY
Sbjct: 68  ARLQDLLLHY 77


>gnl|CDD|198179 cd09925, SH2_SHC, Src homology 2 (SH2) domain found in SH2 adaptor
           protein C (SHC).  SHC is involved in a wide variety of
           pathways including regulating proliferation,
           angiogenesis, invasion and metastasis, and bone
           metabolism. An adapter protein, SHC has been implicated
           in Ras activation following the stimulation of a number
           of different receptors, including growth factors
           [insulin, epidermal growth factor (EGF), nerve growth
           factor, and platelet derived growth factor (PDGF)],
           cytokines [interleukins 2, 3, and 5], erythropoietin,
           and granulocyte/macrophage colony-stimulating factor,
           and antigens [T-cell and B-cell receptors]. SHC has been
           shown to bind to tyrosine-phosphorylated receptors, and
           receptor stimulation leads to tyrosine phosphorylation
           of SHC. Upon phosphorylation, SHC interacts with another
           adapter protein, Grb2, which binds to the Ras GTP/GDP
           exchange factor mSOS which leads to Ras activation. SHC
           is composed of an N-terminal domain that interacts with
           proteins containing phosphorylated tyrosines, a
           (glycine/proline)-rich collagen-homology domain that
           contains the phosphorylated binding site, and a
           C-terminal SH2 domain. SH2 has been shown to interact
           with the tyrosine-phosphorylated receptors of EGF and
           PDGF and with the tyrosine-phosphorylated C chain of the
           T-cell receptor, providing one of the mechanisms of
           T-cell-mediated Ras activation. In general SH2 domains
           are involved in signal transduction.  They typically
           bind pTyr-containing ligands via two surface pockets, a
           pTyr and hydrophobic binding pocket, allowing proteins
           with SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 104

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 41/105 (39%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLS------------------VRTDDKVTHVM 290
           ++AE L LQ   +G FLVRES + PG +VL+                  VRT D+V    
Sbjct: 17  RDAESL-LQT--DGDFLVRESTTTPGQYVLTGMQNGQPKHLLLVDPEGVVRTKDRV---- 69

Query: 291 IRCQAEKYDVGGGEQFDSLTQLIEHYKRNPM-VETSGTVVHLKQP 334
                          F+S++ LI ++  N + + + G+ +HL++P
Sbjct: 70  ---------------FESISHLINYHVTNGLPIISEGSELHLRRP 99


>gnl|CDD|214551 smart00195, DSPc, Dual specificity phosphatase, catalytic domain. 
          Length = 138

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 13/31 (41%), Positives = 19/31 (61%)

Query: 95  VIDMILDQIKKHGPVVVHCSAGIGRTGTFIV 125
            ++ I D   K G V+VHC AG+ R+ T I+
Sbjct: 67  AVEFIEDAESKGGKVLVHCQAGVSRSATLII 97



 Score = 35.7 bits (83), Expect = 0.019
 Identities = 10/21 (47%), Positives = 14/21 (66%)

Query: 75 SAGPVVVHCSAGIGRTGTFIV 95
            G V+VHC AG+ R+ T I+
Sbjct: 77 KGGKVLVHCQAGVSRSATLII 97


>gnl|CDD|198227 cd10364, SH2_Src_Lyn, Src homology 2 (SH2) domain found in Lyn.
           Lyn is a member of the Src non-receptor type tyrosine
           kinase family of proteins and is expressed in the
           hematopoietic cells, in neural tissues, liver, and
           adipose tissue. There are two alternatively spliced
           forms of Lyn.  Lyn plays an inhibitory role in myeloid
           lineage proliferation. Following engagement of the B
           cell receptors, Lyn undergoes rapid phosphorylation and
           activation, triggering a cascade of signaling events
           mediated by Lyn phosphorylation of tyrosine residues
           within the immunoreceptor tyrosine-based activation
           motifs (ITAM) of the receptor proteins, and subsequent
           recruitment and activation of other kinases including
           Syk, phospholipase C2 (PLC2) and phosphatidyl inositol-3
           kinase. These kinases play critical roles in
           proliferation, Ca2+ mobilization and cell
           differentiation. Lyn plays an essential role in the
           transmission of inhibitory signals through
           phosphorylation of tyrosine residues within the
           immunoreceptor tyrosine-based inhibitory motifs (ITIM)
           in regulatory proteins such as CD22, PIR-B and FC RIIb1.
           Their ITIM phosphorylation subsequently leads to
           recruitment and activation of phosphatases such as
           SHIP-1 and SHP-1 which further down modulate signaling
           pathways, attenuate cell activation and can mediate
           tolerance. Lyn also plays a role in the insulin
           signaling pathway. Activated Lyn phosphorylates insulin
           receptor substrate 1 (IRS1) leading to an increase in
           translocation of Glut-4 to the cell membrane and
           increased glucose utilization. It is the primary Src
           family member involved in signaling downstream of the B
           cell receptor. Lyn plays an unusual, 2-fold role in B
           cell receptor signaling; it is essential for initiation
           of signaling but is also later involved in negative
           regulation of the signal. Lyn has a unique N-terminal
           domain, an SH3 domain, an SH2 domain, a kinase domain
           and a regulatory tail, as do the other members of the
           family. In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 101

 Score = 42.3 bits (99), Expect = 4e-05
 Identities = 26/84 (30%), Positives = 45/84 (53%), Gaps = 7/84 (8%)

Query: 242 FYMENQGKEAEQLILQKGKN-GSFLVRESQSKPGDFVLSVR-----TDDKVTHVMIRC-Q 294
           F+ +   K+AE+ +L  G + G+FL+RES++  G + LSVR       D + H  IR   
Sbjct: 6   FFKDITRKDAERQLLAPGNSAGAFLIRESETLKGSYSLSVRDYDPQHGDVIKHYKIRSLD 65

Query: 295 AEKYDVGGGEQFDSLTQLIEHYKR 318
              Y +     F  ++ +I+HY++
Sbjct: 66  NGGYYISPRITFPCISDMIKHYQK 89


>gnl|CDD|198259 cd10396, SH2_Tec_Itk, Src homology 2 (SH2) domain found in Tec
           protein, IL2-inducible T-cell kinase (Itk).  A member of
           the Tec protein tyrosine kinase Itk is expressed thymus,
           spleen, lymph node, T lymphocytes, NK and mast cells. It
           plays a role in T-cell proliferation and
           differentiation, analogous to Tec family kinases Txk.
           Itk  has been shown to interact with Fyn,
           Wiskott-Aldrich syndrome protein, KHDRBS1, PLCG1,
           Lymphocyte cytosolic protein 2, Linker of activated T
           cells, Karyopherin alpha 2, Grb2, and Peptidylprolyl
           isomerase A. Most of the Tec family members have a PH
           domain (Txk and the short (type 1) splice variant of
           Drosophila Btk29A are exceptions), a Tec homology (TH)
           domain, a SH3 domain, a SH2 domain, and a protein kinase
           catalytic domain. The TH domain consists of a
           Zn2+-binding Btk motif and a proline-rich region. The
           Btk motif is found in Tec kinases, Ras GAP, and IGBP. It
           is crucial for the function of Tec PH domains and it's
           lack of presence in Txk is not surprising since it lacks
           a PH domain. The type 1 splice form of the Drosophila
           homolog also lacks both the PH domain and the Btk motif.
           The proline-rich regions are highly conserved for the
           most part with the exception of Bmx whose residues
           surrounding the PXXP motif are not conserved (TH-like)
           and Btk29A  which is entirely unique with large numbers
           of glycine residues (TH-extended).  Tec family members
           all lack a C-terminal tyrosine having an autoinhibitory
           function in its phosphorylated state. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 108

 Score = 42.5 bits (100), Expect = 5e-05
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 14/94 (14%)

Query: 251 AEQLILQKGKNGSFLVRESQSKPGDFVLSVRT------DDKVTHVMIR---CQAEKYDVG 301
           AE+L+  +GK G F+VR+S S+PG + +S+ T      +  + H  I+      +KY + 
Sbjct: 18  AEKLLRDEGKEGGFMVRDS-SQPGLYTVSLYTKAGGEGNPCIRHYHIKETNDSPKKYYLA 76

Query: 302 GGEQFDSLTQLIEHYKRNPMVETSGTVVHLKQPF 335
               F+S+ +LIE++K N     +G V  L+ P 
Sbjct: 77  EKHVFNSIPELIEYHKHN----AAGLVTRLRYPV 106


>gnl|CDD|198273 cd10410, SH2_SH2B1, Src homology 2 (SH2) domain found in SH2B
           adapter proteins (SH2B1, SH2B2, SH2B3).  SH2B1 (SH2-B,
           PSM), like other members of the SH2B adapter protein
           family, contains a pleckstrin homology domain, at least
           one dimerization domain, and a C-terminal SH2 domain
           which binds to phosphorylated tyrosines in a variety of
           tyrosine kinases.  SH2B1 and SH2B2  function in
           signaling pathways found downstream of growth hormone
           receptor and receptor tyrosine kinases, including the
           insulin, insulin-like growth factor-I (IGF-I),
           platelet-derived growth factor (PDGF), nerve growth
           factor, hepatocyte growth factor, and fibroblast growth
           factor receptors. SH2B2beta, a new isoform of SH2B2, is
           an endogenous inhibitor of SH2B1 and/or SH2B2
           (SH2B2alpha), negatively regulating insulin signaling
           and/or JAK2-mediated cellular responses. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 97

 Score = 41.5 bits (97), Expect = 8e-05
 Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 2/93 (2%)

Query: 236 LSELVQFYMENQGKEAEQLILQKG--KNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRC 293
           LS    F+      +A QL+L+ G   +G FLVR+S+++ G++VL+     K  H+ +  
Sbjct: 5   LSGYPWFHGMLSRLKAAQLVLEGGTGSHGVFLVRQSETRRGEYVLTFNFQGKAKHLRLSL 64

Query: 294 QAEKYDVGGGEQFDSLTQLIEHYKRNPMVETSG 326
             E         F S+  ++EH++ +P+   SG
Sbjct: 65  NEEGQCRVQHLWFQSIFDMLEHFRVHPIPLESG 97


>gnl|CDD|216117 pfam00782, DSPc, Dual specificity phosphatase, catalytic domain.
           Ser/Thr and Tyr protein phosphatases. The enzyme's
           tertiary fold is highly similar to that of
           tyrosine-specific phosphatases, except for a
           "recognition" region.
          Length = 131

 Score = 42.3 bits (100), Expect = 9e-05
 Identities = 15/32 (46%), Positives = 21/32 (65%)

Query: 94  IVIDMILDQIKKHGPVVVHCSAGIGRTGTFIV 125
             ++ I D I+K G V+VHC AGI R+ T I+
Sbjct: 59  EAVEFIDDAIQKGGKVLVHCQAGISRSATLII 90



 Score = 35.0 bits (81), Expect = 0.035
 Identities = 11/19 (57%), Positives = 14/19 (73%)

Query: 77 GPVVVHCSAGIGRTGTFIV 95
          G V+VHC AGI R+ T I+
Sbjct: 72 GKVLVHCQAGISRSATLII 90


>gnl|CDD|198215 cd10352, SH2_a2chimerin_b2chimerin, Src homology 2 (SH2) domain
           found in alpha2-chimerin and beta2-chimerin proteins.
           Chimerins are a family of phorbol ester- and
           diacylglycerol-responsive GTPase-activating proteins.
           Alpha1-chimerin (formerly known as n-chimerin) and
           alpha2-chimerin are alternatively spliced products of a
           single gene, as are beta1- and beta2-chimerin. alpha1-
           and beta1-chimerin have a relatively short N-terminal
           region that does not encode any recognizable domains,
           whereas alpha2- and beta2-chimerin both include a
           functional SH2 domain that can bind to phosphotyrosine
           motifs within receptors. All of the isoforms contain a
           GAP domain with specificity in vitro for Rac1 and a
           diacylglycerol (DAG)-binding C1 domain which allows them
           to translocate to membranes in response to DAG signaling
           and anchors them in close proximity to activated Rac.
           Other C1 domain-containing diacylglycerol receptors
           including: PKC, Munc-13 proteins, phorbol ester binding
           scaffolding proteins involved in Ca2+-stimulated
           exocytosis, and RasGRPs, diacylglycerol-activated
           guanine-nucleotide exchange factors (GEFs) for Ras and
           Rap1. In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 91

 Score = 40.8 bits (96), Expect = 1e-04
 Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 1/40 (2%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTH 288
           +EAEQL+     +GS+L+RES    G + LS+R + KV +
Sbjct: 16  EEAEQLLSGAS-DGSYLIRESSRDDGYYTLSLRFNGKVKN 54


>gnl|CDD|198265 cd10402, SH2_C-SH2_Zap70, C-terminal Src homology 2 (SH2) domain
           found in Zeta-chain-associated protein kinase 70
           (ZAP-70).  ZAP-70 and Syk comprise a family of
           hematopoietic cell specific protein tyrosine kinases
           (PTKs) that are required for antigen and antibody
           receptor function. ZAP-70 is expressed in T and natural
           killer (NK) cells  and Syk is expressed in B cells, mast
           cells, polymorphonuclear leukocytes, platelets,
           macrophages, and immature T cells. They are required for
           the proper development of T and B cells, immune
           receptors, and activating NK cells. They consist of two
           N-terminal Src homology 2 (SH2) domains and a C-terminal
           kinase domain separated from the SH2 domains by a linker
           or hinge region. Phosphorylation of both tyrosine
           residues within the Immunoreceptor Tyrosine-based
           Activation Motifs (ITAM; consensus sequence
           Yxx[LI]x(7,8)Yxx[LI]) by the Src-family PTKs is required
           for efficient interaction of ZAP-70 and Syk with the
           receptor subunits and for receptor function. ZAP-70
           forms two phosphotyrosine binding pockets, one of which
           is shared by both SH2 domains.  In Syk the two SH2
           domains do not form such a phosphotyrosine-binding site.
            The SH2 domains here are believed to function
           independently. In addition, the two SH2 domains of Syk
           display flexibility in their relative orientation,
           allowing Syk to accommodate a greater variety of spacing
           sequences between the ITAM phosphotyrosines and singly
           phosphorylated non-classical ITAM ligands. This model
           contains the C-terminus SH2 domains of Zap70. In general
           SH2 domains are involved in signal transduction.  They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 105

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 6/75 (8%)

Query: 261 NGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQFDSLTQLIEHYKRN 319
           +G FL+RE +   G + LS+     V H  I + ++ KY +  G +FD+L QL+E+ K  
Sbjct: 33  DGKFLLRERKES-GTYALSLVYGKTVYHYRIDQDKSGKYSIPEGTKFDTLWQLVEYLKLK 91

Query: 320 PMVETSGTVVHLKQP 334
           P     G +  L++ 
Sbjct: 92  P----DGLIFVLRES 102


>gnl|CDD|198253 cd10390, SH2_SHD, Src homology 2 domain found in SH2
           domain-containing adapter proteins D (SHD).  The
           expression of SHD is restricted to the brain. SHD may be
           a physiological substrate of c-Abl and may function as
           an adapter protein in the central nervous system. It is
           also thought to be involved in apoptotic regulation. SHD
           contains five YXXP motifs, a substrate sequence
           preferred by Abl tyrosine kinases, in addition to a
           poly-proline rich region and a C-terminal SH2 domain. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 98

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 3/74 (4%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQ--FD 307
           +AE L L   K GS+LVR S+++P D  LS+R+     H+      E   V G     F 
Sbjct: 12  DAENL-LSLCKEGSYLVRLSETRPQDCSLSLRSSQGFLHLKFARTRENQVVLGQHSGPFP 70

Query: 308 SLTQLIEHYKRNPM 321
           S+ +L+ HY   P+
Sbjct: 71  SVPELVLHYSSRPL 84


>gnl|CDD|198178 cd09923, SH2_SOCS_family, Src homology 2 (SH2) domain found in
           suppressor of cytokine signaling (SOCS) family.  SH2
           domain found in SOCS proteins. SOCS was first recognized
           as a group of cytokine-inducible SH2 (CIS) domain
           proteins comprising eight family members in human (CIS
           and SOCS1-SOCS7). In addition to the SH2 domain, SOCS
           proteins have a variable N-terminal domain and a
           conserved SOCS box in the C-terminal domain. SOCS
           proteins bind to a substrate via their SH2 domain. The
           prototypical members, CIS and SOCS1-SOCS3, have been
           shown to regulate growth hormone signaling in vitro and
           in a classic negative feedback response compete for
           binding at phosphotyrosine sites in JAK kinase and
           receptor pathways to displace effector proteins and
           target bound receptors for proteasomal degradation. Loss
           of SOCS activity results in excessive cytokine signaling
           associated with a variety of hematopoietic, autoimmune,
           and inflammatory diseases and certain cancers. Members
           (SOCS4-SOCS7) were identified by their conserved SOCS
           box, an adapter motif of 3 helices that associates
           substrate binding domains, such as the SOCS SH2 domain,
           ankryin, and WD40 with ubiquitin ligase components.
           These show limited cytokine induction. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 81

 Score = 39.9 bits (94), Expect = 2e-04
 Identities = 23/72 (31%), Positives = 33/72 (45%), Gaps = 5/72 (6%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKY----DVGGGEQ 305
           EAE+L L     G+FLVR+S      F +S RT  +  H  I     ++          +
Sbjct: 11  EAEEL-LAGKPEGTFLVRDSSDSRYLFSVSFRTYGRTLHARIEYSNGRFSFDSSDPSVPR 69

Query: 306 FDSLTQLIEHYK 317
           F  + +LIEHY 
Sbjct: 70  FPCVVELIEHYV 81


>gnl|CDD|198251 cd10388, SH2_SOCS7, Src homology 2 (SH2) domain found in
           suppressor of cytokine signaling (SOCS) proteins.  SH2
           domain found in SOCS proteins. SOCS was first recognized
           as a group of cytokine-inducible SH2 (CIS) domain
           proteins comprising eight family members in human (CIS
           and SOCS1-SOCS7). In addition to the SH2 domain, SOCS
           proteins have a variable N-terminal domain and a
           conserved SOCS box in the C-terminal domain. SOCS
           proteins bind to a substrate via their SH2 domain. The
           prototypical members, CIS and SOCS1-SOCS3, have been
           shown to regulate growth hormone signaling in vitro and
           in a classic negative feedback response compete for
           binding at phosphotyrosine sites in JAK kinase and
           receptor pathways to displace effector proteins and
           target bound receptors for proteasomal degradation. Loss
           of SOCS activity results in excessive cytokine signaling
           associated with a variety of hematopoietic, autoimmune,
           and inflammatory diseases and certain cancers. Members
           (SOCS4-SOCS7) were identified by their conserved SOCS
           box, an adapter motif of 3 helices that associates
           substrate binding domains, such as the SOCS SH2 domain,
           ankryin, and WD40 with ubiquitin ligase components.
           These show limited cytokine induction. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 101

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 27/87 (31%), Positives = 37/87 (42%), Gaps = 6/87 (6%)

Query: 234 ATLSELVQF--YMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI 291
           A+L EL     Y      E  + +L    +GSFLVR+S      F LS R+   V H  I
Sbjct: 2   ASLRELKDCGWYWGPMSWEDAEKVLSNKPDGSFLVRDSSDDRYIFSLSFRSQGSVHHTRI 61

Query: 292 RCQAEKYDVGGGEQFD----SLTQLIE 314
                 + +G   +F     SL + IE
Sbjct: 62  EQYQGTFSLGSRNKFVDRSQSLVEFIE 88


>gnl|CDD|198246 cd10383, SH2_SOCS2, Src homology 2 (SH2) domain found in
           suppressor of cytokine signaling (SOCS) proteins.  SH2
           domain found in SOCS proteins. SOCS was first recognized
           as a group of cytokine-inducible SH2 (CIS) domain
           proteins comprising eight family members in human (CIS
           and SOCS1-SOCS7).  In addition to the SH2 domain, SOCS
           proteins have a variable N-terminal domain and a
           conserved SOCS box in the C-terminal domain. SOCS
           proteins bind to a substrate via their SH2 domain. The
           prototypical members, CIS and SOCS1-SOCS3, have been
           shown to regulate growth hormone signaling in vitro and
           in a classic negative feedback response compete for
           binding at phosphotyrosine sites in JAK kinase and
           receptor pathways to displace effector proteins and
           target bound receptors for proteasomal degradation. Loss
           of SOCS activity results in excessive cytokine signaling
           associated with a variety of hematopoietic, autoimmune,
           and inflammatory diseases and certain cancers. Members
           (SOCS4-SOCS7) were identified by their conserved SOCS
           box, an adapter motif of 3 helices that associates
           substrate binding domains, such as the SOCS SH2 domain,
           ankryin, and WD40 with ubiquitin ligase components.
           These show limited cytokine induction. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 103

 Score = 40.3 bits (94), Expect = 3e-04
 Identities = 26/78 (33%), Positives = 38/78 (48%), Gaps = 11/78 (14%)

Query: 246 NQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGG-- 303
           N+ KE     LQ    G+FLVR+S        +SV+T    T++ I  Q  K+ +     
Sbjct: 17  NEAKE----KLQDAPEGTFLVRDSSHSDYLLTISVKTSAGPTNLRIEYQDGKFRLDSIIC 72

Query: 304 -----EQFDSLTQLIEHY 316
                +QFDS+  LIE+Y
Sbjct: 73  VKSKLKQFDSVVHLIEYY 90


>gnl|CDD|198269 cd10406, SH2_Vav2, Src homology 2 (SH2) domain found in the Vav2
           proteins.  Proto-oncogene vav is a member of the Dbl
           family of guanine nucleotide exchange factors (GEF) for
           the Rho family of GTP binding proteins. All vavs are
           activated by tyrosine phosphorylation leading to their
           activation. There are three Vav mammalian family
           members: Vav1 which is expressed in the hematopoietic
           system, and Vav2 and Vav3 are more ubiquitously
           expressed. Vav2 is a GEF for RhoA, RhoB and RhoG and may
           activate Rac1 and Cdc42. Vav2 has been shown to interact
           with CD19 and Grb2. Alternatively spliced transcript
           variants encoding different isoforms have been found for
           Vav2. Vav proteins are involved in several processes
           that require cytoskeletal reorganization, such as the
           formation of the immunological synapse (IS),
           phagocytosis, platelet aggregation, spreading, and
           transformation. Vavs function as guanine nucleotide
           exchange factors (GEFs) for the Rho/Rac family of
           GTPases. Vav family members have several conserved
           motifs/domains including: a leucine-rich region, a
           leucine-zipper, a calponin homology (CH) domain, an
           acidic domain, a Dbl-homology (DH) domain, a pleckstrin
           homology (PH) domain, a cysteine-rich domain, 2 SH3
           domains, a proline-rich region, and a SH2 domain.  Vavs
           are the only known Rho GEFs that have both the DH/PH
           motifs and SH2/SH3 domains in the same protein. The
           leucine-rich helix-loop-helix (HLH) domain is thought to
           be involved in protein heterodimerization with other HLH
           proteins and it may function as a negative regulator by
           forming inactive heterodimers. The CH domain  is usually
           involved in the association with filamentous actin, but
           in Vav it controls NFAT stimulation, Ca2+ mobilization,
           and its transforming activity. Acidic domains are
           involved in protein-protein interactions and contain
           regulatory tyrosines. The DH domain is a GDP-GTP
           exchange factor on Rho/Rac GTPases. The PH domain in
           involved in interactions with GTP-binding proteins,
           lipids and/or phosphorylated serine/threonine residues.
           The SH3 domain is involved in localization of proteins
           to specific sites within the cell interacting with
           protein with proline-rich sequences. The SH2 domain
           mediates a high affinity interaction with tyrosine
           phosphorylated proteins. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 40.1 bits (93), Expect = 3e-04
 Identities = 18/83 (21%), Positives = 49/83 (59%)

Query: 242 FYMENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVG 301
           ++  N  ++    +L+   +G++L+RE  ++   F +S++ +D+V H+ +  +     + 
Sbjct: 7   WFAGNMERQQTDNLLKSHASGTYLIRERPAEAERFAISIKFNDEVKHIKVVEKDNWIHIT 66

Query: 302 GGEQFDSLTQLIEHYKRNPMVET 324
             ++F+SL +L+E+Y+ + + E+
Sbjct: 67  EAKKFESLLELVEYYQCHSLKES 89


>gnl|CDD|198270 cd10407, SH2_Vav3, Src homology 2 (SH2) domain found in the Vav3
           proteins.  Proto-oncogene vav is a member of the Dbl
           family of guanine nucleotide exchange factors (GEF) for
           the Rho family of GTP binding proteins. All vavs are
           activated by tyrosine phosphorylation leading to their
           activation. There are three Vav mammalian family
           members: Vav1 which is expressed in the hematopoietic
           system, and Vav2 and Vav3 are more ubiquitously
           expressed. Vav3 preferentially activates RhoA, RhoG and,
           to a lesser extent, Rac1.  Alternatively spliced
           transcript variants encoding different isoforms have
           been described for this gene.  VAV3 has been shown to
           interact with Grb2. Vav proteins are involved in several
           processes that require cytoskeletal reorganization, such
           as the formation of the immunological synapse (IS),
           phagocytosis, platelet aggregation, spreading, and
           transformation. Vavs function as guanine nucleotide
           exchange factors (GEFs) for the Rho/Rac family of
           GTPases. Vav family members have several conserved
           motifs/domains including: a leucine-rich region, a
           leucine-zipper, a calponin homology (CH) domain, an
           acidic domain, a Dbl-homology (DH) domain, a pleckstrin
           homology (PH) domain, a cysteine-rich domain, 2 SH3
           domains,  a proline-rich region, and a SH2 domain. Vavs
           are the only known Rho GEFs that have both the DH/PH
           motifs and SH2/SH3 domains in the same protein. The
           leucine-rich helix-loop-helix (HLH) domain is thought to
           be involved in protein heterodimerization with other HLH
           proteins and it may function as a negative regulator by
           forming inactive heterodimers. The CH domain  is usually
           involved in the association with filamentous actin, but
           in Vav it controls NFAT stimulation, Ca2+ mobilization,
           and its transforming activity. Acidic domains are
           involved in protein-protein interactions and contain
           regulatory tyrosines.  The DH domain is a GDP-GTP
           exchange factor on Rho/Rac GTPases. The PH domain in
           involved in interactions with GTP-binding proteins,
           lipids and/or phosphorylated serine/threonine residues. 
           The SH3 domain is involved in localization of proteins
           to specific sites within the cell interacting with
           protein with proline-rich sequences. The SH2 domain
           mediates a high affinity interaction with tyrosine
           phosphorylated proteins. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 39.6 bits (92), Expect = 4e-04
 Identities = 22/80 (27%), Positives = 43/80 (53%), Gaps = 3/80 (3%)

Query: 244 MENQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGG 303
           ME    E E   L    N ++LVR    + G++ +S++ +++V H+ I  +   + +   
Sbjct: 12  MERLQAETE---LINRVNSTYLVRHRTKESGEYAISIKYNNEVKHIKILTRDGFFHIAEN 68

Query: 304 EQFDSLTQLIEHYKRNPMVE 323
            +F SL +L+E+YK + + E
Sbjct: 69  RKFKSLMELVEYYKHHSLKE 88


>gnl|CDD|198255 cd10392, SH2_SHF, Src homology 2 domain found in SH2
           domain-containing adapter protein F (SHF).  SHF is
           thought to play a role in PDGF-receptor signaling and
           regulation of apoptosis. SHF is mainly expressed in
           skeletal muscle, brain, liver, prostate, testis, ovary,
           small intestine, and colon. SHF contains  four putative
           tyrosine phosphorylation sites and an SH2 domain. In
           general SH2 domains are involved in signal transduction.
           They typically bind pTyr-containing ligands via two
           surface pockets, a pTyr and hydrophobic binding pocket,
           allowing proteins with SH2 domains to localize to
           tyrosine phosphorylated sites.
          Length = 98

 Score = 39.7 bits (92), Expect = 4e-04
 Identities = 24/69 (34%), Positives = 39/69 (56%), Gaps = 3/69 (4%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVG-GGEQFD 307
           +AE L L+  K  S+LVR S++   DF LS+++     H+ + R +  KY +G     F 
Sbjct: 12  DAENL-LRLCKEASYLVRNSETSKNDFSLSLKSSQGFMHMKLSRTKEHKYVLGQNSPPFS 70

Query: 308 SLTQLIEHY 316
           S+ ++I HY
Sbjct: 71  SVPEIIHHY 79


>gnl|CDD|198205 cd10342, SH2_SAP1, Src homology 2 (SH2) domain found in
           SLAM-associated protein (SAP)1.  The X-linked
           lymphoproliferative syndrome (XLP) gene encodes SAP
           (also called SH2D1A/DSHP) a protein that consists of a 5
           residue N-terminus, a single SH2 domain, and a short 25
           residue C-terminal tail.  XLP is characterized by an
           extreme sensitivity to Epstein-Barr virus.  Both T and
           natural killer (NK) cell dysfunctions have been seen in
           XLP patients. SAP binds the cytoplasmic tail of
           Signaling lymphocytic activation molecule (SLAM), 2B4,
           Ly-9, and CD84. SAP is believed to function as a
           signaling inhibitor, by blocking or regulating binding
           of other signaling proteins. SAP and the SAP-like
           protein EAT-2 recognize the sequence motif TIpYXX[VI],
           which is found in the cytoplasmic domains of a
           restricted number of T, B, and NK cell surface receptors
           and are proposed to be natural inhibitors or regulators
           of the physiological role of a small family of receptors
           on the surface of these cells.  In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 38.9 bits (90), Expect = 9e-04
 Identities = 22/92 (23%), Positives = 43/92 (46%), Gaps = 10/92 (10%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKV-THVMIRCQAEKYDVGGGEQ-- 305
           +  E+L+L  G +GS+L+R+S+S PG + L V     + T+ + + +   +         
Sbjct: 13  ETGEKLLLATGLDGSYLLRDSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVH 72

Query: 306 ---FDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
              F  +  LI  +++       G V+ L+ P
Sbjct: 73  KRYFRKIKNLISAFQK----PDQGIVIPLQYP 100


>gnl|CDD|198252 cd10389, SH2_SHB, Src homology 2 domain found in SH2
           domain-containing adapter protein B (SHB).  SHB
           functions in generating signaling compounds in response
           to tyrosine kinase activation. SHB contains proline-rich
           motifs, a phosphotyrosine binding (PTB) domain, tyrosine
           phosphorylation sites, and a SH2 domain. SHB mediates
           certain aspects of platelet-derived growth factor (PDGF)
           receptor-, fibroblast growth factor (FGF) receptor-,
           neural growth factor (NGF) receptor TRKA-, T cell
           receptor-, interleukin-2 (IL-2) receptor- and focal
           adhesion kinase- (FAK) signaling. SRC-like FYN-Related
           Kinase FRK/RAK (also named BSK/IYK or GTK) and SHB
           regulate apoptosis, proliferation and differentiation.
           SHB promotes apoptosis and is also required for proper
           mitogenicity, spreading and tubular morphogenesis in
           endothelial cells. SHB also plays a role in preventing
           early cavitation of embryoid bodies and reduces
           differentiation to cells expressing albumin, amylase,
           insulin and glucagon. SHB is a multifunctional protein
           that has difference responses in different cells under
           various conditions. In general SH2 domains are involved
           in signal transduction.  They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 97

 Score = 38.2 bits (88), Expect = 0.001
 Identities = 24/68 (35%), Positives = 40/68 (58%), Gaps = 2/68 (2%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVG-GGEQFDS 308
           +AE L L+  K  S+LVR SQ+   D+ LS++++    H+ +    EKY +G     FDS
Sbjct: 12  DAENL-LRLCKECSYLVRNSQTSKHDYSLSLKSNQGFMHMKLAKTKEKYVLGQNSPPFDS 70

Query: 309 LTQLIEHY 316
           + ++I +Y
Sbjct: 71  VPEVIHYY 78


>gnl|CDD|198261 cd10398, SH2_Tec_Txk, Src homology 2 (SH2) domain found  in Tec
           protein, Txk.  A member of the Tec protein tyrosine
           kinase Txk is expressed in thymus, spleen, lymph node, T
           lymphocytes, NK cells, mast cell lines, and myeloid cell
           line. Txk plays a role in TCR signal transduction, T
           cell development, and selection which is analogous to
           the function of Itk. Txk has been shown to interact with
           IFN-gamma. Unlike most of the Tec family members Txk
           lacks a  PH domain. Instead Txk has a unique region
           containing a palmitoylated cysteine string which has a
           similar membrane tethering function as the PH domain.
           Txk also has a zinc-binding motif, a SH3 domain, a SH2
           domain, and a protein kinase catalytic domain. The TH
           domain consists of a Zn2+-binding Btk motif and a
           proline-rich region. The Btk motif is found in Tec
           kinases, Ras GAP, and IGBP and crucial to the function
           of the PH domain. It is not present in Txk which is not
           surprising since it lacks a PH domain. The type 1 splice
           form of the Drosophila homolog also lacks both the PH
           domain and the Btk motif. The proline-rich regions are
           highly conserved for the most part with the exception of
           Bmx whose residues surrounding the PXXP motif are not
           conserved (TH-like) and Btk29A  which is entirely unique
           with large numbers of glycine residues (TH-extended).
           Tec family members all lack a C-terminal tyrosine having
           an autoinhibitory function in its phosphorylated state.
           In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 106

 Score = 38.4 bits (89), Expect = 0.001
 Identities = 28/105 (26%), Positives = 57/105 (54%), Gaps = 13/105 (12%)

Query: 238 ELVQFYMENQGK-EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDK------VTHVM 290
           E+ ++Y +N  + +AE+L+ Q+ K G+F+VR+S    G + +SV T  +      + H  
Sbjct: 4   EIYEWYHKNITRNQAERLLRQESKEGAFIVRDS-RHLGSYTISVFTRARRSTEASIKHYQ 62

Query: 291 I-RCQAEKYDVGGGEQFDSLTQLIEHYKRNPMVETSGTVVHLKQP 334
           I +  + ++ V     F S+ +LI++++ N     +G +  L+ P
Sbjct: 63  IKKNDSGQWYVAERHLFQSIPELIQYHQHN----AAGLMSRLRYP 103


>gnl|CDD|198274 cd10411, SH2_SH2B2, Src homology 2 (SH2) domain found in SH2B
           adapter proteins (SH2B1, SH2B2, SH2B3).  SH2B2 (APS),
           like other members of the SH2B adapter protein family,
           contains a pleckstrin homology domain, at least one
           dimerization domain, and a C-terminal SH2 domain which
           binds to phosphorylated tyrosines in a variety of
           tyrosine kinases. SH2B1 and SH2B2  function in signaling
           pathways found downstream of growth hormone receptor and
           receptor tyrosine kinases, including the insulin,
           insulin-like growth factor-I (IGF-I), platelet-derived
           growth factor (PDGF), nerve growth factor, hepatocyte
           growth factor, and fibroblast growth factor receptors.
           SH2B2beta, a new isoform of SH2B2, is an endogenous
           inhibitor of SH2B1 and/or SH2B2 (SH2B2alpha), negatively
           regulating insulin signaling and/or JAK2-mediated
           cellular responses. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 97

 Score = 36.9 bits (85), Expect = 0.003
 Identities = 25/101 (24%), Positives = 49/101 (48%), Gaps = 14/101 (13%)

Query: 234 ATLSELVQFYMENQGKEAEQLILQKG--KNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI 291
             LS+   F+      +A QL+L  G   +G F++R+S+++PG++VL+     K  H+ +
Sbjct: 3   LELSDYPWFHGTLSRVKAAQLVLAGGPRSHGLFVIRQSETRPGEYVLTFNFQGKAKHLRL 62

Query: 292 ------RCQAEKYDVGGGEQFDSLTQLIEHYKRNPMVETSG 326
                 +C  +         F S+  ++ H+  +P+   SG
Sbjct: 63  SLNGHGQCHVQHL------WFQSVFDMLRHFHTHPIPLESG 97


>gnl|CDD|198221 cd10358, SH2_PTK6_Brk, Src homology 2 domain found in
           protein-tyrosine kinase-6 (PTK6) which is also known as
           breast tumor kinase (Brk).  Human protein-tyrosine
           kinase-6 (PTK6, also known as breast tumor kinase (Brk))
           is a member of the non-receptor protein-tyrosine kinase
           family and is expressed in two-thirds of all breast
           tumors. PTK6 (9). PTK6 contains a SH3 domain, a SH2
           domain, and catalytic domains. For the case of the
           non-receptor protein-tyrosine kinases, the SH2 domain is
           typically involved in negative regulation of kinase
           activity by binding to a phosphorylated tyrosine residue
           near to the C terminus. The C-terminal sequence of PTK6
           (PTSpYENPT where pY is phosphotyrosine) is thought to be
           a self-ligand for the SH2 domain. The structure of the
           SH2 domain resembles other SH2 domains except for a
           centrally located four-stranded antiparallel beta-sheet
           (strands betaA, betaB, betaC, and betaD). There are also
           differences in the loop length which might be
           responsible for PTK6 ligand specificity. There are two
           possible means of regulation of PTK6: autoinhibitory
           with the phosphorylation of Tyr playing a role in its
           negative regulation and autophosphorylation at this
           site, though it has been shown that PTK6 might
           phosphorylate signal transduction-associated proteins
           Sam68 and signal transducing adaptor family member 2
           (STAP/BKS) in vivo. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 100

 Score = 36.3 bits (83), Expect = 0.007
 Identities = 20/77 (25%), Positives = 38/77 (49%), Gaps = 1/77 (1%)

Query: 246 NQGKEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAE-KYDVGGGE 304
           ++ +   +L  +    G+FL+R S+    D+VLSVR    V H  I  +A  +  +    
Sbjct: 10  SRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAGGRLHLNEAV 69

Query: 305 QFDSLTQLIEHYKRNPM 321
            F SL +L+ +++   +
Sbjct: 70  SFLSLPELVNYHRAQSL 86


>gnl|CDD|198263 cd10400, SH2_SAP1a, Src homology 2 (SH2) domain found in
           SLAM-associated protein (SAP) 1a.  The X-linked
           lymphoproliferative syndrome (XLP) gene encodes SAP
           (also called SH2D1A/DSHP) a protein that consists of a 5
           residue N-terminus, a single SH2 domain, and a short 25
           residue C-terminal tail. XLP is characterized by an
           extreme sensitivity to Epstein-Barr virus.  Both T and
           natural killer (NK) cell dysfunctions have been seen in
           XLP patients. SAP binds the cytoplasmic tail of
           Signaling lymphocytic activation molecule (SLAM), 2B4,
           Ly-9, and CD84. SAP is believed to function as a
           signaling inhibitor, by blocking or regulating binding
           of other signaling proteins. SAP and the SAP-like
           protein EAT-2 recognize the sequence motif TIpYXX[VI],
           which is found in the cytoplasmic domains of a
           restricted number of T, B, and NK cell surface receptors
           and are proposed to be natural inhibitors or regulators
           of the physiological role of a small family of receptors
           on the surface of these cells.  In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 36.0 bits (83), Expect = 0.008
 Identities = 14/32 (43%), Positives = 23/32 (71%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSV 280
           +  E+L+L  G +GS+L+R+S+S PG + L V
Sbjct: 13  ETGEKLLLAAGLDGSYLLRDSESVPGVYCLCV 44


>gnl|CDD|238073 cd00127, DSPc, Dual specificity phosphatases (DSP); Ser/Thr and Tyr
           protein phosphatases. Structurally similar to
           tyrosine-specific phosphatases but with a shallower
           active site cleft and a distinctive active site
           signature motif, HCxxGxxR. Characterized as VHR- or
           Cdc25-like.
          Length = 139

 Score = 36.8 bits (86), Expect = 0.008
 Identities = 13/31 (41%), Positives = 20/31 (64%)

Query: 95  VIDMILDQIKKHGPVVVHCSAGIGRTGTFIV 125
            +D I D  +K G V+VHC AG+ R+ T ++
Sbjct: 70  AVDFIDDAREKGGKVLVHCLAGVSRSATLVI 100



 Score = 29.1 bits (66), Expect = 3.5
 Identities = 9/19 (47%), Positives = 14/19 (73%)

Query: 77  GPVVVHCSAGIGRTGTFIV 95
           G V+VHC AG+ R+ T ++
Sbjct: 82  GKVLVHCLAGVSRSATLVI 100


>gnl|CDD|198181 cd09927, SH2_Tensin_like, Src homology 2 domain found in
           Tensin-like proteins.  SH2 domain found in Tensin-like
           proteins. The Tensins are a family of intracellular
           proteins that interact with receptor tyrosine kinases
           (RTKs), integrins, and actin. They are thought act as
           signaling bridges between the extracellular space and
           the cytoskeleton. There are four homologues: Tensin1,
           Tensin2 (TENC1, C1-TEN), Tensin3 and Tensin4 (cten), all
           of which contain a C-terminal tandem SH2-PTB domain
           pairing, as well as actin-binding regions that may
           localize them to focal adhesions. The isoforms of
           Tensin2 and Tensin3 contain N-terminal C1 domains, which
           are atypical and not expected to bind to phorbol esters.
           Tensins 1-3 contain a phosphatase (PTPase) and C2 domain
           pairing which resembles PTEN (phosphatase and tensin
           homologue deleted on chromosome 10) protein. PTEN is a
           lipid phosphatase that dephosphorylates
           phosphatidylinositol 3,4,5-trisphosphate
           (PtdIns(3,4,5)P3) to yield phosphatidylinositol
           4,5-bisphosphate (PtdIns(4,5)P2). As PtdIns(3,4,5)P3 is
           the product of phosphatidylinositol 3-kinase (PI3K)
           activity, PTEN is therefore a key negative regulator of
           the PI3K pathway. Because of their PTEN-like domains,
           the Tensins may also possess phosphoinositide-binding or
           phosphatase capabilities. However, only Tensin2 and
           Tensin3 have the potential to be phosphatases since only
           their PTPase domains contain a cysteine residue that is
           essential for catalytic activity. In general SH2 domains
           are involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 116

 Score = 36.3 bits (84), Expect = 0.008
 Identities = 19/78 (24%), Positives = 34/78 (43%), Gaps = 14/78 (17%)

Query: 255 ILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQFDSLTQLIE 314
           +L+    G+FLVR+S +  G + L+V+       V               + D  ++L+ 
Sbjct: 18  LLKDKPPGTFLVRDSTTYKGAYGLAVKVATPPPGVNPF----------EAKGDPESELVR 67

Query: 315 HYKRNPMVETSGTVVHLK 332
           H+    ++E S   V LK
Sbjct: 68  HF----LIEPSPKGVKLK 81


>gnl|CDD|198275 cd10412, SH2_SH2B3, Src homology 2 (SH2) domain found in SH2B
           adapter proteins (SH2B1, SH2B2, SH2B3).  SH2B3 (Lnk),
           like other members of the SH2B adapter protein family,
           contains a pleckstrin homology domain, at least one
           dimerization domain, and a C-terminal SH2 domain which
           binds to phosphorylated tyrosines in a variety of
           tyrosine kinases.  SH2B3 negatively regulates
           lymphopoiesis and early hematopoiesis. The
           lnk-deficiency results in enhanced production of B
           cells, and expansion as well as enhanced function of
           hematopoietic stem cells (HSCs), demonstrating negative
           regulatory functions of Sh2b3/Lnk in cytokine signaling.
           Sh2b3/Lnk also functions in responses controlled by cell
           adhesion and in crosstalk between integrin- and
           cytokine-mediated signaling. In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 97

 Score = 35.6 bits (82), Expect = 0.009
 Identities = 21/85 (24%), Positives = 45/85 (52%), Gaps = 14/85 (16%)

Query: 250 EAEQLILQKG--KNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI------RCQAEKYDVG 301
           +A QL+  +G   +G FLVR+S+++ G++VL+     +  H+ +      +C+ +     
Sbjct: 19  KAAQLVQLQGPDAHGVFLVRQSETRRGEYVLTFNFQGRAKHLRLSLTERGQCRVQHL--- 75

Query: 302 GGEQFDSLTQLIEHYKRNPMVETSG 326
               F S+  ++ H++R+P+    G
Sbjct: 76  ---HFPSVVDMLHHFQRSPIPLECG 97


>gnl|CDD|222063 pfam13350, Y_phosphatase3, Tyrosine phosphatase family.  This
           family is closely related to the pfam00102 and pfam00782
           families.
          Length = 163

 Score = 36.3 bits (85), Expect = 0.018
 Identities = 12/36 (33%), Positives = 22/36 (61%), Gaps = 5/36 (13%)

Query: 95  VIDMILDQIKKHGPVVVHCSAGIGRTGTFIVIDMIL 130
           +++++ D     GPV+ HC+AG  RTG  +   ++L
Sbjct: 115 LLELLADP---DGPVLFHCTAGKDRTG--VAAALLL 145



 Score = 35.2 bits (82), Expect = 0.040
 Identities = 11/24 (45%), Positives = 16/24 (66%), Gaps = 2/24 (8%)

Query: 77  GPVVVHCSAGIGRTGTFIVIDMIL 100
           GPV+ HC+AG  RTG  +   ++L
Sbjct: 124 GPVLFHCTAGKDRTG--VAAALLL 145


>gnl|CDD|225240 COG2365, COG2365, Protein tyrosine/serine phosphatase [Signal
           transduction mechanisms].
          Length = 249

 Score = 36.7 bits (85), Expect = 0.022
 Identities = 11/28 (39%), Positives = 17/28 (60%)

Query: 99  ILDQIKKHGPVVVHCSAGIGRTGTFIVI 126
            L    ++GPV++HC+AG  RTG    +
Sbjct: 129 QLLADAENGPVLIHCTAGKDRTGLVAAL 156



 Score = 32.4 bits (74), Expect = 0.53
 Identities = 10/20 (50%), Positives = 14/20 (70%)

Query: 77  GPVVVHCSAGIGRTGTFIVI 96
           GPV++HC+AG  RTG    +
Sbjct: 137 GPVLIHCTAGKDRTGLVAAL 156


>gnl|CDD|198208 cd10345, SH2_C-SH2_Zap70_Syk_like, C-terminal Src homology 2 (SH2)
           domain found in Zeta-chain-associated protein kinase 70
           (ZAP-70) and Spleen tyrosine kinase (Syk) proteins.
           ZAP-70 and Syk comprise a family of hematopoietic cell
           specific protein tyrosine kinases (PTKs) that are
           required for antigen and antibody receptor function.
           ZAP-70 is expressed in T and natural killer (NK) cells
           and Syk is expressed in B cells, mast cells,
           polymorphonuclear leukocytes, platelets, macrophages,
           and immature T cells. They are required for the proper
           development of T and B cells, immune receptors, and
           activating NK cells. They consist of two N-terminal Src
           homology 2 (SH2) domains and a C-terminal kinase domain
           separated from the SH2 domains by a linker or hinge
           region. Phosphorylation of both tyrosine residues within
           the Immunoreceptor Tyrosine-based Activation Motifs
           (ITAM; consensus sequence Yxx[LI]x(7,8)Yxx[LI]) by the
           Src-family PTKs is required for efficient interaction of
           ZAP-70 and Syk with the receptor subunits and for
           receptor function. ZAP-70 forms two phosphotyrosine
           binding pockets, one of which is shared by both SH2
           domains. In Syk the two SH2 domains do not form such a
           phosphotyrosine-binding site. The SH2 domains here are
           believed to function independently. In addition, the two
           SH2 domains of Syk display flexibility in their relative
           orientation, allowing Syk to accommodate a greater
           variety of spacing sequences between the ITAM
           phosphotyrosines and singly phosphorylated non-classical
           ITAM ligands. This model contains the C-terminus SH2
           domains of both Syk and Zap70. In general SH2 domains
           are involved in signal transduction.  They typically
           bind pTyr-containing ligands via two surface pockets, a
           pTyr and hydrophobic binding pocket, allowing proteins
           with SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 95

 Score = 34.3 bits (78), Expect = 0.027
 Identities = 26/71 (36%), Positives = 42/71 (59%), Gaps = 3/71 (4%)

Query: 249 KEAEQLILQKGK-NGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQF 306
           +E+EQ++L   K NG FL+R   +  G + L +  + KV H  I + +  K  +  G++F
Sbjct: 10  EESEQIVLIGSKTNGKFLIRARDNN-GSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKF 68

Query: 307 DSLTQLIEHYK 317
           D+L QL+EHY 
Sbjct: 69  DTLWQLVEHYS 79


>gnl|CDD|198214 cd10351, SH2_SH2D4B, Src homology 2 domain found in the SH2 domain
           containing protein 4B (SH2D4B).  SH2D4B contains a
           single SH2 domain. In general SH2 domains are involved
           in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 103

 Score = 33.3 bits (76), Expect = 0.068
 Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 5/80 (6%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQ--F 306
           +EAE L++   + GSFLVR S+   G + LS R      H ++    + Y   G +    
Sbjct: 17  EEAEALLMNATE-GSFLVRVSEKIWG-YTLSYRLQSGFKHFLVDASGDFYSFLGVDPNRH 74

Query: 307 DSLTQLIEHYKRNPMVETSG 326
            +LT LI+ +K   ++ TSG
Sbjct: 75  ATLTDLIDFHKEE-IITTSG 93


>gnl|CDD|198199 cd09946, SH2_HSH2_like, Src homology 2 domain found in
           hematopoietic SH2 (HSH2) protein.  HSH2 is thought to
           function as an adapter protein involved in tyrosine
           kinase signaling. It may also be involved in regulating
           cytokine signaling and cytoskeletal reorganization in
           hematopoietic cells. HSH2 contains several putative
           protein-binding motifs, SH3-binding proline-rich
           regions, and phosphotyrosine sites, but lacks enzymatic
           motifs. HSH2 was found to interact with
           cytokine-regulated tyrosine kinase c-FES and an
           activated Cdc42-associated tyrosine kinase ACK1. HSH2
           binds c-FES through both its C-terminal region and its
           N-terminal region including the SH2 domain and binds
           ACK1 via its N-terminal proline-rich region. Both
           kinases bound and tyrosine-phosphorylated HSH2 in
           mammalian cells.  In general SH2 domains are involved in
           signal transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 102

 Score = 33.3 bits (76), Expect = 0.079
 Identities = 21/75 (28%), Positives = 38/75 (50%), Gaps = 3/75 (4%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEKYDVGGGEQ--F 306
           +EA + +L+    GSFL+R S S  G + LS +      H M++   +   +  GE+   
Sbjct: 16  REAAENMLESQPLGSFLIRVSHSHVG-YTLSYKAQSSCRHFMVKLLDDGTFMIPGEKVAH 74

Query: 307 DSLTQLIEHYKRNPM 321
            SL  L+  +++ P+
Sbjct: 75  TSLHALVTFHQQKPI 89


>gnl|CDD|198250 cd10387, SH2_SOCS6, Src homology 2 (SH2) domain found in
           suppressor of cytokine signaling (SOCS) proteins.  SH2
           domain found in SOCS proteins. SOCS was first recognized
           as a group of cytokine-inducible SH2 (CIS) domain
           proteins comprising eight family members in human (CIS
           and SOCS1-SOCS7). In addition to the SH2 domain, SOCS
           proteins have a variable N-terminal domain and a
           conserved SOCS box in the C-terminal domain. SOCS
           proteins bind to a substrate via their SH2 domain. The
           prototypical members, CIS and SOCS1-SOCS3, have been
           shown to regulate growth hormone signaling in vitro and
           in a classic negative feedback response compete for
           binding at phosphotyrosine sites in JAK kinase and
           receptor pathways to displace effector proteins and
           target bound receptors for proteasomal degradation. Loss
           of SOCS activity results in excessive cytokine signaling
           associated with a variety of hematopoietic, autoimmune,
           and inflammatory diseases and certain cancers. Members
           (SOCS4-SOCS7) were identified by their conserved SOCS
           box, an adapter motif of 3 helices that associates
           substrate binding domains, such as the SOCS SH2 domain,
           ankryin, and WD40 with ubiquitin ligase components.
           These show limited cytokine induction. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 100

 Score = 32.1 bits (73), Expect = 0.18
 Identities = 20/58 (34%), Positives = 26/58 (44%), Gaps = 3/58 (5%)

Query: 261 NGSFLVRESQSKPGDFVLSVRTDDKVTHVMIRCQAEK---YDVGGGEQFDSLTQLIEH 315
           +GSFLVR+S        LS R+  K  H  I     +   Y+    E   S+  LIEH
Sbjct: 31  DGSFLVRDSSDDRYLLSLSFRSHGKTLHTRIEHSNGRFSFYEQPDVEGHTSIVDLIEH 88


>gnl|CDD|198254 cd10391, SH2_SHE, Src homology 2 domain found in SH2
           domain-containing adapter protein E (SHE).  SHE is
           expressed in heart, lung, brain, and skeletal muscle.
           SHE contains two pTry protein binding domains, protein
           interaction domain (PID) and a SH2 domain, followed by a
           glycine-proline rich region, all of which are N-terminal
           to the phosphotyrosine binding (PTB) domain. In general
           SH2 domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 98

 Score = 31.8 bits (72), Expect = 0.20
 Identities = 20/69 (28%), Positives = 38/69 (55%), Gaps = 3/69 (4%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI-RCQAEKYDVGGGEQ-FD 307
           EAE   LQ  K  S+LVR S+S    + ++++T     H+++ + +  KY +      FD
Sbjct: 12  EAESR-LQPCKEASYLVRNSESGNSKYSIALKTSQGCVHIIVAQTKDNKYTLNQTSAVFD 70

Query: 308 SLTQLIEHY 316
           S+ +++ +Y
Sbjct: 71  SIPEVVHYY 79


>gnl|CDD|198174 cd09918, SH2_Nterm_SPT6_like, N-terminal Src homology 2 (SH2)
           domain found in Spt6.  N-terminal SH2 domain in Spt6.
           Spt6 is an essential transcription elongation factor and
           histone chaperone that binds the C-terminal repeat
           domain (CTD) of RNA polymerase II. Spt6 contains a
           tandem SH2 domain with a novel structure and CTD-binding
           mode. The tandem SH2 domain binds to a serine
           2-phosphorylated CTD peptide in vitro, whereas its
           N-terminal SH2 subdomain does not. CTD binding requires
           a positively charged crevice in the C-terminal SH2
           subdomain, which lacks the canonical phospho-binding
           pocket of SH2 domains. The tandem SH2 domain is
           apparently required for transcription elongation in vivo
           as its deletion in cells is lethal in the presence of
           6-azauracil.  In general SH2 domains are involved in
           signal transduction.  They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 85

 Score = 31.1 bits (71), Expect = 0.33
 Identities = 17/77 (22%), Positives = 33/77 (42%), Gaps = 11/77 (14%)

Query: 249 KEAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVT-HVMIRCQAEKYDVG------ 301
           K+AE   L+    G  ++R S        ++ +  D V  H+ I  +  K +        
Sbjct: 11  KQAEAY-LKSKDVGEVVIRPSSKGVDHLTVTWKVADGVYQHIDIE-ELNKENPFSLGKEL 68

Query: 302 --GGEQFDSLTQLIEHY 316
             GGE+++ L ++I  +
Sbjct: 69  IIGGEEYEDLDEIIARF 85


>gnl|CDD|198285 cd10718, SH2_CIS, Src homology 2 (SH2) domain found in
           cytokine-inducible SH2-containing protein (CIS).  CIS
           family members are known to be cytokine-inducible
           negative regulators of cytokine signaling. The
           expression of the CIS gene can be induced by IL2, IL3,
           GM-CSF and EPO in hematopoietic cells.
           Proteasome-mediated degradation of this protein has been
           shown to be involved in the inactivation of the
           erythropoietin receptor. Suppressor of cytokine
           signalling (SOCS) was first recognized as a group of
           cytokine-inducible SH2 (CIS) domain proteins comprising
           eight family members in human (CIS and SOCS1-SOCS7).  In
           addition to the SH2 domain, SOCS proteins have a
           variable N-terminal domain and a conserved SOCS box in
           the C-terminal domain. SOCS proteins bind to a substrate
           via their SH2 domain. The prototypical members, CIS and
           SOCS1-SOCS3, have been shown to regulate growth hormone
           signaling in vitro and in a classic negative feedback
           response compete for binding at phosphotyrosine sites in
           JAK kinase and receptor pathways to displace effector
           proteins and target bound receptors for proteasomal
           degradation. Loss of SOCS activity results in excessive
           cytokine signaling associated with a variety of
           hematopoietic, autoimmune, and inflammatory diseases and
           certain cancers. In general SH2 domains are involved in
           signal transduction.  They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 88

 Score = 30.1 bits (68), Expect = 0.79
 Identities = 19/42 (45%), Positives = 23/42 (54%), Gaps = 1/42 (2%)

Query: 250 EAEQLILQKGKNGSFLVRESQSKPGDFVLSVRTDDKVTHVMI 291
           EA Q  LQK   G+FLVR+S        LSV+T    T+V I
Sbjct: 15  EAHQ-ALQKAPEGTFLVRDSSHPSYMLTLSVKTTRGPTNVRI 55


>gnl|CDD|198219 cd10356, SH2_ShkA_ShkC, Src homology 2 (SH2) domain found in SH2
           domain-bearing protein kinases A and C (ShkA and ShkC). 
           SH2-bearing genes cloned from Dictyostelium include two
           transcription factors, STATa and STATc, and a signaling
           factor, SHK1 (shkA). A database search of the
           Dictyostelium discoideum genome revealed two additional
           putative STAT sequences, dd-STATb and dd-STATd, and four
           additional putative SHK genes, dd-SHK2 (shkB), dd-SHK3
           (shkC), dd-SHK4 (shkD), and dd-SHK5 (shkE). This model
           contains members of shkA and shkC.  All of the SHK
           members are most closely related to the protein kinases
           found in plants.  However these kinases in plants are
           not conjugated to any SH2 or SH2-like sequences.
           Alignment data indicates that the SHK SH2 domains carry
           some features of the STAT SH2 domains in Dictyostelium.
           When STATc's linker domain was used for a BLAST search,
           the sequence between the protein kinase domain and the
           SH2 domain (the linker) of SHK was recovered, suggesting
           a close relationship among these molecules within this
           region. SHK's linker domain is predicted to contain an
           alpha-helix which is indeed homologous to that of STAT.
           Based on the phylogenetic alignment, SH2 domains can be
           grouped into two categories, STAT-type and Src-type. SHK
           family members are in between, but are closer to the
           STAT-type which indicates a close relationship between
           SHK and STAT families in their SH2 domains and further
           supports the notion that SHKs linker-SH2 domain evolved
           from STAT or STATL (STAT-like Linker-SH2) domain found
           in plants. In SHK, STAT, and SPT6, the linker-SH2
           domains all reside exclusively in the C-terminal
           regions. In general SH2 domains are involved in signal
           transduction. They typically bind pTyr-containing
           ligands via two surface pockets, a pTyr and hydrophobic
           binding pocket, allowing proteins with SH2 domains to
           localize to tyrosine phosphorylated sites.
          Length = 113

 Score = 30.3 bits (68), Expect = 0.91
 Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 2/59 (3%)

Query: 256 LQKGKNGSFLVRESQSKPGDFVLS-VRTDDKVTHVMIRCQAEKYDVGGGEQFDSLTQLI 313
           L     G+FLVR S S+PG + +S V  +  ++H  I     K+ V    ++ S+ +LI
Sbjct: 26  LNGKPEGTFLVRFSTSEPGAYTISKVSKNGGISHQRIHRPGGKFQV-NNSKYLSVKELI 83


>gnl|CDD|198222 cd10359, SH2_SH3BP2, Src homology 2 domain found in c-Abl SH3
           domain-binding protein-2 (SH3BP2).  The adaptor protein
           3BP2/SH3BP2 plays a regulatory role in signaling from
           immunoreceptors. The protein-tyrosine kinase Syk
           phosphorylates 3BP2 which results in the activation of
           Rac1 through the interaction with the SH2 domain of Vav1
           and induces the binding to the SH2 domain of the
           upstream protein-tyrosine kinase Lyn and enhances its
           kinase activity. 3BP2 has a positive regulatory role in
           IgE-mediated mast cell activation. In lymphocytes,
           engagement of T cell or B cell receptors triggers
           tyrosine phosphorylation of 3BP2. Suppression of the
           3BP2 expression by siRNA results in the inhibition of T
           cell or B cell receptor-mediated activation of NFAT.
           3BP2 is required for the proliferation of B cells and B
           cell receptor signaling. Mutations in the 3BP2 gene are
           responsible for cherubism resulting in excessive bone
           resorption in the jaw.  In general SH2 domains are
           involved in signal transduction. They typically bind
           pTyr-containing ligands via two surface pockets, a pTyr
           and hydrophobic binding pocket, allowing proteins with
           SH2 domains to localize to tyrosine phosphorylated
           sites.
          Length = 101

 Score = 30.3 bits (68), Expect = 0.91
 Identities = 23/76 (30%), Positives = 34/76 (44%), Gaps = 8/76 (10%)

Query: 250 EAEQLILQKG-----KNGSFLVRESQSKPGDFVLSV--RTDDKVTHVMIRCQAEKYDVGG 302
           E E+L          ++G + +R S S  G  VL V     +KV +  I  +  K+ +  
Sbjct: 11  EVERLFKATSPKGGPQDGLYCIRNS-STKGGKVLVVWDGGAEKVRNYRIFEKDCKFYLHE 69

Query: 303 GEQFDSLTQLIEHYKR 318
            E F SL  L+EHY  
Sbjct: 70  REVFSSLGSLVEHYAT 85


>gnl|CDD|241125 cd12681, RRM_SKAR, RNA recognition motif in S6K1 Aly/REF-like
           target (SKAR) and similar proteins.  This subgroup
           corresponds to the RRM of SKAR, also termed polymerase
           delta-interacting protein 3 (PDIP3), 46 kDa DNA
           polymerase delta interaction protein (PDIP46), belonging
           to the Aly/REF family of RNA binding proteins that have
           been implicated in coupling transcription with pre-mRNA
           splicing and nucleo-cytoplasmic mRNA transport. SKAR is
           widely expressed and localizes to the nucleus. It may be
           a critical player in the function of S6K1 in cell and
           organism growth control by binding the activated,
           hyperphosphorylated form of S6K1 but not S6K2.
           Furthermore, SKAR functions as a protein partner of the
           p50 subunit of DNA polymerase delta. In addition, SKAR
           may have particular importance in pancreatic beta cell
           size determination and insulin secretion. SKAR contains
           a well conserved RNA recognition motif (RRM), also
           termed RBD (RNA binding domain) or RNP
           (ribonucleoprotein domain).
          Length = 69

 Score = 28.8 bits (65), Expect = 1.2
 Identities = 9/14 (64%), Positives = 11/14 (78%)

Query: 338 TRITVSNIHDRVTE 351
           TR+ VSN+H  VTE
Sbjct: 1   TRLVVSNLHPSVTE 14


>gnl|CDD|227653 COG5350, COG5350, Predicted protein tyrosine phosphatase [General
           function prediction only].
          Length = 172

 Score = 30.6 bits (69), Expect = 1.5
 Identities = 9/28 (32%), Positives = 16/28 (57%), Gaps = 3/28 (10%)

Query: 96  IDMILDQIKKH---GPVVVHCSAGIGRT 120
           +  I+D   +     P+++HC AGI R+
Sbjct: 80  VRAIIDFADEWPRFAPLLIHCYAGISRS 107


>gnl|CDD|198256 cd10393, SH2_RIN1, Src homology 2 (SH2) domain found in Ras and Rab
           interactor 1 (RIN1)-like proteins.  RIN1, a member of
           the RIN (AKA Ras interaction/interference) family, have
           multifunctional domains including SH2 and proline-rich
           (PR) domains in the N-terminal region, and RIN-family
           homology (RH), VPS9 and Ras-association (RA) domains in
           the C-terminal region. RIN proteins function as
           Rab5-GEFs. Previous studies showed that RIN1 interacts
           with EGF receptors via its SH2 domain and regulates
           trafficking and degradation of EGF receptors via its
           interaction with STAM, indicating a vital role for RIN1
           in regulating endosomal trafficking of receptor tyrosine
           kinases (RTKs). RIN1 was first identified as a
           Ras-binding protein that suppresses the activated RAS2
           allele in S. cerevisiae. RIN1 binds to the activated Ras
           through its carboxyl-terminal domain and this
           Ras-binding domain also binds to 14-3-3 proteins as
           Raf-1 does. The SH2 domain of RIN1 are thought to
           interact with the phosphotyrosine-containing proteins,
           but the physiological partners for this domain are
           unknown. The proline-rich domain in RIN1 is similar to
           the consensus SH3 binding regions. In general SH2
           domains are involved in signal transduction. They
           typically bind pTyr-containing ligands via two surface
           pockets, a pTyr and hydrophobic binding pocket, allowing
           proteins with SH2 domains to localize to tyrosine
           phosphorylated sites.
          Length = 101

 Score = 29.1 bits (65), Expect = 2.2
 Identities = 20/68 (29%), Positives = 30/68 (44%), Gaps = 7/68 (10%)

Query: 255 ILQKGKNGSFLVRESQSKPGDFVLSVRTDDK-----VTHVMIRCQAEKYDVGGGE-QFDS 308
           +L+    G+FLVR+S ++     L VR  +      V+   I+       + G E  F  
Sbjct: 25  VLRTEPPGTFLVRKSNTRQCQ-ALCVRLPEASGPSFVSSHYIQESPGGVSLEGSELTFPD 83

Query: 309 LTQLIEHY 316
           L QLI  Y
Sbjct: 84  LVQLICAY 91


>gnl|CDD|236830 PRK11049, PRK11049, D-alanine/D-serine/glycine permease;
           Provisional.
          Length = 469

 Score = 30.9 bits (70), Expect = 2.2
 Identities = 13/34 (38%), Positives = 18/34 (52%), Gaps = 2/34 (5%)

Query: 30  DISLSFPGPWTKYFMPYTYLLIWL--GLADLFLI 61
           D +    GPW  YF  +TY   W+  G+AD+  I
Sbjct: 88  DFASDLLGPWAGYFTGWTYWFCWVVTGIADVVAI 121


>gnl|CDD|217940 pfam04177, TAP42, TAP42-like family.  The TOR signalling pathway
           activates a cell-growth program in response to
           nutrients. TIP41 (pfam04176) interacts with TAP42 and
           negatively regulates the TOR signaling pathway.
          Length = 335

 Score = 30.7 bits (70), Expect = 2.5
 Identities = 19/71 (26%), Positives = 33/71 (46%), Gaps = 10/71 (14%)

Query: 190 YLAVQHYIQTLSQRLIEE---QKSIQLGREYTN---IRCDCYDLYGGEKFATLSELVQFY 243
           YL + +Y+  L+QRLI      K ++  ++Y      R D Y+L   E    L +L++ Y
Sbjct: 66  YLLLPYYLGELTQRLINNSDRLKILEAAKQYLKDFLSRLDDYELLDKE----LKKLLERY 121

Query: 244 MENQGKEAEQL 254
                  + +L
Sbjct: 122 ESASESSSLEL 132


>gnl|CDD|240399 PTZ00393, PTZ00393, protein tyrosine phosphatase; Provisional.
          Length = 241

 Score = 29.9 bits (67), Expect = 3.7
 Identities = 12/27 (44%), Positives = 15/27 (55%)

Query: 103 IKKHGPVVVHCSAGIGRTGTFIVIDMI 129
           IK +  V VHC AG+GR      I +I
Sbjct: 167 IKNNRAVAVHCVAGLGRAPVLASIVLI 193


>gnl|CDD|185524 PTZ00242, PTZ00242, protein tyrosine phosphatase; Provisional.
          Length = 166

 Score = 28.8 bits (65), Expect = 4.9
 Identities = 10/36 (27%), Positives = 17/36 (47%), Gaps = 5/36 (13%)

Query: 99  ILDQIKKH-----GPVVVHCSAGIGRTGTFIVIDMI 129
           +LDQ           + VHC AG+GR    + + ++
Sbjct: 86  LLDQEFAKQSTPPETIAVHCVAGLGRAPILVALALV 121


>gnl|CDD|129843 TIGR00760, araD, L-ribulose-5-phosphate 4-epimerase.  E. coli has
           two genes, sgaE and sgbE (YiaS), that are very close
           homologs of araD, the established L-ribulose-5-phosphate
           4-epimerase of E. coli. SgbE, part of an operon for
           L-xylulose metabolism, also has L-ribulose-5-phosphate
           4-epimerase activity; L-xylulose-5-phosphate may be
           converted into L-ribulose-5-phosphate by another product
           of that operon. The homolog to this family from
           Mycobacterium smegmatis is flanked by putative araB and
           araA genes, consistent with it also being araD [Energy
           metabolism, Sugars].
          Length = 231

 Score = 29.4 bits (66), Expect = 5.1
 Identities = 10/32 (31%), Positives = 21/32 (65%), Gaps = 2/32 (6%)

Query: 155 LKPSTNSSTSLFSITYKPYPNVSGMVQTEAQY 186
            KPS+++ T L    Y+ +P++ G+V T +++
Sbjct: 71  KKPSSDTPTHLA--LYRAFPSIGGIVHTHSRH 100


>gnl|CDD|233947 TIGR02600, Verru_Chthon_A, Verru_Chthon cassette protein A.  In
            Verrucomicrobium spinosum and Chthoniobacter flavus, a
            four-gene operon that includes proteins with an
            N-terminal signal sequence for cleavage and methylation
            recurs many times. Each operon is likely to encode a
            membrane complex, the function of which is unknown. This
            model represents a long protein from this putative
            membrame complex, with members averaging about 1300 amino
            acids. The N-terminal region includes an apparent signal
            sequence. The function is unknown. Most cassettes are
            adjacent to an unusually large protein with both an outer
            membrane autotransporter region and PEP-CTERM putative
            protein-sorting motif [Cell envelope, Surface
            structures].
          Length = 1265

 Score = 29.8 bits (67), Expect = 5.5
 Identities = 15/39 (38%), Positives = 19/39 (48%)

Query: 338  TRITVSNIHDRVTELQKENSSKAGFWEEFESLQQQESRH 376
            TR  V  +H RV  L+K  S+ A  W+E   L   E R 
Sbjct: 1182 TRSNVFTVHFRVQSLKKARSTDADEWDEDRDLVTSEYRG 1220


>gnl|CDD|216123 pfam00793, DAHP_synth_1, DAHP synthetase I family.  Members of this
           family catalyze the first step in aromatic amino acid
           biosynthesis from chorismate. E-coli has three related
           synthetases, which are inhibited by different aromatic
           amino acids. This family also includes KDSA which has
           very similar catalytic activity but is involved in the
           first step of liposaccharide biosynthesis.
          Length = 271

 Score = 29.2 bits (66), Expect = 6.8
 Identities = 17/71 (23%), Positives = 26/71 (36%), Gaps = 9/71 (12%)

Query: 72  YSISAGPVVVHCSAGI--GRTGTFIVIDM----ILDQIKKHGPVVVHCSAGIGRTG---T 122
             +   P  + C  GI  G     + +D+    IL +   H PV+V  S   GR      
Sbjct: 154 LFLGNTPGNILCERGIRGGYGPNRLTLDVSAVPILKEETGHLPVMVDPSHSNGRKDGGRQ 213

Query: 123 FIVIDMILDQI 133
            +V  +    I
Sbjct: 214 PLVPPLARAAI 224


>gnl|CDD|223318 COG0240, GpsA, Glycerol-3-phosphate dehydrogenase [Energy
           production and conversion].
          Length = 329

 Score = 29.1 bits (66), Expect = 7.8
 Identities = 6/44 (13%), Positives = 21/44 (47%), Gaps = 1/44 (2%)

Query: 68  TNMKYSISAGPVVVHCSAGIGRTGTFIVIDMILDQIKKHGPVVV 111
             +K  +    ++V  + G+      ++ ++I +++  + P+ V
Sbjct: 89  RQLKPLLLKDAIIVSATKGLEPETGRLLSEIIEEELPDN-PIAV 131


  Database: CDD.v3.10
    Posted date:  Mar 20, 2013  7:55 AM
  Number of letters in database: 10,937,602
  Number of sequences in database:  44,354
  
Lambda     K      H
   0.320    0.136    0.413 

Gapped
Lambda     K      H
   0.267   0.0705    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 30,956,762
Number of extensions: 3004970
Number of successful extensions: 2845
Number of sequences better than 10.0: 1
Number of HSP's gapped: 2766
Number of HSP's successfully gapped: 167
Length of query: 614
Length of database: 10,937,602
Length adjustment: 103
Effective length of query: 511
Effective length of database: 6,369,140
Effective search space: 3254630540
Effective search space used: 3254630540
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 62 (27.7 bits)